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ABSTRACT 
Poly-γ-glutamic acid (γ-PGA) is a naturally occurring biopolymer made up of repeating units 
of glutamic acid and can be potentially used for multiple applications. This study compared 
the production of γ-PGA by eight bacteria (B. subtilis 23856, B. subtilis 23857, B. subtilis 
23858 B. subtilis 23859, B. subtilis natto, B. licheniformis 1525, B. licheniformis 6816 and B. 
licheniformis 9945a) in GS and E media. B. subtilis natto and B. licheniformis 9945a have 
been investigated extensively for γ-PGA production, however, the remaining six have not 
previously been used. Using the eight bacteria, yields of up to 22.3 g/l were achieved in shake 
flasks. On characterization, it was observed that γ-PGA with different properties 
(crystallinity, acid/salt form and molecular weights ranging from 3,000 Da to 871,000 Da) 
was produced. Production of γ-PGA by B. subtilis natto in GS medium was scaled up using a 
fermenter and was tested for novel probiotic applications. The survival of probiotics during 
freeze drying, storage and ingestion was improved by combining them with a γ-PGA matrix. 
For L. paracasei, 10% γ-PGA protected the cells significantly better (P < 0.05) than 10% 
sucrose during freeze drying, whereas for B. longum and B. breve, it showed comparable 
cryoprotectant activity (P > 0.05) to 10% sucrose. This study also demonstrated the potential 
use of a non-dairy foodstuff (orange juice) for delivery of probiotics. Two Bifidobacteria 
strains protected with γ-PGA survived significantly better (P < 0.05) in orange juice for 39 
days, with a log reduction in viability of less than 2.99 CFU/ml, when compared to 
unprotected cells, which showed complete loss in viability by day 20. In addition, γ-PGA 
protection improved survival of Bifidobacteria in a solution mimicking the environment of 
the stomach. γ-PGA-protected Bifidobacteria showed little (< 0.47 log CFU/ml) or no loss in 
viability when stored in simulated gastric juice (pH 2.0) for four hours, whereas unprotected 
cells died within two hours. 
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1. INTRODUCTION – POLY-γ-GLUTAMIC ACID 
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1.1 INTRODUCTION TO γ-PGA 
Polyglutamic acid (PGA) is a biodegradable, non-immunogenic and anionic homopolyamide 
that is made up of D and L glutamic acid units (Shih and Van, 2001). 
 
                                                         
Fig 1.1: a) Structure of α-PGA where individual glutamic acid residues are connected to each other by 
amide linkages between α-amino and α-carboxylic acid groups b) Structure of γ-PGA where individual 
glutamic acid residues are connected to each other by amide linkages between α-amino and γ-carboxylic 
acid groups. (Buescher and Margaritis, 2007) 
 
It is protein-like, but while proteins have more than one type and a fixed number of amino 
acids, PGA is made up of only glutamic acid residues and does not have a fixed molecular 
weight (Shi et al., 2007). PGA can be differentiated into 2 isoforms – poly-α-glutamic acid 
(α-PGA) and poly-γ-glutamic acid (γ-PGA) - depending on the attachment of the amino 
group to the carboxyl group (Fig 1.1). α-PGA is synthesized chemically by nucleophile 
initiated polymerization of the γ-protected N-carboxyanhydride of L-glutamic acid (Buescher 
and Margaritis, 2007). Microbial production of α-PGA is difficult and the polymer can only 
be produced by recombinant technology (Buescher and Margaritis, 2007). γ- PGA has been 
produced extensively using bacteria, especially those of Bacillus sp. It is different from other 
proteins, because inside the cell, glutamate is polymerized via the γ-amide linkages, and thus 
is synthesized in a ribosome independent manner (Bodnár et al., 2008; Akagi et al., 2007). 
Hence, substances that can inhibit translation of proteins, such as chloramphenicol, have no 
effect on the production of γ-PGA. Due to the γ-linkage of its component glutamate residues, 
a) b) 
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γ-PGA is resistant to α-proteases, since α-proteases cleave α-amino linkages (Candela and 
Fouet, 2006).  
 
In their review paper on PGA, Buescher and Margaritis (2007) have pointed out that α-PGA 
and γ-PGA have sometimes been confused with each other (Buescher and Margaritis, 2007). 
Section 1 provides a brief updated review on the production, properties, mechanism of 
synthesis and applications of microbially produced γ-PGA. 
 
1.2 PRESENCE OF γ-PGA IN NATURE 
Some of the natural sources of γ-PGA can be seen in Fig 1.2. γ-PGA was first discovered by 
Ivonovics and co-workers in 1937 when the capsule of Bacillus anthracis was released into 
the medium upon autoclaving or upon aging and autolysis of the cells (Shih and Van, 2001). 
Another naturally occurring source of γ-PGA is the mucilage of natto and chungkookjang, 
traditional foods in Japan and Korea respectively, that contain soybeans fermented with 
Bacillus subtilis natto and Bacillus subtilis subsp. chungkookjang (Shih and Van, 2001; 
Candela and Fouet, 2006; Park et al., 2005). γ-PGA is produced by some Gram-positive 
bacteria (such as B. subtilis and B. licheniformis), some archaea and some eukaryotes 
(Weber, 1990; Hezayen et al., 2001). No Gram-negative bacteria were known to produce the 
polymer, until the work done by Candela et al. (2009), which demonstrated that 
Fusobacterium nucleatum produces γ-PGA (Candela et al., 2009). Efforts have been made to 
insert the genes responsible for γ-PGA production into E. coli and plants such as tobacco, to 
gain more knowledge regarding the molecular mechanism for γ-PGA production as well as 
increase yield while reducing cost of production (Ashiuchi et al., 1999; Tarui et al., 2005). γ-
PGA has also been found covalently linked to tubulin in neurons of mice (Edde et al., 1990).  
 
 
17 
 
  
 
 
 
 
 
 
 
 
 
 
Fig 1.2: Some examples of γ-PGA in nature 
 
1.3 FUNCTION OF γ-PGA 
The function of γ-PGA depends on the organism producing it and the environment the 
organism inhabits. For instance, presence of γ-PGA has been shown in neurons of mice 
where it is thought to play a role in the regulation of microtubule dynamics by modifying the 
interaction of tubulin with tubulin-associated proteins and calcium
 
(Edde et al., 1990). 
Cnidaria are also known to produce γ-PGA. These animals have nematocysts (stinging cells) 
which are used for prey capture, for locomotion and for protection by an explosion 
mechanism. Large amounts of γ-PGA help to trigger this explosion by creating an osmotic 
pressure (Weber, 1990). In other organisms producing γ-PGA, the function depends on 
whether it is membrane bound or released into the environment.  
 
 
 
               B. anthracis                    
(Produces membrane-bound γ-PGA) 
              Hydra               
(Present in nematocysts) 
                 B. subtilis                        
(Produces γ-PGA extracellularly) 
           Mice              
(Present in neurons) 
           Natto            
(Japanese food item) 
               B. licheniformis                 
(Produces γ-PGA extracellularly) 
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1.3.1 Membrane bound γ-PGA 
If γ-PGA is membrane bound, it may act as a source of glutamate when bacteria are starved 
in late stationary phase (Kocianova et al., 2005; Kimura et al., 2004b). Glutamate is a source 
of nitrogen and can also be used for conversion into other amino acids and Krebs cycle 
intermediates. In addition, it has been shown that the capsules of virulent strains of B. 
anthracis contain solely γ-D-PGA (Tomcsik and Szongott, 1933 in Candela and Fouet, 
2006). The D enantiomer in B. anthracis capsule makes the bacterium non-immunogenic 
(Zwartouw and Smith, 1956). The γ-PGA protects the bacterial cells against phage infections 
and also prevents antibodies from gaining access to the bacterium (Mesnage, 1998). 
Likewise, Staphylococcus epidermidis also synthesize surface associated γ-PGA (Kocianova 
et al., 2005). The γ-PGA protects Staphylococcus epidermidis against antimicrobial peptides 
(Kocianova et al., 2005). In both cases, γ-PGA helps the bacteria to escape phagocytosis, 
hence contributing to virulence. In addition, since γ-PGA has non-peptide bonds, it is not 
cleaved by common proteases. This provides protection to cells producing the polymer from 
various cell extracellular enzymes that cleave cell wall associated proteins (Kaplan, 1998). 
 
1.3.2 Released γ-PGA 
Unlike B. anthracis, some of the soil bacteria release γ-PGA into the environment after 
production, where it can help them survive adverse conditions (McLean et al., 1990; Kimura 
et al., 2004b). Bacteria use the released γ-PGA for the sequestration of toxic metal ions, 
increasing their resistance to challenging environments (McLean et al., 1990). Planococcus 
halophilus, Sporosarcina halophila and Natrialba aegyptiaca specifically use γ-PGA to 
decrease high local salt concentrations (Hezayen et al., 2001; Kandler et al., 1983). It is 
thought that some bacteria such as B. licheniformis produce extracellular γ-PGA as an 
alternative to sporulation for cell survival (Kaplan, 1998).  
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1.4 MECHANISM OF γ-PGA PRODUCTION  
One of the major challenges of making γ-PGA usage applicable in industry is reducing the 
cost of its production. It has been estimated that the cost of using γ-PGA is several tens to 
hundred fold more expensive than the conventional materials it could replace (Sung et al., 
2005). Reducing the cost of production is the only foreseeable solution to this problem. 
Designing mass production systems for γ-PGA would be a major step towards a potential 
solution. To achieve this, the knowledge of how different factors affect the yield of 
production needs to be obtained. Information about genes and enzymes involved in γ-PGA 
production would certainly help in manipulating organisms for more efficient production of 
γ-PGA. Also, γ-PGA production in bacteria can change unexpectedly, even if strict 
conditions are maintained (Bajaj and Singhal, 2011). Therefore, it becomes all the more 
important to identify the factors involved in γ-PGA production on a molecular level and 
assess factors affecting its production. 
 
Many researchers have investigated the genetics of γ-PGA in the last decade (Sung et al., 
2005; Buescher and Margaritis, 2007; Candela and Fouet, 2006; Ashiuchi and Misono, 2002) 
and genes that play a role in every step of γ-PGA production have been identified. Therefore, 
a brief understanding of the current probable aspects of the mechanism of γ-PGA synthesis is 
provided in this section. 
 
The process of γ-PGA production can be seen to have 4 distinct branches – γ-PGA 
racemisation, γ-PGA polymerization, γ-PGA degradation and γ-PGA regulation.  Each of 
these are discussed in the sections below. 
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1.4.1 γ-PGA racemisation  
γ-PGA can be composed of only L, or only D, or a mixture of both L and D enantiomers of 
glutamic acid in varying amounts, depending on the bacterial strain producing it and the 
culture medium used for its production. Incorporation of D-glutamic acid into the growing 
chain of γ-PGA requires racemization of L-glutamic acid, which is either exogenously 
supplied or produced de novo by the bacterium (Shih and Van, 2001). 
 
For B. subtilis, the genes responsible for coding the enzymes involved in racemisation are glr 
and yrpC (Ashiuchi and Misono, 2002; Buescher and Margaritis, 2007). Glr is a cytosolic 
enzyme with a high selectivity for glutamic acid and a preference for L-glutamic acid 
(Thorne et al., 1955; Buescher and Margaritis, 2007). It was also shown that Glr formed D-
glutamic acid only when the cells were grown on complex medium whereas YrpC was found 
to be active when the cells were grown on minimal medium (Kimura et al., 2004a). In B. 
anthracis, B. subtilis, B. licheniformis and S. epidermidis, the chromosomal positions of glr 
and yrpC are a long distance (500 kB) from the glutamic acid synthesis genes. Hence, it 
seems unlikely that genes responsible for racemisation would be involved in γ-PGA synthesis 
(Buescher and Margaritis, 2007). Research has shown that Mn
2+ 
affects the enantiomeric 
composition of γ-PGA (Cromwick and Gross, 1995a; Cromwick and Gross, 1995b; Perez-
Camero et al., 1999; Wu et al., 2006) and it has been shown that Mn
2+
 affected the 
enantiomeric composition by altering the expression of the glr gene (Ashiuchi et al., 2004). 
 
A mechanism for racemization of L-glutamic acid to D-glutamic acid has been proposed by 
multiple researchers (Ho et al., 2006a; Shih and Van, 2001). A diagrammatic representation 
of this mechanism can be seen in Fig 1.3. The enzyme L-glutamic acid : pyruvic acid 
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aminotransferase catalyzes the conversion of L-glutamic acid to L-alanine (1). L-alanine is 
then racemized into D-alanine using alanine racemase (2). D-alanine is then converted to D-
glutamic acid using the enzyme D-glutamic acid : pyruvic acid aminotransferase (3). The L-
glutamic acid and D-glutamic acid are then incorporated into the growing γ-PGA chain. 
 
Fig 1.3: Conversion of L-glutamic acid to D-glutamic acid during synthesis of γ-PGA (Shih and Van, 
2001) 
 
Bacteria producing D-rich γ-PGA, such as B. anthracis, demonstrate a high D-amino acid 
aminotransferase activity. D-amino acid transferase is thought to be functionally insignificant 
in synthesis of γ-PGA from B. subtilis. 
 
1.4.2 γ-PGA polymerization 
In the case of B. anthracis, the genes involved in γ-PGA synthesis lie on a large plasmid, 
whilst in other Bacillus species, the genes are present on the chromosome (Shih and Van, 
2001; Ashiuchi et al., 2001). 
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When γ-PGA is surface associated or anchored (as in the case of B. anthracis), the ―cap‖ 
(capsule) genes are required for its production. On the other hand, for γ-PGA that is released, 
the ―pgs‖ (polyglutamate synthase) genes come into action (Candela and Fouet, 2006). Both 
the cap and pgs gene sets have at least 4 genes, designated the cap (or pgs) B, C, A and E (Fig 
1.4). The pgsBCA genes of B. subtilis IFO3336 (B. natto) are homologous to capBCA genes 
of B. anthracis (Makino et al., 1989; Shih and Van, 2001). The unique membrane bound 
PgsBCA complex in B. subtilis is highly unstable and hydrophobic which makes isolation of 
this complex challenging (Shih and Van, 2001). However, attempts have been made to 
understand its importance on γ-PGA production (Ashiuchi et al., 1999; Sung et al., 2005). 
 
Fig 1.4: The genetic setup required for γ-PGA synthesis when it is anchored (B. anthracis) and when it is 
released (B. subtilis and B. licheniformis) (Candela and Fouet, 2006). 
 
pgsBCA has been identified as the sole machinery responsible for γ-PGA synthesis in 
Bacillus subtilis, when it was shown that pgsBCA null mutants produced by disruption of 
pgsBCA genes in B. subtilis (chungkookjang) were incapable of γ-PGA production (Sung et 
al., 2005). They showed that, even if one of the genes is absent, γ-PGA production is 
impossible. In contrast, Urushibata et al. (2002) are of the opinion that only pgsB and pgsC 
are required for the production of γ-PGA (Urushibata et al., 2002a). These authors also found 
that strains that have pgsBCA, but which do not produce γ-PGA, do so because the genes are 
not translated, not because an inactive gene product is produced (Urushibata et al., 2002b). 
Candela et al. (2005) showed that CapE (a 47 amino acid peptide) is also responsible and 
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essential for the production of γ-PGA (Candela et al., 2005) as it appeared to interact with 
CapA. 
 
The mechanism of polymerisation is shown to be dependent on ATP (Fig 1.5). The proposed 
reaction mechanism for γ-PGA synthesis (Sung et al., 2005) is as follows: firstly, a terminal 
carboxyl group of the growing γ-PGA chain acts as an acceptor for phosphoryl group transfer 
from the gamma phosphate of ATP. Secondly, the amino group of glutamic acid acts as a 
donor for nucleophilic attack on the phosphorylated carboxyl group, resulting in the 
formation of an amide linkage and a γ-PGA chain elongated by one glutamic acid residue. 
This reaction continues to polymerize γ-PGA at the active site of the synthetase complex 
(PgsBCA).  
 
 
Fig 1.5: Reaction showing the dependence of γ-PGA polymerization on ATP (Sung et al., 2005).  
 
 
PgsB and PgsC together form the catalytic site whereas PgsA is involved in the removal of 
the elongated chain from the active site so that the next glutamic acid monomer can be added. 
Activity of PgsBCA is dependent on Mg
2+
 (Buescher and Margaritis, 2007). Transportation 
of γ-PGA outside the cell can be facilitated by a less compact cell membrane with shorter 
phospholipids (Buescher and Margaritis, 2007). γ-PGA can be anchored to the bacterial 
surface or released (Fig 1.6). CapD, a γ-glutamyl-transpeptidase, catalyses the anchorage of 
γ-PGA to peptidoglycan in B. anthracis (Candela and Fouet, 2006). On the other hand, PgsS 
is a hydrolase that catalyses the release of γ-PGA. The location of PgsS has not yet been 
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determined, but is assumed to be present on the surface of the cells (Candela and Fouet, 
2006). 
 
 
Fig 1.6: Schematic representation of γ-PGA synthesis membrane-anchored complex. A: γ-PGA is 
anchored covalently to the peptidoglycan in B. anthracis via CapD. B: γ-PGA is released in B. subtilis and 
B. licheniformis via PgsS. “?” represents lack of location certainty (Candela and Fouet, 2006). 
 
A full biosynthetic pathway for the production of γ-PGA has been proposed (Fig 1.7). 
Synthesis of γ-PGA is thought to be a two-step process. The first step involves the production 
of L-glutamic acid and D-glutamic acid which is followed by polymerization of these 
glutamic acid residues to form γ-PGA (Bajaj and Singhal, 2009a). L-glutamic acid units that 
make up γ-PGA can be derived from two sources. It can either be obtained exogenously or 
endogenously via the glutamic acid biosynthetic pathway. Endogenous production of L-
glutamic acid requires conversion of a carbon source via acetyl-CoA and TCA cycle 
intermediates. α-ketoglutaric acid from the TCA cycle serves as a direct precursor of 
glutamic acid synthesis (Ko and Gross, 1998; Rehm, 2009). Exogenous L-glutamic acid can 
be converted to L-glutamine with the help of the enzyme glutamine synthetase. L-glutamine 
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can be a precursor of γ-PGA because it can be involved in amino group transfer to α-
ketoglutaric acid, forming two molecules of L-glutamic acid from one L-glutamine and one 
α-ketoglutaric acid molecule. These reactions are catalysed by L-glutamine synthetase and 
glutamine-2-oxoglutarate aminotransferase (Bajaj and Singhal, 2009a). When glutamine is 
not available, inorganic ammonia and α-ketoglutaric acid are used for L-glutamic acid 
production, involving the enzyme L-glutamic acid dehydrogenase (Bajaj and Singhal, 2009a). 
L-aspartic acid and α-ketoglutaric acid can also be converted to oxaloacetic acid and L-
glutamic acid using L-aspartic acid aminotransferase. In addition, exogenous amino acids that 
belong to the glutamic acid family, such as L-arginine and L-proline can be imported into the 
cell and converted to L-glutamic acid, which can then be incorporated into the growing γ-
PGA chain (Ashiuchi, 2010). 
 
 
Fig 1.7: A proposed pathway for the synthesis of γ-PGA in Bacilli. TCA = Tricarboxylic acid cycle (Ho et 
al., 2006a). 
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1.4.3 γ-PGA degradation 
Two enzymes (endo-γ-glutamyl peptidase and exo-γ-glutamyl peptidase) have been shown to 
be associated with degradation of γ-PGA in vivo. The endo-γ-glutamyl peptidase coding 
genes – ywtD, dep or pgdS – are located downstream from and in the same orientation as the 
pgsBCA operon (Ashiuchi et al., 2003; Buescher and Margaritis, 2007; Suzuki and Tahara, 
2003). The exo-γ-glutamyl peptidase genes – ggt or capD are located some distance away 
from the pgsBCA complex in most Bacilli (Uchida et al., 1993). However, in the case of B. 
anthracis, they are placed directly downstream of the pgsBCA complex. Recently, Yao et al. 
(2009) investigated the presence and activity of γ-PGA depolymerase enzyme in B. subtilis 
NX-2 which is responsible for the depolymerisation of γ-PGA in batch culture (Yao et al., 
2009). The enzyme was seen to be active extracellularly in the culture and was shown to be 
an endo-hydrolase. The gene encoding the enzyme was ywtD. The YwtD protein was 
obtained in purified form after the gene was cloned and expressed in E. coli. The enzyme was 
active between a temperature range of 30-40°C and a pH range of 5-8. At the optimal pH and 
temperature (5 and 30°C respectively), a reduction in the molecular weight of γ-PGA (from 
1000 – 20 kDa) was observed. Polydispersity decreased as a function of depolymerization 
time. The enzyme was also seen to be active extracellularly during the late stationary phase. 
When compared with physical and chemical methods of γ-PGA degradation, enzymatic 
degradation was seen to be a milder technique that reduced the molecular weight of γ-PGA 
with better control and a narrower polydispersity, without disturbing the chemical 
constitution of the polymer (Yao et al., 2009).  
 
1.4.4 γ-PGA regulation 
It was found that ComPA, DegSU and DegQ regulate γ-PGA production at the transcriptional 
level in response to quorum sensing, osmolarity and phase variation signals (Stanley and 
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Lazazzera, 2005). The ComPA system activates transcription of the pgsBCA operon at high 
cell density. DegSU activates transcription of pgsBCA in response to an increase in 
osmolarity. DegQ also regulates transcription of pgsBCA in an unknown fashion. SwrA 
regulates γ-PGA production post-transcriptionally, again, in an unknown manner (Stanley 
and Lazazzera, 2005). 
 
1.5 CONFORMATION & ENANTIOMERIC STATES OF γ-PGA 
 
1.5.1 Conformation of γ-PGA 
Knowledge of the conformational state of γ-PGA is essential when it is used in medical/food 
applications since it is known that a small change in environmental conditions can change the 
properties of γ-PGA to a large extent. Depending on the environmental conditions, five 
different γ-PGA conformations – alpha helix, beta sheet, helix to random coil transition, 
random coil and enveloped aggregate – have been observed (Ho et al., 2006a). The 
conformational state of γ-PGA can change depending on a number of factors. For instance, it 
has been shown that γ-PGA purified from B. licheniformis can exist in different 
conformational states depending on the concentration of γ-PGA and the pH of the solution 
(He et al., 2000). At low concentration (0.1% w/v) and when the pH is below 7.0, γ-PGA 
adopts a conformation based largely on α-helices, whereas a β-sheet-based conformation 
predominates at higher pH. The β-sheet conformation seems to expose the negative charges 
of γ-PGA most efficiently. γ-PGA conformation is also sensitive to small changes in specific 
factors. For example, changes in PGA side-chain ionisation can have a pronounced effect on 
the conformation (Tiffany and Krimm, 1969; Shih and Van, 2001). A small amount of 
sodium chloride has also been shown to switch the preferred conformation of poly-L-
glutamate from an extended conformation to a compact α-helix (Fedorov et al., 2009). 
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1.5.2 Enantiomeric state of γ-PGA 
In addition to conformation of γ-PGA, culture conditions also seem to have an  impact on the 
enantiomeric composition of γ-PGA, which can alter its properties (Rehm, 2009). The 
enantiomeric composition of γ-PGA determines how γ-PGA is extracted after fermentation. If 
γ-PGA contains only L or D enantiomers, it is soluble in ethanol. However, if the 
enantiomers are mixed in equimolar amounts, then γ-PGA precipitates in ethanol (Candela 
and Fouet, 2006). As mentioned earlier (see section 1.4.1), the D and L isomer composition 
depend on a racemisation reaction, which is dependent on divalent cations (Leonard et al., 
1958). As discussed previously, Mn
2+
 affects the expression of the genes that code for 
enzymes responsible for racemisation reaction (Ashiuchi et al., 2004).  Other researchers 
have also confirmed that the enantiomeric composition of γ-PGA is dependent on Mn2+ in 
both B. licheniformis and B. subtilis (Wu et al., 2006; Cromwick and Gross, 1995a). The ratio 
between L and D-glutamate in γ-PGA produced by B. licheniformis also depends on the 
concentration of Co
2+
 and Zn
2+ 
(Cromwick and Gross, 1995a). 
 
Optimization to determine the effect of the enantiomeric composition of γ-PGA on its 
behaviour and efficacy for a specific application is necessary. When γ-PGA with different 
enantiomeric composition was tested for its antifreeze properties, it was seen that the 
antifreeze activity of γ-PGA was not affected by its enantiomeric composition, but only by its 
molecular weight (Shih et al., 2003). The antifreeze property was also seen to be affected by 
the concentration of cations in the order of Mg
2+
>>Ca
2+
Na
+
>>K
+
. The effect of different 
enantiomeric composition of γ-PGA on other applications should also be identified.  
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1.6 PRODUCTION OF γ-PGA BY MICROBIAL FERMENTATION 
Much research has gone into the production of γ-PGA from bacterial fermentation. γ-PGA 
producing bacteria usually produce and secrete the polymer into the medium in the late 
logarithmic and stationary phase of growth. 
 
The most common genus used for producing γ-PGA is Bacillus and various strains of B. 
licheniformis and B. subtilis have been exploited for this purpose. It was Bovarnick in 1942 
who first showed that γ-PGA is freely secreted into the medium after fermentation of B. 
subtilis (Bovarnick, 1942). After this, many researchers identified that B. licheniformis and B. 
subtilis secrete most of the product into the medium, which makes the recovery of the 
polymer relatively simple (Cheng et al., 1989; Goto and Kunioka, 1992; Thorne et al., 1954). 
The optimal nutrients that various bacteria can utilise to produce γ-PGA have been 
thoroughly investigated (Bajaj et al., 2008; Cromwick et al., 1996; Du et al., 2005; Feng et 
al., 2007; Huang et al., 2011; Kazuki et al., 2007; Kedia et al., 2010; Ko and Gross, 1998; 
Wu et al., 2010b; Xu et al., 2005a; Yamashiro et al., 2011).  
 
Bacteria can produce γ-PGA with different properties, such as molecular weight and 
enantiomeric composition (Bajaj and Singhal, 2011; Buescher and Margaritis, 2007; Shih and 
Van, 2001; Sung et al., 2005). γ-PGA can also be produced in its pure acid form or as a salt 
of the polymer (Fig 1.8) and it can be crystalline or amorphous (Ho et al., 2006a). These 
properties can determine the application for which γ-PGA is used. The medium composition 
is one of the factors that can influence the properties of γ-PGA and can be used to control 
them (Bajaj and Singhal, 2011; Shih and Van, 2001).  
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Fig 1.8: Structure of a) Na salt of γ-PGA b) Acid form of γ-PGA (Sung et al., 2005).   
 
Hence, the medium used to produce γ-PGA by various bacteria is crucial because it directly 
affects the properties of γ-PGA. The nutrient requirements and growth conditions vary with 
the bacterial strain used for production. Some of the factors affecting γ-PGA production in 
different bacteria have been enumerated in the following sections.  
 
1.6.1 Effect of carbon and nitrogen source on γ-PGA production 
Choosing the appropriate C source that can be utilized by bacteria can help produce γ-PGA 
efficiently. An interesting study has been done to understand the effect of different carbon 
sources (glucose and glycerol) on the yield, cell growth and molecular weight of γ-PGA 
produced from B. licheniformis (Ko and Gross, 1998). It was seen that glucose was consumed 
much quicker and the cell growth was better with glucose as the carbon source. However, the 
yield increased considerably (from 5.7 to 20.5 g/L) when a combination of glycerol and 
glucose was used rather than glucose on its own, although glucose was still consumed much 
quicker than glycerol. The actual mechanism by which glycerol causes an increase in the 
yield of γ-PGA was a mystery until the work done by Du and co-workers (2005), where the 
a) b) 
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effect of glycerol on γ-PGA production with a mutant strain of B. licheniformis ATCC 9945A 
(also called B. licheniformis WBL-3) was studied (Du et al., 2005). It was seen that the yield 
of γ-PGA increased from 9.7 to 16.7 g/l as the concentration of glycerol was increased in the 
medium from 0 to 70 g/l. Above this concentration the yield of γ-PGA started decreasing. 
The reason for the increase in yield was found to be due to a change in the phospholipid 
composition of the cell membrane due to the addition of glycerol, which increased the 
permeability of the cell membrane for γ-PGA. Without the use of glycerol (only citric acid 
and glutamic acid were used in this case), the intracellular concentration of γ-PGA was quite 
high which hampered the synthesis of γ-PGA. The importance of glycerol was highlighted in 
another study, where it was seen that addition of glycerol during production of γ-PGA using 
B. subtilis NX-2 was seen to reduce broth viscosity which resulted in an increase in the 
uptake of other nutrients, which in turn resulted in a higher yield and reduction in molecular 
weight of γ-PGA (Wu et al., 2010a). B. subtilis NX-2 was earlier isolated from soil by Xu et 
al and γ-PGA production was optimized recently to produce 42 g/l of γ-PGA in a fed batch 
culture (Xu et al., 2005a; Yao et al., 2010).  
 
Recently, Yamashiro and co-workers (2011) investigated the effect of different carbon 
sources on the production of γ-PGA using B. subtilis chungkookjang (Yamashiro et al., 
2011). They found that D-glucose and D-fructose were effective for γ-PGA production. 
However, D-galactose and lactose were not as effective. It was also found that pentoses such 
as xylose and arabinose can be utilized effectively for γ-PGA production. This finding is 
useful, as these pentoses are derived from inedible biomasses which could lead to reduction 
in raw material cost for mass production of γ-PGA. In addition, the induction of the pgsE-
gene product using Zn
2+
 as an activator increased the productivity of γ-PGA three fold 
(Yamashiro et al., 2011).  
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For B. subtilis ZJU-7, it was found that glucose was a better C source for cell growth, 
however, more γ-PGA was produced when sucrose was used in the medium (Shi et al., 2006; 
Xu et al., 2005a). Among the nitrogen sources, tryptone was most effective, both in terms of 
cell growth and γ-PGA production. The optimized medium gave a maximum yield of 58.2 g/l 
after 24h of cultivation. This is the highest yield of γ-PGA obtained thus far using B. subtilis 
in submerged fermentation. Chen et al. (2010) demonstrated that replacing tryptone with 
yeast extract paste can make the large scale production of γ-PGA (100 l fermenter) from B. 
subtilis ZJU-7 cost-effective by reducing the cost of nitrogen source needed to produce 1 kg 
of γ-PGA from $161.60 (tryptone) to $1.80 (yeast extract paste) (Chen et al., 2010). The 
highest yield (54 g/l) achieved using yeast extract as the nitrogen source was only slightly 
lower than the yield of γ-PGA produced when tryptone was used as the nitrogen source (58.2 
g/l) (Xu et al., 2005a).  
 
Kedia and co-workers (2010) also investigated the effect of different media on the production 
of γ-PGA in B. subtilis natto (Kedia et al., 2010). Of the media tested (Medium E, C, F and 
GS), GS medium, with sucrose as C source, was most effective for γ-PGA production, 
resulting in the production of 26-28 g/l of γ-PGA after 96 h. When medium C with glucose as 
C source was used to produce γ-PGA, the yields obtained were lower than when GS medium 
with sucrose was used. In fact, when glucose at 80 g/l was used in medium C, the precipitated 
γ-PGA seemed to contain impurities (non-consumed glucose, yeast extract and peptone).  
 
As has been discussed previously (see section 1.4.2), bacteria utilize exogenously provided 
L-glutamic acid for the production of γ-PGA. However, in some instances glutamic acid 
independent γ-PGA production has been shown (Ito et al., 1996). B. subtilis TAM-4 
produced γ-PGA in the presence of ammonium salt and different sugars. On evaluating the 
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effect of C sources on γ-PGA production, it was found that fructose was the best C source. 
Likewise, it was found that ammonium chloride was the best nitrogen source for polymer 
production with this bacterial strain. B. subtilis TAM-4 produced 22.1 g/l of γ-PGA without 
any polysaccharide by-products when grown on 1.8% ammonium chloride and 7.5% fructose 
at 30˚C for 96h (Ito et al., 1996). 
 
1.6.2 Effect of salts on γ-PGA production 
Salts in the medium can also affect properties of the produced γ-PGA, such as molecular 
weight. For instance, when NaCl concentration in the medium was increased from 0% to 4%, 
the molecular weight of the resultant γ-PGA produced by B. licheniformis 9945a increased 
from 1.2 x 10
6
 Da to 2.2 x 10
6
 Da (Birrer et al., 1994). A higher salt concentration in the 
medium used to grow B. megaterium also produced γ-PGA with a higher molecular weight 
(Kazuki et al., 2007). 5% NaCl produced γ-PGA with a molecular weight of 1 x 106 Da, 
whereas 10% NaCl increased the molecular weight to 2 x 10
6 
Da. The salt concentration also 
seemed to affect the enantiomeric composition of γ-PGA. In another study, γ-PGA produced 
by B. subtilis chungkookjang was affected differently by salt concentration in production 
medium (Sung et al., 2005). Interestingly, a high-molecular weight polymer (>2000 KDa) 
was synthesized at low NaCl concentrations (0.5%) whereas a lower molecular weight 
polymer (10-200 KDa) was produced when the NaCl concentration was increased (>10%). 
This is in contrast to the study by Birrer and co-workers (1994) with B. licheniformis, where 
increasing the salt concentration increased the molecular weight (Birrer et al., 1994), thus 
indicating that molecular weight is dependent on both bacteria and medium used for γ-PGA 
production.  
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Ammonium salts could also affect γ-PGA production and cell growth. More specifically, 
ammonium sulphate was seen to be useful for decreasing cell growth, increasing γ-PGA 
productivity and producing a high molecular weight polymer from B. subtilis IFO3335 
without by-product formation (Feng et al., 2007; Goto and Kunioka, 1992; Kaplan, 1998). 
When the ammonium sulphate concentration was increased from 0 to 10 g/l, an increase in γ-
PGA yield from 0.8 to 10 g/l was observed, without any polysaccharide by-product formation 
(Kaplan, 1998). In fact, a high concentration of ammonium sulphate also caused the γ-PGA 
produced by B. subtilis subsp. chungkookjang to be richer in L-glutamate than its D-
enantiomer (Park et al., 2005).  
 
Recently, the effect of CaCl2 was tested on the production of γ-PGA in B. subtilis CGMCC 
2108 (Huang et al., 2011). Addition of CaCl2 reduced broth viscosity and increased 
consumption of extracellular glutamate by 11.4%. It also increased γ-PGA yield from 7.88 g/l 
to 9.07 g/l. It was found that CaCl2 increased activities of the three enzymes involved in γ-
PGA synthesis at the 2-oxoglutarate branch of the TCA cycle (isocitrate dehydrogenase, 
glutamate dehydrogenase and 2-oxoglutarate dehydrogenase complex). Addition of CaCl2 
seemed to ensure that more oxoglutarate was converted into glutamate which could then be 
incorporated into the growing γ-PGA chain. The molecular weight remained unaffected with 
changes in CaCl2 concentration. This is the first report where the effect of Ca
2+
 has been 
shown to affect γ-PGA production. 
 
1.6.3 Effect of pH on γ-PGA production 
The optimum pH of the medium is crucial for γ-PGA production and differs for different 
bacteria. It has been shown that pH 6.5 is optimal for γ-PGA produced by B. licheniformis 
9945a, since citric acid was utilized better at this pH when compared to other pH values 
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(Cromwick et al., 1996). In another study (Richard and Margaritis, 2003b), optimizing the pH 
of B. subtilis IFO3335 fermentation to pH 7 increased the yield of γ-PGA to 23 g/l, which 
was 1.44 times greater than that observed in a different study (Kunioka and Goto, 1994) with 
the same bacteria, where pH was not optimized.  
 
In some cases, a two stage pH shift strategy needs to be employed when the optimal pH for 
growth and γ-PGA production are different. For instance, when γ-PGA production in B. 
subtilis CGMCC 0833 was analysed, it was found that the optimum pH for glutamate 
utilization was 6.5 (Wu et al., 2010b). However, the optimum pH for cell growth was found 
to be pH 7.0. Hence, a two stage pH shift strategy was proposed, where for the first 24 h the 
pH was kept at pH 7.0 for maximum cell growth, following which the pH was lowered to pH 
6.5 for maximum utilization of glutamate. Using the pH shift strategy, glutamate utilization 
was increase from 24.3 to 29.5 g/l and the yield of γ-PGA was increased by 24.8%.  
 
1.6.4 Effect of metabolic precursors on γ-PGA production 
An increase in the yield of γ-PGA has been achieved by addition of small quantities of 
precursors for γ-PGA production (Bajaj and Singhal, 2009a). When B. licheniformis NCIM 
2324 was fed with L-glutamine (0.07 g/l) and α-ketoglutaric acid (1.46 g/l) in addition to the 
basal medium, the γ-PGA yield increased to 35.75 g/l, in contrast to 26.12 g/l when no 
metabolic precursors were added. The added precursors also helped improve consumption of 
L-glutamic acid. In another study using B. subtilis R23, only α-ketoglutaric acid was seen to 
improve γ-PGA yield (Bajaj and Singhal, 2009b) while L-glutamine had no effect on polymer 
yield. Sequential optimization technique caused the yield of γ-PGA to increase from 7.64 to 
25.38 g/l. These studies demonstrate that addition of relatively inexpensive metabolic 
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precursors can lead to a reduced cost in γ-PGA production, since small quantities are 
converted into a high-value multifunctional biopolymer. 
 
1.6.5 Effect of aeration/agitation on γ-PGA production 
γ-PGA production makes the medium viscous, which hampers the mass transfer rate of 
oxygen and nutrients. This makes control and maintenance of aeration and agitation 
extremely crucial for γ-PGA production. When Cromwick et al. (1996) increased the aeration 
from 0.5 l/min to 2.0 l/min and agitation from 250 rpm to 800 rpm during production of γ-
PGA with B. licheniformis, the yield increased significantly from 15 g/l to 23 g/l (Cromwick 
et al., 1996). Other effects included rapid consumption of L-glutamic acid and citric acid and 
a lower molecular weight product. Even though the agitation and aeration was increased, the 
partial pressure of oxygen (pO2) still decreased (to < 1%) by 29 hours. The lower transfer rate 
of oxygen could be due to two reasons. It could either be due to increased viscosity of the 
culture media on γ-PGA production, or because the oxygen demands of the high cell density 
culture could not be sustained by the system.  
 
1.6.6 Effect of Mn
2+
 on γ-PGA production 
As mentioned previously (see section 1.4.1 & 1.5.2), change in concentration of Mn
2+
 can 
have several effects on the production of γ-PGA. Recently, Kedia and co-workers (2010) 
demonstrated the importance of MnSO4 during the growth of B. licheniformis 9945a and 
production of γ-PGA (Kedia et al., 2010). When MnSO4 was absent in the medium, cell 
viability started to decline after 50 h of incubation. Medium containing 2.46 mM MnSO4 
showed no loss in viability after 96 h. Presence of MnSO4 also caused the cells to assimilate 
glycerol, L-glutamic acid and citric acid better as compared to when MnSO4 was absent. In 
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addition, presence of MnSO4 in the medium increased the yield of γ-PGA (13 g/l) as 
compared to when no MnSO4 was used (5 g/l). Hence, MnSO4 can be used appropriately to 
achieve prolonged cell viability, better utilization of nutrients and increased yield of γ-PGA 
production.   
 
Until the work done by Cromwick and Gross (1995a), which finally resolved the debate, 
there was divided opinion regarding Mn
2+ affecting the enantiomeric composition of γ-PGA 
(Cromwick and Gross, 1995a). This study showed that the proportion of L-glutamic acid in γ-
PGA varies inversely with MnSO4 content. When the concentration of MnSO4 was increased 
from zero to 615 μM, the L-glutamic acid repeating units in γ-PGA decreased from 50% to 
10% (Cromwick and Gross, 1995a). Ca
2+ 
did not seem to affect the percentage of D-glutamic 
acid. The effect of Mn
2+
 on γ-PGA was confirmed by another study (Perez-Camero et al., 
1999) where the concentration of Mn
2+
 was found to affect the enantiomeric composition of 
γ-PGA, especially when it was present in low concentrations (≤ 20 μM) in the medium. 
Varying Mn
2+
 from 0 to 1230 μM resulted in polymers ranging between 10 to 90% D-units 
and with molecular weights between 4 x 10
5
 to 2.0 x 10
6
 Da. It has been shown that Mn
2+ 
affected the stereochemical and enantiomeric composition of γ-PGA produced with B. 
subtilis NX-2 as well (Wu et al., 2006). When the concentration of Mn
2+
 varied from 0 to 
0.09 g/L, the proportion of D-glutamate increased from 18 to 77%. Mn
2+
 seemed to affect the 
stereochemical properties of γ-PGA by altering the activity of glutamate racemase (Wu et al., 
2006).  Controlling the enantiomeric composition of γ-PGA could be useful since γ-PGA 
with different D/L compositions could be used for different applications. 
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1.6.7 Effect of cell wall lytic enzymes on γ-PGA production 
Recently, Mitsui and co-workers (2011) were first to report the role of cell wall lytic enzymes 
in γ-PGA production (Mitsui et al., 2011). More specifically, it was seen that Cwl0, a cell 
wall lytic enzyme belonging to a D,L-endopeptidase was found to play an important role in γ-
PGA production and also affected the molecular size of the polymer. Cwl0 was found to be 
the major enzyme responsible for degradation of γ-PGA in B. subtilis natto (Mitsui et al., 
2011). Disruption of the cwl0 gene increased the yield of γ-PGA produced while producing a 
higher molecular weight polymer.  
 
Some interesting examples of γ-PGA production are summarized in Table 1.1 below. 
Table 1.1: Examples of γ-PGA production in different organisms 
Organism Comments References 
 
B. subtilis  
chungkookjang 
 
Produces super-high-molecular-weight γ-PGA - 2 x 106 Da without the 
formation of any by products. Promising for various industrial applications. 
 
 
(Park et al., 2005) 
B. subtilis  
CCTCC202048 
γ-PGA produced using solid state fermentations. Maximum γ-PGA 
production of 83.61 g kgds-1 was obtained. 
 
(Jian et al., 2005) 
B. licheniformis  
NCIM 2324  
γ-PGA produced using solid state fermentations. Maximum yield of 98.64 g 
kgds-1 was obtained. 
 
(Bajaj et al., 2008) 
B. licheniformis  
strain-R 
γ-PGA production by cells immobilized using an agar-alginate gel beads 
mixture (γ-PGA yield – 36.75 g/l). Luffa pulp-adsorbed cells produced γ-PGA 
yield of 50.4 g/l. First study that uses immobilized cells for γ-PGA 
production. 
 
(Berekaa et al., 2009) 
B. licheniformis S2 Newly isolated strain shown to have ability to reduce ammonium nitrogen 
content in swine manure by converting ammonium into biomass and γ-PGA. 
Bacteria could be used to prevent eutrophication of ground and surface water 
and pollution of atmosphere. 
 
(Hoppensack et al., 2003) 
Bacillus sp. RKY3 Newly isolated strain used for γ-PGA production. Maximum yield of 48.7 g/l 
was achieved using optimized medium in a 3 l volume lab-scale fermenter. 
 
(Jeong et al., 2010; Jung 
et al., 2005) 
B. subtilis NX-2 & 
Corynebacterium  
glutamicum 
Corynebacterium glutamicum  have the ability to produce high levels of 
glutamic acid. Co-culturing bacteria for γ-PGA production eliminated the 
need to add exogenous L-glutamic acid. Reduced fermentation time and 
production cost.  
 
(Xu et al., 2005b) 
B. mesentericus MJMI Bacteria isolated from Korean domestic bean paste. γ-PGA consisted of 2000 
glutamic acid residues. 
 
(Zhao et al., 2005) 
E. coli pgsBCA genes that are responsible for γ-PGA production were cloned and 
expressed in E. coli. Low yields of γ-PGA were obtained (~0.024 g/l) 
 
(Ashiuchi et al., 1999) 
Tobacco leaves γ-PGA production in tobacco leaves was achieved by introducing the pgsBCA 
complex via Agrobacterium infection. 600 µg of γ-PGA per gram of leaf 
material was obtained. 
(Tarui et al., 2005) 
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It is evident that the appropriate carbon and nitrogen source for γ-PGA production would 
depend on the bacteria used for its production. Some bacteria utilize different carbon sources 
for growth and γ-PGA production at different pH. In addition, cost of production could be 
reduced by replacing an expensive nutrient with an inexpensive one which does not change 
the productivity significantly, hence optimization of these nutrients is important before 
industrial production of γ-PGA. 
 
1.7 APPLICATIONS OF γ-PGA 
γ-PGA is an extremely important substance that has been exploited for a wide array of useful 
applications due to its unique properties. It is biodegradable, edible and non-toxic for 
humans, which are prerequisites for the polymer to be used for human benefit. Moreover, γ-
PGA breaks down into its component glutamic acid residues in the body. These can enter 
normal cellular metabolism and the polymer is not excreted by the kidney (Singer, 2005).  
 
1.7.1 Medical applications of γ-PGA 
Previously, α-PGA has been used for medical applications (Hashida et al., 1999; Li et al., 
1998; Zou et al., 2007). However, multiple researchers have shown that using γ-PGA for 
medical applications could be more promising, because it cannot be broken down in the body 
by α-proteases (Hsu and Lin, 2007; Shih and Van, 2001; Ye et al., 2006). Therefore, medical 
applications of γ-PGA have attracted a lot of interest in the last decade and much research has 
been carried out in this area. Some of the more important potential medical applications of γ-
PGA are summarized in Table 1.2. 
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Table 1.2: Potential applications of γ-PGA and its derivatives 
Potential Application Findings/Benefit References 
 
Drug carrier Yield of cis-dichlorodiammineplatinum(II) (CDDP) incorporation into γ-PGA 
was 12.3% better than α-PGA. Higher antitumour activity than CDDP alone, 
while being less toxic than the free drug. Can potentially be used for treatment 
of breast cancer. 
 
Improved sustained delivery of diphenhydramine (DPH) when administered as a 
complex with γ-PGA. Complex was less stable in weak acidic or neutral pH and 
more stable in high acidic pH. γ-PGA was also useful for blocking the bitter 
taste of DPH.  
 
(Ye et al., 2006) 
 
 
 
 
(Agresti et al., 2008) 
Protein carrier Sustained delivery of bone morphogenetic proteins for bone regenerative 
therapy.  
Potential vaccine carrier for systemic and mucosal administration. No cytotoxic 
effect. 
Effective oral delivery of insulin. Intestinal adsorption of insulin was enhanced 
& prolonged reduction in blood glucose level was achieved. 
 
(Hsieh et al., 2006) 
 
(Akagi et al., 2005) 
 
(Sonaje et al., 2010) 
Monoclonal antibodies 
 
No deactivation and increased stability of monoclonal antibodies when 
administered in γ-PGA nanoparticles. 
 
(Sung et al., 2009) 
 
Gene delivery γ-PGA complexes were used for effective gene delivery with low toxicity along 
with high uptake and gene expression. 
 
(Kurosaki et al., 2009; 
Kurosaki et al., 2010) 
Antitumourogenic agent Oral administration of γ-PGA induced Natural Killer (NK) cell-mediated 
antitumour immunity in mice bearing MHC class I-deficient tumours. 
 
(Kim et al., 2007) 
Antimutagenic food 
additive 
γ-PGA suppressed SOS response of Salmonella typhimurium.  
 
(Sato et al., 2008) 
Biodegradable scaffold γ-PGA fibres cross-linked with cystamine improved growth of mouse L929 
fibroblast cells. Can be used for biomedical and tissue engineering applications. 
 
Better growth of rat osteosarcoma cells on γ-PGA chitosan matrices than on 
chitosan alone.  
 
(Yoshida et al., 2009) 
 
 
(Hsieh et al., 2005) 
 
Biological antiadhesive Cross-linked γ-PGA reduced tissue adhesion over injured surfaces in a rat model 
by forming a viscous hydrogel over it. 
 
(Izumi et al., 2007) 
Soft tissue adhesive γ-PGA/gelatin hydrogels used as tissue adhesive. The hydrogel was more stable 
than fibrin glue.  
 
(Hsu and Lin, 2007) 
Wound healing γ-PGA complexes were shown to have good wound healing properties. 
 
(Lee et al., 2011; Tsao et 
al., 2010) 
Antibacterial activity γ-PGA-coated magnetite nanoparticles exhibited antibacterial activity against 
Salmonella enteritidis SE01. 
 
(Inbaraj et al., 2011) 
Calcium absorption Administration of γ-PGA increased calcium absorption in the intestine in post-
menopausal women by inhibition of formation of an insoluble calcium complex 
with phosphate. Can be potentially used for treatment of bone disorders. 
 
(Tanimoto et al., 2007) 
Inhibition of influenza 
virus 
γ-PGA based glycopolymers (used to inhibit influenza virus) showed higher 
solubility in water & heat stability and lower toxicity & immunogenicity 
compared to glycopolymers without γ-PGA. 
 
(Ogata et al., 2009) 
Glucose sensor Needle-type glucose sensors prepared by covalent immobilization of glucose 
oxidase on γ-PGA film. Increased stability of the electrode to a month.  
 
(Yasuzawa et al., 2011) 
Treatment of xerostomi  
(dry mouth) 
γ-PGA promoted salivary secretion and produces moisturizing effect. Solved 
problems associated with sticky displeasure of the mouth, difficulties in 
speaking, bad breath, dental caries, periodontal disease and mucosal infectious 
disease. 
 
(Uotani et al., 2011) 
Nutrition supplement  γ-PGA may increase in vivo bioavailability and solubility of calcium & 
magnesium, reduced progress of osteoporosis, facilitated growth of osteoblast 
cells, reduced calcium loss and maintained bone strength. 
(Ho et al., 2006b) 
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γ-PGA remains stable in a low pH environment by conforming to an α-helical structure and 
disintegrates in a weaker acidic or neutral environment. This property of γ-PGA has been 
exploited for sustainable delivery of various drugs and proteins that are often destroyed or 
degraded quickly when administered orally, due to the harsh conditions of the gastrointestinal 
tract.  
 
For instance, Agresti et al. (2008) have been successful in making a complex of 
Diphenhydramine (DPH) and α-helical γ-PGA (Agresti et al., 2008). DPH is a first 
generation antihistamine drug and has a bitter taste. The use of this complex was found to be 
advantageous for two reasons. Firstly, the DPH/γ-PGA complex was less stable at neutral and 
weak acidic pH (5-7) and hence, it dissolved readily and completely. At neutral pH (7.2) 
more than 95% of DPH was released from the complex within 20 minutes. The α-helical 
structure collapse of γ-PGA was thought to be responsible for the pH-induced dissolution of 
the complex.  The complex was seen to be stable in a pH range of 2.0 - 4.5, with partial 
dissolution observed at pH 4.5. Secondly, γ-PGA was effective in blocking the bitter taste of 
DPH.  
 
The oral administration of insulin is beneficial but challenging, due its instability in the 
gastrointestinal tract. Recently, nanoparticles comprising chitosan and γ-PGA have been used 
for effective oral delivery of insulin (Sonaje et al., 2010). The nanoparticles were freeze dried 
and filled inside an enteric-coated capsule. Freeze drying did not seem to affect the internal 
structure and pH stability of the nanoparticles. The insulin release was shown to be pH 
dependent. Intestinal absorption of insulin was enhanced and a prolonged reduction in blood 
glucose level was achieved. This formulation could potentially be used for oral delivery of 
other therapeutic proteins as well. 
 
42 
 
  
γ-PGA has also been used to develop a non-viral vector for safe gene delivery, where a 
complex of γ-PGA, pDNA and polyethylenimine (PEI) complex was used (Kurosaki et al., 
2009). A pDNA/PEI complex, when used alone, shows high transgene efficiency, but is 
accompanied with agglutination with erythrocytes and extremely high cytotoxicity. Addition 
of γ-PGA to this complex contributed to low toxicity and agglutination, along with exhibiting 
high uptake and gene expression. In the follow up study, safe and effective gene delivery 
vectors using γ-PGA to coat polyplexes and lipoplexes were developed (Kurosaki et al., 
2010). γ-PGA coated vectors showed high transfection efficiencies with markedly low 
toxicities.  
 
γ-PGA, on its own, has been shown to have potential antitumourogenic activity and could 
play a role in cancer immunotherapy (Kim et al., 2007). Oral administration of γ-PGA, 
isolated from B. subtilis chungkookjang, with a molecular weight as high as 2 x 10
6
 Da, 
induced significant Natural Killer (NK) cell-mediated antitumour immunity in mice bearing 
MHC class I-deficient tumours. γ-PGA with lower molecular weight (10 and 100 kDa) did 
not generate significant antitumour activity which suggests that molecular weight is a critical 
factor in optimizing the antitumour applications of γ-PGA. The mechanism underlying the 
antitumour immunity was thought to be due to the activation of NK cells by γ-PGA rather 
than a direct cytotoxic effect.  
 
γ-PGA could also be used to make a novel biocompatible and biodegradable scaffold for 
biomedical and tissue engineering applications (Yoshida et al., 2009).  Among others, it has 
also been shown to be beneficial as a biological adhesive for sutures (Hsu and Lin, 2007; 
Shih and Van, 2001), as an antiadhesive (Izumi et al., 2007), as a wound healing agent (Lee 
et al., 2011; Tsao et al., 2011), as an antibacterial agent (Inbaraj et al., 2011; Tsao et al., 
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2010), for improvement of calcium absorption in the intestine (Tanimoto et al., 2007; Sung et 
al., 2005), as a component in an agent for inhibition of influenza virus (Ogata et al., 2009) 
and for increased stability of a glucose sensor (Yasuzawa et al., 2011), for treatment of 
xerostomia (Uotani et al., 2011) and as a nutritional supplement (Ho et al., 2006b).  
 
1.7.2 Food applications of γ-PGA 
γ-PGA is food derived, since it is naturally present in the mucilage of natto (fermented 
soybeans) and chungkookjang, which are traditional foods in Japan and Korea respectively. 
In addition, γ-PGA is generally recognized as safe (GRAS) by the FDA (Shyu and Sung, 
2010) and hence has been utilized for different food applications.  
 
One of the prominent applications of γ-PGA in food is as an antifreeze agent. Preservation of 
foodstuffs by freezing is an effective and popular method. However, when it is frozen and 
thawed, there are undesirable effects, such as deterioration of living cells and foods due 
formation of ice crystals. These deleterious effects can be prevented by the addition of 
antifreeze agents, which exhibit antifreeze activity by reducing the freezing point of the 
product they are added to. It has been found that certain salts of acidic amino acids (mainly 
sodium salts) show good antifreeze properties (Shih and Van, 2001). Glucose is considered to 
be an agent with excellent antifreeze activity (Mizuno et al., 1997). Mitsuiki et al. (1998) 
investigated the antifreeze activities of γ-PGA using differential scanning calorimetry and 
found that γ-PGA, which had a molecular weight less than 20,000 Da, showed an antifreeze 
activity much higher than that of glucose (Mitsuiki et al., 1998). The antifreeze activity of γ-
PGA produced from B. licheniformis CCRC 12826 was also analysed in another study (Shih 
et al., 2003). Different molecular weights and enantiomeric compositions and salts were 
tested. Lower molecular weight γ-PGA was shown to have a higher antifreeze activity. The 
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antifreeze activity was unaffected by enantiomeric composition. It was also seen to be 
dependent on cations decreasing in the following order – Mg2+ >> Ca2+ ~ Na+ >> K+. There 
are two distinct advantages when γ-PGA is used as an antifreeze agent. Firstly, it has a weak 
taste when compared to the conventional agents used, such as saccharides, inorganic salts and 
amino acids. This means the taste and palatability of food would not change, even if γ-PGA is 
added in large quantities. Secondly, when γ-PGA is used with high mineral food preparations, 
it accelerates the absorption of minerals in the small intestine (Ashiuchi, 2010). In addition, it 
is also successful in masking the taste of the enriched minerals (Ashiuchi, 2010). 
 
γ-PGA has also been used as a bitterness relieving agent (Sonoda et al., 2000), an agent for 
prolonging shelf life in bakery products and noodles (Kunno et al., 1988a; Kunno et al., 
1988b), a texture enhancing agent, an ice-cream stabilizer and a thickener for fruit juice 
beverages (Yamanaka and Kikuchi, 1991). The use of γ-PGA has been shown to significantly 
improve the rheological and thermal properties of wheat dough (Soliman et al., 2005). γ-PGA 
addition made wheat bread softer and eventually retarded staling of bread. More recently, it 
has been used to improve the emulsion stability of sponge cake. A high molecular weight Na 
salt of γ-PGA (> 106 Da) delayed the staling of cake crumb as well as improved the texture of 
the cake (Shyu and Sung, 2010). 
 
1.7.3 Other applications of γ-PGA 
Due to its biodegradability, heavy metal binding capability and high flocculating activity, γ-
PGA can be potentially used in wastewater treatment plants, in the drinking water processing 
industry and in downstream processing for food and fermentation industries (Shih and Van, 
2001). Recently, due to its high flocculating activity, γ-PGA was shown to be effective in 
treatment of vinnase to remove suspended solids (Octavio et al., 2012). Vinnase is the waste 
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water produced from ethanol distillation and is difficult to dispose of. One of the reasons why 
this is difficult is due to its low pH. The low pH of vinnase actually enhanced γ-PGA 
flocculating efficiency. Also, pre-treatment processes were not required, making γ-PGA ideal 
for disposal of vinnase in combination with a mild chemical treatment for removal of 
coloured compounds (Octavio et al., 2012). 
 
The preparation and characterisation of novel biodegradable nanoparticles based on 
complexation of γ-PGA (derived from B. licheniformis 9945a) with bivalent lead ion (Bodnár 
et al., 2008) has also been investigated.  The prepared complex was stable in aqueous media 
at low, neutral and mild alkaline conditions. This complex is thought to have useful water 
treatment applications due to its biodegradability along with heavy metal binding activity. 
 
γ-PGA (molecular weight: 9.9 x 105 Da) has been used effectively to remove basic dyes from 
aqueous solution (Inbaraj et al., 2006). It was found that 98% of the dye adsorbed on γ-PGA 
could be recovered at pH 1 which facilitates the reuse of spent γ-PGA. As γ-PGA is non-toxic 
and biodegradable, the adsorption system developed could offer green solutions to the dye 
industry. More recently, magnetite particles were coated with γ-PGA and were used for their 
methylene blue dye adsorption capability. The particles were stabilized in deionized, tap and 
river waters as well as in acidic and basic media. The dye was completely recovered using 
these particles by lowering the pH to 1.0. These magnetite particles coated with γ-PGA could 
be used for removal of cationic dyes from wastewaters (Inbaraj and Chen, 2011).  
 
γ-PGA has successfully been used as an active ingredient in a hyaluronidase inhibitor, 
demonstrating its utility in the cosmetic industry (Sung et al., 2007). Hyaluronidase is an 
enzyme that degrades hyaluronic acid present in the skin dermis. The composition was tested 
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on fifty women (age group between 30 and 50) and was shown to maintain skin elasticity by 
inhibiting the activity of hyaluronidase and reducing allergenic reactions by inhibiting the 
permeability of inflammatory cells (Sung et al., 2007).  
 
Other interesting applications of γ-PGA include using it as a component in biodegradable 
golf balls (Egashira and Takehana, 2011) and as a protein crystallization inducer (Hu et al., 
2008).  
 
1.7.4 Optimization of γ-PGA for applications 
As previously discussed, since γ-PGA with different properties is useful for different 
applications, optimization of γ-PGA with respect to its properties is very important. 
Properties such as molecular weight, conformational state, enantiomeric composition and 
form of the polymer can affect the efficiency of γ-PGA for a particular application. Probably 
the most decisive property of γ-PGA is its molecular weight. For example, polymers of 
different molecular weights are required to control a drug‘s release into the tissue. In this 
effort (Richard and Margaritis, 2006), it was found that the molecular weight of γ-PGA 
produced by bacteria is usually higher than that required for drug delivery applications. The 
molecular weight of PGA required for conjugation with Paclitaxel, for example, has been 
determined to be 3 x 10
4 
- 6 x 10
4
 Da (Li et al., 1998). The molecular weight of γ-PGA 
required would differ depending on the drug and application. Molecular weight reduction can 
be an important step in producing PGA for a drug delivery application. Different techniques 
used for this purpose are ultrasonic degradation, alkaline hydrolysis, alteration of medium 
composition and microbial or enzymatic degradation (Shih and Van, 2001). 
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Ultrasonic degradation in particular was shown to be an effective method to reduce both the 
molecular weight and the polydispersity of naturally produced PGA, without disturbing the 
chemical structure of the polymer (Graciela et al., 2000). In another study, in situ 
depolymerisation of γ-PGA in the cell-free fermentation broth of B. subtilis IFO 3335 was 
carried out (Richard and Margaritis, 2006). The molecular weight, when measured with the 
help of Gel Permeation Chromatography (GPC) and intrinsic viscosity correlations, reduced 
from about 4. x 10
6
 Da to 5.5 x 10
4
 Da over a period of 144 h. As with the study done by Yao 
et al., the polydispersity of γ-PGA decreased as a function of hydrolysis time (Yao et al., 
2009). Enzymatic degradation seems to be a better method to obtain γ-PGA of the required 
molecular weight in a controlled fashion. Simple hydrolysis of γ-PGA in aqueous solution 
has also been studied at different temperatures (80˚C, 100˚C and 120˚C) (Goto and Kunioka, 
1992). γ-PGA was rapidly hydrolysed from 226 kDa to 18 kDa in 30 mins at 120˚C. 
Hydrolysis was much slower at lower temperatures. Hydrolytic degradation of γ-PGA was 
found to proceed through random chain scission. 
 
1.8 SUMMARY 
γ-PGA is biodegradable, edible and non-immunogenic. Because of this it can be safely used 
for a variety of applications, which are fast increasing. Knowledge of the genes and enzymes 
involved in γ-PGA regulation throws light on the conditions that support γ-PGA production 
(for e.g. high osmolarity). This information could be used to isolate and screen new γ-PGA 
producing strains from different sources. Since every application of γ-PGA exploits specific 
properties of γ-PGA, it would be interesting to compare different γ-PGA producing bacteria 
and analyse the properties of the produced γ-PGA in these organisms.  
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For conventional materials to be replaced with new sources of γ-PGA, the cost of production 
of γ-PGA needs to be several tens to hundreds of times lower than what it is at present. Using 
cheap nutrients for production of γ-PGA is one way to reduce costs. For instance, corn steep 
liquor, which is an agricultural waste product, could be used as an effective nitrogen source 
for γ-PGA production (Jung et al., 2005). In addition, a complete understanding of γ-PGA 
synthesis, especially regulation of γ-PGA production within the cell, would help in making 
the production process more economical. Statistical analyses of large scale γ-PGA production 
could also lead to answers for cost-effective production of γ-PGA. Bajaj and Singhal have 
shown that sequential optimization approach using statistical analysis (Plackett-Burman 
design and response surface methodology) is a useful way of optimizing the nutrients 
required for γ-PGA production (Bajaj and Singhal, 2009b; Bajaj et al., 2008; Bajaj et al., 
2009; Bajaj and Singhal, 2009a). Addition of cheap γ-PGA precursors in small quantities that 
can increase the yield of γ-PGA produced could also make the production process more cost-
efficient.  
 
α-PGA has been widely exploited for medical applications, chiefly for sustained drug 
delivery. However, researchers have pointed out that there could be several advantages of 
using γ-PGA over α-PGA (Hsu and Lin, 2007; Shih and Van, 2001; Ye et al., 2006). Pure γ-
PGA can be obtained in large quantities without any chemical modification steps. It is not 
susceptible to proteases and hence could provide better sustained delivery of conjugated 
drugs in the body. Better incorporation of drug in terms of quantity of drug conjugated into γ-
PGA has been achieved.  
 
γ-PGA can exhibit different properties and it is important to choose γ-PGA with appropriate 
properties for a specific application. Optimization of γ-PGA with respect to molecular 
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weight, enantiomeric composition and conformational states is an indispensable step in 
making specific applications of γ-PGA practical. The Bacillus genus has thus far dominated 
the production of γ-PGA. Various strains of Bacillus have been researched for γ-PGA 
production (Bajaj et al., 2009; Birrer et al., 1994; Du et al., 2005; Bovarnick, 1942; Jian et 
al., 2005; Kubota et al., 1993; Park et al., 2005; Zhao et al., 2005; Liu et al., 2011). It is 
essential to investigate the production of γ-PGA in bacteria that have not previously been 
used for this purpose. These bacteria could produce γ-PGA with higher yields or with 
properties suitable for particular applications. The aim of this work was to investigate and 
contribute the production of γ-PGA in eight different strains of Bacillus. Six of these bacteria 
have not been previously used for production of this multifunctional biopolymer. It is known 
from previous research that B. subtilis and B. licheniformis are able to produce extracellular 
γ-PGA which can be recovered from the production medium (Bajaj et al., 2008; Bajaj et al., 
2009; Birrer et al., 1994; Buescher and Margaritis, 2007; Shih and Van, 2001; Xu et al., 
2005a). In this work, five strains of B. subtilis - B. subtilis ATCC 23856, B. subtilis ATCC 
23857, B. subtilis ATCC 23858, B. subtilis ATCC 23859 & B. subtilis natto - and three 
strains of B. licheniformis - B. licheniformis NCIMB 1525, B. licheniformis NCIMB 6816 & 
B. licheniformis 9945a will be investigated for the production of γ-PGA.  
 
To obtain γ-PGA with different yields and properties, two different media will be used for 
production. Previous research demonstrates that media composition can influence the 
molecular weight (Shih and Van, 2001). Our endeavour was to investigate whether properties 
of γ-PGA such as molecular weight, crystallinity, form of peptide and yield were dependent 
on media composition or on bacteria producing it or on both these factors. 
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In addition, this work will evaluate the protective effect of γ-PGA on the viability of probiotic 
bacteria under conditions where unprotected cells struggle to survive. This work will be novel 
since γ-PGA has not been used for maintaining viability of probiotic bacteria. An 
introduction to probiotics is given in Section 2.   
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2. INTRODUCTION – PROBIOTICS 
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This section will describe the history and significance of probiotics. Various health benefits 
of probiotics will be explained and the challenges of producing a viable probiotic product will 
be highlighted. Some of the current solutions to these challenges will be discussed and the 
need to come up with a better and unique method to overcome these challenges will be 
illustrated. 
 
2.1 INTRODUCTION 
Promoting the use of food as medicine has existed since the time of Hippocrates, albeit 
without scientific backing. However, over the years, a strong relationship between diet and 
health has been well established (Figueroa-González et al., 2011). A lot of scientific studies 
have highlighted the importance of functional foods for treatment or prevention of certain 
disorders (Allaker and Douglas, 2009; Anukam et al., 2008; Figueroa-González et al., 2011; 
Hlivak et al., 2005; de LeBlanc et al., 2005; Perdigón et al., 1991). Although there is no 
precise definition for functional food, one can define it as any fresh or processed food that 
has an ability to promote health or prevent a disease beyond the basic function of providing 
nutrients. Within functional foods, probiotic food has gathered a lot of interest. Probiotics can 
be defined as ―live microorganisms that when administered in adequate amounts confer a 
health benefit on the host‖ (Vasiljevic and Shah, 2008; Reid et al., 2003). 
 
In total, the human gut microbiota contains about 10
13
 to 10
14
 bacterial cells (Cani and 
Delzenne, 2009). In fact, the number of bacterial cells in our body exceeds the number of 
human cells by a factor of 10 (Turnbaugh et al., 2007).  These bacteria are acquired rapidly 
after birth (Vinderola et al., 2011). Different number and type of bacteria reside in different 
parts of the gastrointestinal tract (Fig 2.1).  
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Fig 2.1: GIT characteristics and localization of various bacterial populations in the gut (Prakash et al., 
2011). 
 
 
The stomach is highly acidic (pH 1-2) due to the presence of hydrochloric acid and houses 
less than 10
3
 cells/gm of bacteria. The prominent bacterial population in this region 
comprises of Lactobacilli and Streptococci (Prakash et al., 2011). The small intestine 
(duodenum, jejunum and ileum) has a higher pH (6-7). Lactobacilli, E. coli and Enterococcus 
reside in this region, with populations ranging from 10
4
 to 10
7
 cells/gm. The large intestine, 
comprising of the ascending, transverse and descending colon is the richest in terms of 
bacterial cells, with cell numbers ranging from 10
10
 to 10
12
 cells/gm. Bacteria living in the 
large intestine include lactic acid bacteria, Bacteroides and Bifidobacterium species. The 
bacteria in the body are present throughout our lives and undergo change in their composition 
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and number depending on various intrinsic (age, stress etc) and extrinsic (diet, medical 
treatment) factors. Of the different bacteria that colonize the gastrointestinal tract, 
Bifidobacteria and Lactobacilli are the most beneficial. Not surprisingly, these are chosen 
most often for use as probiotics, because they promote healthy effects in their natural niche. 
These bacteria have also been shown to decrease the occurrence of certain disorders (see 
Section 2.4), which further suggests that targeted increase in their numbers could help 
ameliorate disorders, thus promoting overall well-being (Prakash et al., 2011).  
 
The cost of healthcare is increasing. The elderly expect an improved quality of life. In 
addition, healthy living and nutrition is being given a lot of importance. There is a marked 
concern over side effects of some of the available medicines for age-related disorders. Due to 
this, naturally occurring health treatments are being heavily promoted. The western world 
especially looks at food today for promoting a state of well-being, improving health and 
reducing the risk of diseases (Granato et al., 2010). Probiotics are not only used to achieve 
overall well-being, but also for prevention of initiation, promotion and development of non-
transmissable chronic diseases (Granato et al., 2010). 
 
Probiotics can be administered in a number of forms. They can either be in the form of 
capsules, health food supplements or administered in food products. Dairy foods such as 
milk, yoghurt and yoghurt drinks are common vehicles for delivery of probiotic bacteria 
(Burgain et al., 2011; Forssten et al., 2011; Vinderola et al., 2011). 
 
2.2 SIGNIFICANCE OF FUNCTIONAL FOODS AND PROBIOTICS 
Functional foods, in particular probiotics, have garnered a lot of interest, especially in 
developed countries and hence, their market is increasing rapidly. In 2003, the world market 
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for functional foods was estimated to be US$33 billion (Menrad, 2003). The European 
market alone was estimated to be more than US$2 billion (Menrad, 2003). According to a 
market survey, the average North-American consumer spent approximately US$90 per year 
on functional foods and beverages in 2007 (Euromonitor, 2009). Development and 
production of functional foods is one of the fastest growing industries and according to a 
market research performed by Just-Food, sales were expected to exceed $167 billion US by 
2010 (Just-Food, 2004). 
 
The global market for probiotic ingredients, supplements and foods was worth US$14.9 
billion in 2007 and was US$16 billion in 2008. By 2013, it is estimated that probiotic sales 
would reach US$ 19.6 billion. Interestingly, Lactobacillus accounted for the largest share in 
sales of probiotic bacteria, representing 61.9% of total sales in 2007 (Granato et al., 2010). In 
Europe, the probiotic food and beverage market is expected to rise from its 2006 position of 
US$ 61.7 million to US$ 163.4 million by 2013 (Granato et al., 2010). 
 
2.3 HISTORY OF PROBIOTIC DEVELOPMENT 
Although scientists like Escherich (1885), Moro (1900) and Tissier (1908) initially 
recognized the importance of studying bacteria appearing in the faeces and the intestinal tract 
of humans and the difference between breast fed and bottle fed infants with respect to their 
intestinal bacterial population, it was Metchnikoff who first observed the benefits of 
microorganisms on human beings (Vasiljevic and Shah, 2008). He observed that Bulgarian 
peasants had an exceptionally long life span (87 years). He soon attributed this to the 
consumption of large amounts of fermented milk in their diet. He then proposed the auto-
intoxication theory (Metchnikoff, 2004) which states that pathogens in the body continuously 
produce toxins, thereby weakening the immune system and our body‘s resistance. According 
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to Metchnikoff, this could be prevented by the consumption of sour milk and lactic acid 
producing bacteria. He studied this further and proposed that Lactobacillus bulgaricus can 
launch into the intestinal tract and prevent putrefactive effects by reducing the number of 
putrefactive bacteria in the intestine. However, this was later refuted by Herter and Kendall 
(Herter and Kendall, 1908).  
 
Even though Metchnikoff‘s theory was challenged, other scientists had already shown 
interest in investigating health benefits conferred by other microorganisms. Probiotics 
became more promising owing to growing research on microorganisms with respect to their 
health benefits on humans.  They managed to attract commercial attention in products 
fermented by L. acidophilus (Burke, 1938). In Japan in 1930, Minoru Shirota succeeded in 
isolating and culturing a Lactobacillus strain capable of surviving the passage through the 
gastrointestinal tract. The culture identified as Lactobacillus casei strain Shirota was 
successfully used for the production of the fermented dairy product called ―Yakult‖, which 
initiated the foundation of the company with the same name in 1935. In the late 1930s to late 
1950s, research on probiotics starting fading away, possibly due to the difficulties faced by 
the world during those times, such as depression and war. However, there was rejuvenated 
interest in the late 1950s and early 1960s, which led to the introduction of the probiotic 
concept (Vasiljevic and Shah, 2008). By 2004, there were more than 70 probiotic-containing 
products in the market worldwide. 
 
For simplicity, probiotic can be thought of as an antonym to antibiotic. Vergin (1954) used 
the term probiotic in reference to a substance that could be used to restore the microbial 
imbalance in the body that was caused after an antibiotic treatment (Vergin, 1954). This is 
thought to be the first reference to probiotics as they are defined nowadays. Following this 
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many researchers defined probiotic in their own way (Fujii, 1973; Kollath, 1953; Lilly and 
Stillwell, 1965; Parker, 1974). In 2002, the WHO/FAO defined probiotics as ―live 
microorganisms that when administered in adequate amounts confer a health benefit on the 
host‖ (Vasiljevic and Shah, 2008; Reid et al., 2003). A more recent definition of probiotics is 
provided by Fric (2007), who states that ―probiotics are non-pathogenic micro-organisms, 
mostly of human origin, which confer a health benefit on the host and enable to prevent or 
improve some diseases when administered in adequate amounts‖ (Fric, 2007). 
 
There are a wide variety of microorganisms with potential probiotic properties. However, the 
bacteria that stand out for their role as probiotic microorganisms conferring a health benefit 
on the host are Lactic Acid Bacteria (LAB) and Bifidobacteria. LAB are Gram positive, acid 
tolerant, strictly fermentative bacteria that produce lactic acid as their main product (Stiles 
and Holzapfel, 1997). The advantage of using lactic acid bacteria is that they can convert 
sugars into other carbohydrates and lactic acid. This provides the characteristic sour taste of 
fermented dairy foods such as yogurt but also the low pH makes sure that undesirable 
microorganisms fail to grow and hence this could be instrumental in preventing 
gastrointestinal infections. Bifidobacteria are Gram-positive, anaerobic, rod shaped bacteria. 
They have been shown to play important roles in human health by increased humoral 
immunity and maintaining balance of intestinal microflora (De Simone et al., 1992; Benno 
and Mitsuoka, 1992). The population of Bifidobacteria in the human gut decreases with age 
and is affected by other external factors (Bornside, 1978). Therefore, it is important to 
replenish the population of these bacteria using probiotics. Both LAB and Bifidobacteria 
have been incorporated in various dairy and other food products, being commercially 
available in milk, sour milk, fruit juices, ice cream, single shots and oat-based products. 
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2.4 HEALTH BENEFITS FROM PROBIOTICS 
Over the years, extensive research has been done to determine the efficacy of probiotic foods 
in controlling and alleviating disorders and diseases. Tests have been performed using 
animals as well as human volunteers. Overall, it has been seen (Fig 2.2) that probiotics can 
exert their beneficial effects by 5 different mechanisms (Prakash et al., 2011; Rolfe, 2000). 
 
1) Production of pathogen inhibitory substances: Probiotic bacteria can produce substances 
(organic acids, hydrogen peroxide or bacteriocins) that can inhibit the growth/metabolism of 
pathogenic bacteria and can also reduce toxin production. 
 
2) Blocking of adhesion sites: Some probiotic bacteria can adhere to epithelial cells, where 
they can competitively inhibit bacteria from attaching to the intestinal epithelial surfaces. 
 
3) Nutrient competition: Probiotics may consume nutrients that would otherwise be utilized 
by other bacteria, thus challenging their survival. 
 
4) Degradation of toxins and toxin receptors: Probiotics can also degrade the toxin receptors 
for bacteria, such as C. difficile, on the intestinal mucosa, rendering them ineffective. 
 
5) Modulation of immune responses: Stimulation of specific and non-specific immunity by 
probiotic bacteria is another mechanism by which protection against intestinal disorders 
could be sought.  
 
The numerous health benefits of probiotics will be discussed in the following sections. 
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Fig 2.2: The five mechanisms by which probiotic bacteria can positively influence human health (Prakash 
et al., 2011). 
 
 
2.4.1 Effect against gastrointestinal disorders 
Researchers have demonstrated the role of probiotics in alleviating several gastrointestinal 
disorders and promoting healthy digestive functions (Garrait et al., 2009; Hammerman and 
Kaplan, 2006; Kligler et al., 2007). This is achieved by competitively inhibiting and 
excluding pathogens (Figueroa-González et al., 2011). For instance, probiotics have been 
used for eradication of primary and recurrent infection by Clostridium difficile (Pochapin, 
2000). In this study, the bacteria that proved to be useful for control and treatment of C. 
difficile infection were Lactobacillus rhamnosus GG and Saccharomyces boulardi.  
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The use of probiotics to cure Ulcerative Colitis (UC) has also been investigated (Cui et al., 
2004). Capsules of Bifidobacteria were administered to patients suffering from UC after 
treatment with a UC standard therapy. Only 20% of the patients that were given the probiotic 
suffered a disease relapse in comparison with 93.3% patients in the control group. 
 
In another study, the effect of probiotics on the eradication of Helicobacter pylori (HP) was 
studied (Park et al., 2007). HP infections are common among individuals, especially in 
tropical countries. Usually, these infections are treated using a triple antibiotic therapy. In this 
study, 352 HP infected individuals were divided randomly into two groups. One group 
received treatment containing triple-plus probiotics (a mixture of B. subtilis and 
Streptococcus faecium) and the control received triple-only treatment. The patients were 
evaluated for four weeks. The triple-plus-probiotics group showed a higher eradication rate 
than the triple-only group (83.5% as opposed to 73.3%). The triple-only group showed more 
overall side effects and diarrhoea, demonstrating that probiotic bacteria can help with the 
treatment of HP infections and alleviate side effects of the triple antibiotic therapy.  
 
In an interesting study, twenty four Human Immunodeficiency Virus (HIV)/Acquired 
Immunodeficiency Syndrome (AIDS) patients with clinical signs of moderate diarrhoea, CD4 
counts over 200 and not receiving any antiretrovirals or dietary supplements were 
administered with conventional yogurt (fermented with L. delbruekii var bulgaricus and 
Streptococcus thermophiles) supplemented with Lactobacillus rhamnosus GR-1 and 
Lactobacillus reuteri RC-14 (Anukam et al., 2008). 12 patients were given supplemented 
product and the other 12 were given unsupplemented yogurt (control group). Diarrhoea, 
flatulence and nausea were cured in 12/12 probiotic treated subjects within two days 
compared to 2/12 receiving unsupplemented yogurt for 15 days. It was shown the probiotic 
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yogurt can be used to improve the quality of life of women in Nigeria with HIV/AIDS 
(Anukam et al., 2008).  
 
In another study, administration of L. rhamnosus strains shortened the duration of rotaviral 
diarrhoea in children (Szymanski et al., 2006). Intervention shortened the time needed for 
intravenous rehydration. A similar study was conducted a year later which showed that 
rotavirus was challenged by probiotic L. rhamnosus GG (Pant et al., 2007). When it was used 
in combination with immunoglobulins, the diarrhoea outcomes were shown to reduce 
significantly. The histopathological changes (swollen villus tips and vacuolization) were 
prevented and the virus load on the intestines was also reduced. Due to the use of probiotics, 
the treatment procedure was seen to be quicker and more cost efficient. Also, probiotics do 
not require special storage conditions like vaccines and hence, it has the potential to 
complement the rehydration therapy that is being currently used in areas where storage and 
transport of vaccines is challenging (Pant et al., 2007). 
 
Diarrhoea (developed after administration of antibiotics) in two oncology patients was treated 
with the help of probiotics  and this may therefore offer a way to bring about resolution in 
antibiotic-associated chronic diarrhoea (Benchimol and Mack, 2004). Another study (Delia et 
al., 2007) also suggested that probiotic lactic acid-producing bacteria are an easy, safe, and 
feasible approach to protect cancer patients against the risk of radiation-induced diarrhoea. 
 
2.4.2 Effect against infections 
Probiotics can also be used to suppress, prevent or treat infections by modulating the immune 
system. For instance, oral administration of Bifidobacterium breve was seen to provide 
protection against rotavirus or influenza virus by activating the humoral immune system 
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(Kaur et al., 2002). The bacteria were seen to augment anti-rotavirus IgA production or anti-
influenza virus, IgG production, thus preventing the respective infections. When infants were 
fed with these bacteria, a significant reduction in the frequency of rotavirus shedding in stool 
samples was observed. Enhancing the immune function by administering L. coryniformis 
CECT5711 and L. gasseri CECT5714 to improve defence against gastrointestinal aggressions 
and infections has also been demonstrated in 30 healthy children in the age group of 3-12 
(Lara-Villoslada et al., 2007).  
 
Researchers have also shown (Falagas et al., 2006a) the effectiveness of probiotics for 
prevention of urinary tract infections (UTI). UTIs occur majorly because of the lack of 
presence of healthy Lactobacilli in the vagina which are normally present in healthy pre-
menopausal women. Hence, there is a possibility of curing UTIs by using probiotics to 
replenish the absent Lactobacilli. L. rhamnosus GR-1 and L. reuteri RC-14 seemed to be the 
most effective among the studied bacteria for the prevention of UTIs. The same group of 
researchers have also suggested that probiotics such as L. acidophilus, L. rhamnosus GR-1 
and L. fermentum RC- 14 can help control vulvovaginal candidiasis (VVC) when 
administered orally or intravaginally (Falagas et al., 2006b). VVC is a common infection in 
women. It is thought to occur due to lack of presence of appropriate number of Lactobacilli 
in the vagina or with presence of H2O2-non-producing vaginal Lactobacilli. It is thought to 
work by preventing the colonization and infection of the vagina by Candida albicans. 
Probiotics could also be used for the treatment of bacterial vaginosis (BV) (Falagas et al., 
2007). However a small number of clinical trials are not sufficient to support this and hence 
more work needs to be done to be certain of the effectiveness of probiotics on VVC and BV.  
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A systematic review, assessing the effectiveness of various probiotic bacteria (Lactobacillus 
strains, combinations of Lactobacillus and Bifidobacterium strains, Bifidobacterium strain 
and a non-pathogenic Enterococcus faecalis strain) for treatment of Respiratory Tract 
Infections (RTIs), has been conducted (Vouloumanou et al., 2009). In 14 randomised 
controlled trials, it was concluded that probiotics may have a beneficial effect on the severity 
and duration of symptoms of RTIs but probiotic treatment does not appear to reduce the 
incidence of RTIs. The administration of probiotics also appeared to have a good safety 
profile with mild or no side effects on the individuals. 
 
2.4.3 Effect against cancer 
There is substantial experimental evidence to suggest that probiotics may be beneficial in the 
prevention and treatment of various types of cancer. LAB have shown antitumour activity in 
murine breast cancer (de LeBlanc et al., 2005). A study demonstrated that 7 days of cyclical 
administration of milk fermented by 2 strains of L. helveticus diminishes tumour growth, 
stimulating an antitumour response. It was seen to modulate the relationship between the 
immune and endocrine systems, which has a crucial effect on oestrogen-dependent tumour 
and induced cellular apoptosis. In another study (de Moreno de LeBlanc et al., 2007), 
treatment of colon cancer and breast cancer has been shown to benefit from the use of LAB. 
The mode of action of LAB was thought to be due to their suppressive action against bacteria 
that convert procarcinogens into carcinogens, hence reducing the amount of carcinogens in 
the intestine. 
 
The mortality rate of rats suffering from 1,2-dimethylhydrazine induced colon cancer reduced 
when they were fed with S. thermophilus-fermented skim milk (Shackelford et al., 1983). In 
another study, Geier et al. (2006) showed that probiotics and prebiotics have the potential to 
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impact significantly on the development, progression and treatment of colorectal cancer and 
may have a valuable role in cancer prevention (Geier et al., 2006). Bacillus polyfermenticus 
SCD was seen to have strong adherent properties in the colon and also have anticarcinogenic 
effects in vitro and in vivo (Lee et al., 2007). In 1995, a study showed  L. casei to be effective 
in preventing the recurrence of superficial bladder cancer (Aso et al., 1995). B. longum has 
also been shown to inhibit carcinogen induced colon cancers and precursor lesions in several 
studies (Singh et al., 1997; Reddy and Rivenson, 1993).  
 
2.4.4 Other health benefits 
The effect of Enterococcus faecium M-74 enriched with selenium was investigated on the 
levels of total cholesterol in 43 volunteers (Hlivak et al., 2005). The subjects were divided 
into 2 groups and the group that was administered with the bacterium for 56 weeks showed a 
marked reduction (by 12%) in total serum cholesterol as opposed to the placebo group, which 
did not show any significant change in levels of cholesterol. This proved that probiotic 
bacteria could be used to alleviate disorders linked to high cholesterol in the blood. The 
researchers believe that probiotics will surely find their place as a therapeutic alternative in 
human medicine. 
 
In addition, research has shown that probiotics can be used to cure dental disorders. L. 
rhamnosus CG, L. casei, L. reuteri and Bifidobacterium DN-173010 have all demonstrated 
the potential to alter colonisation of cariogenic bacteria and thus prevent dental caries 
(Allaker and Douglas, 2009). Krasse et al. in 2006 showed that gingivitis can be cured with 
the help L. reuteri, where a reduction in plaque levels and gingival inflammation was seen. 
There appeared to be two modes of action (direct and indirect) for the alleviation of dental 
diseases. Microbes could directly interact with the dental plaque, where they could compete 
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for binding sites on host tissues and for nutrients with the microbes already present in the 
plaque biofilm. Bacteria like lactic acid bacteria produce a range of antimicrobial agents 
which include organic acids, hydrogen peroxide, low-molecular weight antimicrobial 
compounds, bacteriocins and adhesion inhibitors, which give them a competitive advantage. 
Indirectly, the probiotic bacteria can alter the innate and specific immune function which 
could help alleviate the dental disorder (Allaker and Douglas, 2009). 
 
2.5 MAINTAINING PROBIOTIC VIABILITY 
As previously mentioned (see section 2.4), there is a lot of evidence in the literature about the 
benefits of probiotics. However, there remains an uncertainty about the usefulness of these 
bacteria. Some data showing positive effects may be irreproducible and one of the reasons for 
this could be insufficient/inconsistent numbers of live bacteria reaching the intestine. Many 
different probiotics have been defined by researchers (for some examples, see section 2.3). 
Most of the definitions used for probiotics stress the importance of ―adequate‖ numbers of 
administered bacteria. The benefits of probiotic bacteria are largely dependent on their ability 
to survive, colonize and multiply in the host (Anal and Singh, 2007; Burgain et al., 2011). If 
enough viable bacteria do not reach the target site, the probiotic product would not be useful. 
Many of the probiotic microorganisms used in food and drink products do not survive for 
long enough to confer a health benefit on the host. Several review articles on probiotics have 
mentioned studies that highlight the loss in viability of probiotic bacteria during different 
stages in their manufacture, storage and after ingestion (Kailasapathy and Chin, 2000; 
Figueroa-González et al., 2011). Therefore, the major challenge for administering a useful 
probiotic product is to maintain viability, which is a prerequisite for achieving health benefits 
via microorganisms. Recently, the importance of improving probiotic viability during the 
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manufacturing process and storage of functional foods has been highlighted (Figueroa-
González et al., 2011).  
 
It has been established by WHO/FAO that any food sold with health claims based on the 
addition of probiotics must contain at least 10
6
 to 10
7
 CFU/ml of viable probiotic bacteria 
(Kailasapathy and Chin, 2000; Kurmann and Rasic, 1991). There are several stages where the 
viability of probiotic bacteria is susceptible. Firstly, the bacteria have to survive the 
processing stage. Following this, if the probiotic bacteria are to be administered in food, they 
have to endure the storage period or shelf life of the food in which they are delivered 
(Forssten et al., 2011). Finally, upon ingestion, they have to survive the acidic conditions of 
the stomach as well as the bile salts in the small intestine, before reaching the lower portions 
of the gastrointestinal tract where they will provide beneficial effects (Kailasapathy and 
Rybka, 1997). Some of the challenges encountered will be discussed in more detail in the 
following sections. 
 
2.5.1 Viability during freeze drying 
It is common practice to freeze dry bacteria, so that they can be stored in the form of dry 
powders for a longer period of time. In addition, transportation of freeze dried bacteria is 
easier. Freeze drying is based upon sublimation and occurs in three phases – freezing, 
primary drying and secondary drying (Meng et al., 2008). Probiotic cultures are frequently 
supplied as freeze-dried or spray-dried powders. However, the procedures used to prepare 
freeze dried probiotic bacteria are detrimental to cell structure and viability (Saarela et al., 
2005). Freeze drying can cause protein denaturation and DNA damage that leads to a 
decrease in cell viability (Carvalho et al., 2004). Also, desiccated bacteria could lose viability 
on rehydration (Peccia et al., 2001). The cell membrane has been reported to be the major site 
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of damage during drying or rehydration (Santivarangkna et al., 2008). The viability of lactic 
acid bacteria has been assessed before and after freeze drying (Jagannath et al., 2010). In the 
study, it was observed that the viability decreased by 3 log CFU/g (from 10
10
 CFU/g to 10
7
 
CFU/g) immediately after the freeze drying process. 
  
2.5.2 Viability during storage 
The viability of probiotic bacteria in food products decreases due to exposure to detrimental 
environmental factors such as organic acids, hydrogen ions, molecular oxygen and 
antibacterial components (Mortazavian et al., 2007; Sultana et al., 2000; Vinderola et al., 
2000). Many researchers have tried to enumerate bacteria (L. acidophilus and 
Bifidobacterium) in commercial probiotic foods, only to find that the levels are either not 
consistent or are very low (Huys et al., 2006; Masco et al., 2005; Micanel et al., 1997; 
Tharmaraj and Shah, 2003; Vinderola et al., 2000). The concentration of microorganisms in 
the probiotic products fail to correspond to the information on the label. Kailasapathy and 
Rybka (1997) observed that at the expiration date (4 weeks) of yoghurt, the contents of L. 
acidophilus and B. bifidum were lower than the levels on the label (10
6
 CFU/g), indicating 
failure to survive (Kailasapathy and Rybka, 1997). A pH value of 4.5 or lower was 
detrimental to cell viability of the probiotic organisms in yoghurt, which was stored at 5°C. In 
a study to determine viability of B. longum during refrigerated storage in yoghurt, it was 
found that bacterial viability decreased by 98% after 28 days (Akalin et al., 2004). In fact, 
after 14 days, the viability of B. longum was 4.8 x 10
5
 CFU/g, which is lower than the 
recommended FAO/WHO value (10
6
 – 107 CFU/g). In a different study (Christopher et al., 
2009), the viability of B. bifidum strains was evaluated in set and stirred yoghurts for 35 days. 
It was seen that the viability of all bacteria decreased (from 8.4-8.94 log CFU/g to 4.83-5.93 
log CFU/g) at the end of the storage period. When B. longum was incorporated in orange 
 
68 
 
  
juice, cells showed rapid loss in viability over the juice‘s storage period (Ding and Shah, 
2008). By the fifth week of storage, a complete loss in viability was seen.  
 
2.5.3 Viability after ingestion 
It is important that probiotic bacteria survive passage through the upper gastrointestinal tract 
and colonize the large intestine. This is especially crucial for probiotic bacteria used for 
treatment/prevention of diarrhoea (Figueroa-González et al., 2011). It has been established 
that probiotic microorganisms are extremely susceptible to environmental conditions such as 
water activity, redox potential, temperature and acidity (Siuta-Cruce and Goulet, 2001). 
There is enough evidence in the literature stating that the viability of probiotics depends the 
most on the acidity levels of the delivery system (for example yogurt) and the stresses 
encountered in the gastrointestinal tract (Vasiljevic and Shah, 2008). Probiotics do not seem 
to thrive below pH 4.4, although this is dependent on the microorganism. Compared to 
Bifidobacterium spp., which is very susceptible to low pH levels, L. acidophilus is more 
resistant due to its high cytoplasmic buffering capacity (Rius et al., 1994). The growth of 
Bifidobacterium is hampered significantly in highly acidic environments or in the presence of 
oxygen. When commercial Bifidobacteria cultures were exposed to simulated gastric fluid 
(pH 1.5) for 2 h, their viability decreased from 10
11
 CFU/g to <10
3
 CFU/g (Cui et al., 2000). 
In a recent study, a loss in viability of more than 1 x 10
8
 CFU/ml was observed for B. longum 
cells when they were exposed to simulated gastric juice for 2 h (Su et al., 2011).  
 
2.6 MAINTAINING PROBIOTIC VIABILITY - CURRENT SOLUTIONS 
Scientists have endeavoured to use different techniques to resolve the loss of viability in 
probiotics. Cryoprotectants could be used to avoid/minimize loss in viability during freeze 
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drying. For instance, ‗Unjpectine™ RS 150‘ has been successfully used to prevent loss in 
viability during freeze drying of probiotic bacteria (Capela et al., 2006). Other 
cryoprotectants that have been used include bacterial cellulose, sucrose, trehalose, skimmed 
milk, glycerol, polyvinylpyrrolidone and DMSO (Palmfeldt et al., 2003; Barbaree et al., 
1982; Panoff et al., 2000; Jagannath et al., 2010). These materials, although useful for certain 
applications, are expensive to obtain and maintain and are known to be impractical when 
equipment and refrigeration are not readily available (Krumnow et al., 2009). 
 
For protection of probiotic bacteria during storage and after ingestion, microencapsulation 
and enteric coating have been suggested and investigated (Özer et al., 2009; Vasiljevic and 
Shah, 2008). Microencapsulation is a process where the cells are enclosed within an 
encapsulating membrane so that they can be protected from the environment. It can be 
defined as the ―entrapment of a compound or a system inside a dispersed material for its 
immobilization, protection, controlled release, structuration and functionalization‖ (Poncelot, 
2006). It provides an effective barrier and protects the cells from degradation by elements of 
the external environment and from various stresses present during production and/or storage. 
As such, it preserves the viability of the probiotic microorganism and improves its shelf life, 
even at room temperature (Del Piano et al., 2006). Some of the encapsulating materials used 
are gelatine gum, vegetable gum and alginate. When encapsulated probiotic microorganisms 
were incorporated in fermented frozen dairy desserts, yoghurt or freeze dried yogurt, they 
showed improved viability in comparison to their non-encapsulated counterparts (Capela et 
al., 2006; Ravula and Shah, 2000).  
 
Although there is evidence of the positive effects of microencapsulation for probiotics, it is 
still far from being used routinely in the industry, because the current technologies used 
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present difficulties for scaling up (Mortazavian et al., 2007; Burgain et al., 2011). The 
process of encapsulation itself can have detrimental effects on the viability of probiotic 
bacteria and can cause cell damage. Microencapsulation by spray drying, for instance, is an 
effective and economical technology for protecting materials, however, it is rarely considered 
for cell immobilization because it requires simultaneous dehydration and thermal inactivation 
steps which lead to high cell mortality (Anal and Singh, 2007). Methods for production of 
beads, such as extrusion cannot be used for large scale production due to slow formation of 
beads (Burgain et al., 2011). The emulsion method can be easily scaled up, but it is costlier 
than the extrusion method (Burgain et al., 2011). Also, the presence of residual oil on the 
capsule surface is detrimental to the texture and the organoleptic properties of the product. 
 
Encapsulation techniques are also limited by the size of beads. In their review, Anal and 
Singh (2007) point out that the large size of microbial cells or particles of freeze-dried culture 
limits cell loading for small capsules (Anal and Singh, 2007). Large capsules have 
undesirable effects on the textural and sensorial properties of food products to which they are 
added. However, reduction in capsule size may result in loss of protective ability of the 
capsule. For instance, it has been reported that very large calcium alginate beads (>1 mm) 
change the texture in live microbial feed supplement (Hansen et al., 2002). In addition, small 
beads (< 100 µm) are unable to significantly protect bacteria in simulated gastric juice when 
compared to unprotected cells. In some studies, it is evident that although microencapsulation 
of  Bifidobacteria and Lactobacillus spp. with calcium alginate improves survival during 
refrigerated storage, it does not cause a marked improvement in their survival when exposed 
to highly acidic environments such as simulated gastric juice (Chandramouli et al., 2004; 
Hansen et al., 2002; Anal and Singh, 2007; Mortazavian et al., 2008; Krasaekoopt et al., 
2004). In fact, in low pH conditions, the beads are known to significantly shrink in size and 
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exhibit decreased mechanical strength. In a recent study, after incubation in simulated gastric 
juice (pH 2.0, 2h), B. longum encapsulated in microspheres made from 1.5% (w/v) alginate - 
2% (w/v) human-like collagen showed a decrease in viability of 4.66 log CFU/ml (Su et al., 
2011). The total number of live bacteria after 2 h incubation in simulated gastric juice was 
4.81 log CFU/ml, lower than the recommended FAO value (6-7 log CFU/ml). 
 
Burgain et al. (2011) have highlighted the advantages and disadvantages of using different 
materials for encapsulation, such as alginate, gellan gum, κ-carrageenan, chitosan, starch, etc 
(Burgain et al., 2011). For instance,  κ-carrageenan beads keep the bacteria in a viable state 
but the produced gels are brittle and are not stress resistant (Chen and Chen, 2007). In 
addition, it needs potassium ions for structural stabilization, which is harmful for the body in 
high concentrations (Mortazavian et al., 2007). A mixture of chitosan with alginate is a good 
coating agent for reducing loss in viability of probiotic bacteria. However, it was seen to have 
inhibitory effects on Lactic acid bacteria (Groboillot et al., 1993). Starch has been shown to 
offer good protection to probiotic bacteria. In addition, because of its prebiotic functionality, 
starch can also be utilized by probiotic bacteria in the large intestine (Mortazavian et al., 
2008). However, starch was seen to enhance probiotic viability in the product, but not under 
simulated gastrointestinal conditions (Sultana et al., 2000). Moreover, starch is a 
polysaccharide made of up of a large number of glucose units joined together. Therefore, a 
health-promoting probiotic product containing starch is not ideal, especially for diabetic 
patients. Also, substances such as alginate, κ-carrageenan, gellan-gum or xanthan cannot be 
used as coating materials in dairy products in certain countries (Picot and Lacroix, 2004). 
 
Although microencapsulation has provided significant advancements in the field of 
probiotics, a number of issues regarding the formulation of a microencapsulated probiotic 
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product need to be addressed (Prakash et al., 2011). It is apparent from the studies mentioned 
above that a convincing solution to the problem of loss in viability of probiotics is yet to be 
achieved. 
 
Alternatively, the viability of probiotics in the product and subsequently in the 
gastrointestinal tract can be improved by addition of an appropriate prebiotic. Prebiotics are 
defined as ―non-digestible food ingredients that beneficially affect the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria in the colon that 
have the potential to improve health‖ (Gibson and Roberfroid, 1995). Prebiotics such as 
‗Raftilose®P95‘ have been successfully used to improve the viability of probiotics in yogurt 
(Capela et al., 2006). 
 
Shima et al. (2009) have come up with another way of preventing loss of viability of 
probiotic organisms due to the environmental stresses in the gastrointestinal tract (Shima et 
al., 2009). They found that incorporation of L. acidophilus in the inner-water phase of a 
water/oil/water (W/O/W) emulsion significantly improved the cell viability compared to free 
cells, when they were incubated in a model stomach solution for 2 h. 
 
Recently, chocolate matrices have also been used as delivery agents for probiotic bacteria 
(Possemiers et al., 2010). Dark and milk chocolates were evaluated for their protective effect 
on the viability of probiotic bacteria during their passage through the stomach and small 
intestine. Milk chocolate offered better protection to the cells (91% and 80% survival for L. 
helveticus and B. longum respectively) than dark chocolate, when they were passed through 
simulated gastric and intestinal juices for 3.5 h, and this was thought to be due to the presence 
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of 5-fold lower polyphenol content in milk chocolate. However, using milk chocolate as a 
delivery vehicle for probiotic bacteria might not be ideal for diabetic patients. 
 
As is evident from the literature, scientists are putting in considerable effort to come up with 
an optimum technology to avoid loss in viability of probiotic cultures due to different 
stresses, so that its usefulness in conferring health benefits to the consumer can be improved. 
It has been stated that the current commercial expansion in the use of probiotic bacteria in 
functional foods must be accompanied by an in depth understanding of the different factors 
inherent to technological process, the physicochemical environment of food and the 
gastrointestinal tract that affect viability and functionality of bacteria, along with new 
knowledge and exploration of new concepts to tackle these problems (Vinderola et al., 2011).   
 
2.7 NON-DAIRY PROBIOTIC PRODUCTS 
According to a report, 78% of current probiotic sales in the world are delivered through 
yoghurt (Granato et al., 2010). It is important to come up with probiotic delivery vehicles 
other than dairy products for those with lactose intolerance or with an allergy to milk proteins 
(Saarela et al., 2005). Identification of non-dairy probiotic foodstuffs to administer probiotic 
bacteria has an additional advantage, since these products may have reduced cholesterol 
levels when compared to dairy products (Granato et al., 2010). Recently, several such food 
products have been researched (Khalf et al., 2010; Ding and Shah, 2008; Possemiers et al., 
2010). Fruit juices could be attractive delivery agents for probiotic bacteria because they 
inherently contain essential nutrients, they are ―good looking‖ and have good taste (Luckow 
and Delahunty, 2004; Sheehan et al., 2007). However, fruit juices provide a less suitable 
environment for survival of probiotic bacteria. Viability of Bifidobacteria has been shown to 
be poorer in fruit juice than in milk (Saarela et al., 2006). One of the aims of this study was to 
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explore the use of γ-PGA as a delivery tool for probiotics in an attempt to improve survival of 
bacteria in orange and pomegranate juice during storage.   
 
2.8 USE OF γ-PGA WITH PROBIOTICS 
To our knowledge, γ-PGA has not been used for maintaining viability of probiotic bacteria 
during different stages of production, storage and ingestion. This work will utilize γ-PGA for 
a novel probiotic application where the effect of γ-PGA will be tested on the viability of 
probiotic bacteria during freeze drying, during storage in fruit juice and in simulated gastric 
juice.  
 
As previously discussed (see sections 1.1 & 1.5.1), γ-PGA has unique properties. It is edible, 
non-toxic and biodegradable. It has been shown to be stable at low pH and to dissolve readily 
at higher pH (Agresti et al., 2008). Since some of the major challenges for probiotic products 
is the survival of beneficial microorganisms in the low pH environments during extended 
cold storage and in the stomach, there is enough evidence to hypothesize that if probiotics are 
administered with γ-PGA, they will be protected from the deleterious effects of both of these. 
In the stomach, which is an environment of high acidity, γ-PGA would remain intact, thus 
masking the organisms from the surroundings. In the intestine, which is an environment of 
higher pH levels, γ-PGA would dissolve, thus delivering the organisms to the target site 
intact.  
 
Probiotic products, especially yoghurt, undergo freeze drying to lengthen preservation. 
However, freeze drying has been known to decrease viability and this has been successfully 
prevented with the use of cryoprotectants. It is a well-known fact that γ-PGA can be used as a 
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cryoprotectant (Mitsuiki et al., 1998; Mizuno et al., 1997; Shih et al., 2003). This application 
of γ-PGA could also be exploited with probiotics.  
 
Dairy products that deliver probiotics are also a rich source of calcium. People who are 
lactose intolerant also show an inadequate ingestion of calcium and other milk provided 
nutrients, since they do not consume appropriate amounts of dairy products. This increases 
the probability of developing bone disorders such as osteoporosis. Hence, it would be ideal if 
the delivery agent in a non-dairy probiotic product could improve calcium absorption in the 
intestine. Tanimoto and co-workers (2001) have demonstrated that γ-PGA accelerates the 
absorption of minerals in the rat small intestine (Tanimoto et al., 2001). Later, they also used 
human volunteers to prove that calcium absorption is better when it is administered with γ-
PGA (Tanimoto et al., 2007). Therefore, if γ-PGA is used in conjunction with calcium (or 
other minerals) and probiotics, it can possibly confer better health benefits on the consumer 
(for example, prevention or treatment of some calcium deficiency disorders). 
 
There is also concern over change in palatability of fruit juices when probiotic bacteria are 
introduced in them (Granato et al., 2010). γ-PGA has been used as a bitterness relieving agent 
(Sonoda et al., 2000) and it could help mask the change in taste of fruit juices with probiotic 
bacteria, thus improving drinkability. 
 
Another reason for the loss in viability of probiotics could be the induction of the hosts 
immune system upon ingestion of probiotic bacteria, which could potentially attack the 
delivered cells (Prakash et al., 2011). Protection of cells with γ-PGA could help to shield the 
cells from the body‘s immune system, since it is known that bacteria such as B. anthracis and 
S. epidermidis use γ-PGA in the capsule to escape the immune response of the host (Candela 
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and Fouet, 2006; Candela et al., 2005; Kocianova et al., 2005; Makino et al., 1989; Mesnage, 
1998; Zwartouw and Smith, 1956).  
 
While choosing a substance to protect probiotic bacteria, it is important to ensure that it helps 
maintain viability during all the stages where viability could be affected – freeze drying, 
during storage and after ingestion. The effect of γ-PGA on the viability of probiotic bacteria 
during these three steps will be evaluated. 
 
2.9 AIMS OF THIS STUDY 
 
The aims of this study are to:  
1. Investigate production of γ-PGA in shake flasks using two media. Eight bacteria will 
be used, six of which have not been investigated previously. 
2. Characterize the γ-PGA produced by each organism with respect to molecular 
weight, yield, form (salt or acid) and crystallinity using different analytical 
techniques. 
3. Recognize factors affecting properties of γ-PGA. 
4. Identify and choose the bacterium and medium that would be appropriate to produce 
γ-PGA for probiotic tests. 
5. Use the chosen bacterium and medium to produce γ-PGA using 5 l fermentations. 
6. Test the effect of γ-PGA on the viability of probiotic bacteria during freeze drying. 
7. Test the effect of γ-PGA on the viability of probiotic bacteria during incubation in 
orange and pomegranate juice. 
 
77 
 
  
8. Identify changes, if any, in the organic acid content and pH of fruit juices on 
introduction of probiotics to ensure maintenance of organoleptic and nutritional 
properties of the juices. 
9. Test the effect of γ-PGA on the viability of probiotic bacteria during storage in 
simulated gastric juice. 
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3. MATERIALS AND METHODS 
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3.1 γ-PGA PRODUCTION 
 
3.1.1 Bacterial Strains 
All bacteria (B. subtilis natto ATCC 15245, B. subtilis ATCC 23856, B. subtilis ATCC 
23857, B. subtilis ATCC 23858, B. subtilis ATCC 23859, B. licheniformis 9945a, B. 
licheniformis NCIMB 1525 and B. licheniformis NCIMB 6816) were obtained from National 
Collection of Industrial and Marine Bacteria (NCIMB). The stock cultures were freeze-dried 
and stored at -20°C. Before use, cultures were revived aseptically and grown aerobically on 
general purpose microbiology media overnight at 37°C.  
 
3.1.2 Growth Media 
Tryptone soya broth (TSB), tryptone soya agar (TSA) and one-quarter strength Ringer 
solution were purchased and prepared according to the manufacturer‘s protocol (Lab M, UK). 
The compositions are shown in Table 3.1 & 3.2. 
Table 3.1: Composition of TSB         Table 3.2: Composition of TSA 
     
To determine whether the bacteria under study could produce γ-PGA in the absence of 
precursors, GS medium was used. Medium E contains citric acid, which is known to be the 
best precursor for γ-PGA production (Du et al., 2005; Xu et al., 2005a). Hence, this medium 
Chemical Amount 
Tryptone (casein digest) 17 g/l 
Soy Peptone 3 g/l 
NaCl 5 g/l 
K2HPO4 2.5 g/l 
D-glucose 2.5 g/l 
Chemical Amount 
Tryptone (casein digest) 15 g/l 
Soy Peptone 5 g/l 
Agar No.2 12 g/l 
K2HPO4 2.5 g/l 
D-glucose 2.5 g/l 
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was used to assess whether the bacteria could produce γ-PGA in the presence of the 
precursor. The composition of GS and E media has been given in Tables 3.3 & 3.4. The pH 
of GS and E media was adjusted to 7.2 using 3 M NaOH and 1 M HCl.  
 
Table 3.3: Composition of GS medium  
Chemical Amount (g/l) Source 
L-glutamic acid 20 Sigma-Aldrich 
Sucrose 50 Acros Organics 
KH2PO4 2.7 Fisher Scientific 
Na2HPO4 4.2 AnalaR 
NaCl 50 Aldrich Chemical Co. Ltd 
MgSO4·7H20 5 AnalaR 
1 ml/l of filter sterilized Murashige-Skoog vitamin solution (2.0 mg/ml glycine, 100 mg/ml myo-inositol, 0.50 
mg/ml nicotinic acid, 0.50 mg/ml pyridoxine hydrochloride, 0.10 mg/ml thiamine hydrochloride) from Sigma-
Aldrich was added separately to GS medium. 
 
Table 3.4: Composition of Medium E 
Chemical Amount (g/l) Source 
L-glutamic acid 20 Sigma-Aldrich 
Citric acid 12 Acros Organics 
Glycerol 80 Avocado 
NH4Cl 7 Riedel-de Haën 
MgSO4·7H20 0.5 AnalaR 
FeCl3·6H20 0.2 Sigma-Aldrich 
K2HPO4 0.5 AnalaR (BDH) 
CaCl2·2H20 0.15 Fisher Chemicals 
MnSO4·H20 0.2 Sigma 
 
All media were prepared using de-ionised water and sterilized by autoclaving at 121ºC at 
1.035 BAR for 20 min. Sucrose solution was sterilised separately by autoclaving at 110ºC at 
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0.35 BAR for 30 min to avoid caramelization and vitamin solution was filter sterilised (0.2 
µm Ministart) and added separately to GS medium.  
 
3.1.3 Production of γ-PGA in shake flask cultures 
Production of γ-PGA with each bacterial strain in shake flasks was done independently in 
triplicate. Bacteria producing γ-PGA usually appear to be mucoid when grown on agar plates. 
Highly mucoid colonies of the appropriate strain were selected and inoculated in flasks 
containing 250 ml TSB and incubated at 37°C for 24h. At the end of 24 h, the seed culture 
reached a population of ~ 7 log CFU/ml. 5% of this culture was inoculated into 250 ml of γ-
PGA production medium. All flasks were incubated at 37ºC on a rotary shaker (Innova 43) at 
150 rpm. γ-PGA recovery time depends on the bacteria and medium used for production. 
Previous research has demonstrated that γ-PGA production in Bacillus usually takes place in 
the late logarithmic and stationary phase of the culture (Bajaj and Singhal, 2011; Buescher 
and Margaritis, 2007; Shi et al., 2007). Hence, in this study, γ-PGA was recovered after 96 h, 
which is seen to be the ideal time to recover γ-PGA from the culture. 5 ml samples were 
taken aseptically at 0, 24, 48, 72 and 96 h for analysis of cell growth and nutrient 
consumption. 
 
3.1.4 Scale-up of γ-PGA production in fermentation culture 
To produce γ-PGA for probiotic tests, 4 l batch fermentations of B. subtilis natto were 
performed in a 5 l Electrolab fermenter. Highly mucoid colonies were first selected and 
inoculated in flasks containing 250 ml of TSB at 37°C for 24 h. The fermenter was washed 
thoroughly and dried. The pH probe of the fermenter was calibrated according to 
manufacturer‘s instructions. GS medium (without sucrose) was added to the fermenter, after 
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which the fermenter was sealed appropriately and sterilized by autoclaving at 121˚C at 1.035 
BAR for 20 mins. Sucrose solution was sterilized separately by autoclaving at 110ºC at 0.35 
BAR for 30 min and added to the fermenter aseptically. Acid, base and antifoam bottles were 
connected to the fermenter while being careful to not introduce any contamination. pH of the 
medium was adjusted to 6.8 with 3 M NaOH and 3 M HCl using the Electrolab automatic pH 
control system. The fermentation temperature was maintained at 37°C using a heating jacket. 
The dissolved oxygen (dO2) probe was then calibrated according to manufacturer‘s protocol. 
Before adding the inoculum, Electrolab software was set up to monitor temperature, pH, dO2 
and agitation parameters. 5% of the inoculum was then added to the sterilized fermenter with 
GS medium. The stirring speed and airflow rate were set at 250 rpm and 2.0 l/min 
respectively at the start of fermentation. Since γ-PGA is an extracellular polymer, the culture 
medium becomes highly viscous with increasing polymer production. The increased viscosity 
decreases the volumetric oxygen mass transfer, leading to oxygen limitation. The supply of 
oxygen was maintained above 40% saturation by controlling the agitation speed and air flow 
rate.  
 
3.1.5 Isolation of γ-PGA 
After 96 h, the cell culture broth from the shake flasks or the fermenter was transferred 
equally (± 0.1 g) to 6 centrifuge tubes and centrifuged at 17000g for 30 minutes (Hermele 2 
300 K) to separate cells from the supernatant. The cell pellets were inactivated using trigene 
(Medichem International, UK) before being discarded appropriately. Four volumes of cold 
90% (v/v) ethanol was added to the cell free supernatant and incubated at 4°C for 72 h. Wet 
γ-PGA powder was obtained as sediment. The majority of the supernatant was removed using 
aspiration, while making sure that the sediment was not disturbed. The sediment was 
separated from the remaining supernatant by centrifugation at 17000g for 30 mins. The wet 
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crude polymer was then dissolved in water. This solution was introduced in Spectra/Por
®
 
Dialysis Membrane (MWCO: 10,000) tubes supplied by Spectrum Labs, UK. The tubes were 
sealed and placed in a beaker filled with deionised water at room temperature for 24 h. The 
water was changed at 2, 4 and 16 h to ensure a concentration gradient was maintained. This 
procedure eliminates impurities lower than 10,000 Da. The obtained pure polymer solution 
was prepared for lyophilisation in round bottom flasks. The flasks were rotated gently on a 
mixture of 90% (v/v) ethanol at -20ºC and dry ice to freeze the biopolymer in the form of a 
thin film. The frozen biopolymer was then lyophilized in an Edwards Freeze Dryer (UK), 
connected to an Edwards vacuum pump at -40 ºC at 5 MBAR pressure for 48-72 h to obtain 
dry γ-PGA powder. The pure dried powder was weighed to calculate yield in g/l and stored in 
a desiccator for further analysis and tests with probiotics. 
 
3.1.6 Determination of growth 
It was important to assess the growth of bacteria during the culture so that it could be 
compared with nutrient consumption and yield of γ-PGA obtained in different media. It 
would also help to ensure that the culture has not been contaminated with foreign 
microorganisms. Samples were taken aseptically at 0, 24, 48, 72 and 96 h to monitor cell 
growth. The Miles and Misra technique was used to calculate Colony Forming Units/ml 
(CFU/ml) in triplicate. Serial dilutions from 10
-1
 to 10
-10
 were performed by dispensing 0.5 
ml of sample in 4.5 ml of sterile 1/4
th
 strength Ringer solution. 20 µl of each dilution was 
dispensed onto TSA plates under aseptic conditions. The plates were then incubated 
aerobically at 37°C for 24 h, after which plates with less than 20 colonies were selected and 
used for viable count determination. Viable cell count in CFU/ml was calculated using the 
formula:  
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FDvolumeSample
n
ml
CFU   
Where:  
n is the number of colonies  
D.F. is the dilution factor 
3.1.7 Chemical analysis 
3.1.7.1 Nutrient consumption analysis 
It was essential to identify how the carbon and nitrogen sources were consumed by the 
bacteria in GS and E media. Comparing the consumption of nutrients to the growth of 
bacteria and yield of γ-PGA produced may provide important information of nutrient 
preference of bacteria. Nutrient consumption analysis was performed using High 
Performance Liquid Chromatography (HPLC). HPLC is a chromatographic analytical 
technique used for separation, identification and quantification of analytes based on selective 
partitioning of the molecules of interest between two different phases. The sample is 
introduced into the mobile phase and is passed through a column (stationary phase) using 
pressure. Depending on the size and interactions of the analytes present in the sample with 
the column, the analytes are eluted at different times. The characteristic retention times of the 
analytes and the chromatogram obtained are used for identification and quantification.  
 
An HP series 1100 HPLC machine at University of Reading (Department of Food and 
Nutritional Sciences), U.K. was used for analysis. A Prevail Organic Acid 5µm column with 
a UV detector was used for analyzing L-glutamic acid whereas a Phenomenex carbohydrate 
column (Rezex RCM - monosaccharide Ca
2+ 
- 8%) was used for sucrose and glycerol 
determination. Filtered deionised water was used as the eluent for sucrose/glycerol analysis. 
For organic acid analysis, 25 mM KH2PO4 (pH 2.5 adjusted with phosphoric acid) was used 
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as the eluent. Before loading, the samples were filtered using 0.45 µm filters and were diluted 
10 fold with filtered deionised water. 
 
To identify and quantify L-glutamic acid, sucrose and glycerol in the samples, known 
concentrations of these analytes were first used to prepare standard curves (Fig 3.1). 
 
  
 
Fig 3.1: L-glutamic acid, sucrose and glycerol standard curves for nutrient consumption analysis using 
HPLC. Some standard error bars are too small to be seen. 
 
3.1.7.2 Identification of γ-PGA 
It was important to identify the recovered polymer as γ-PGA. Isolated biopolymer was 
analysed using Fourier Transform InfraRed spectroscopy (FT-IR). FT-IR is a quick, non-
destructive technique and provides precise measurement which requires no external 
calibration. This technique involves infrared radiation being passed through the sample. The 
radiation is absorbed or transmitted by the sample. The resulting spectrum represents the 
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molecular absorption and transmission and can be considered to be a molecular fingerprint of 
the sample. Every molecular structure yields its unique spectrum and 2 distinct molecular 
structures will never produce the same infrared spectrum. Each absorption peak on the FT-IR 
spectrum represents the frequencies of vibrations between the bonds of the atoms making up 
the material. The FT-IR spectra can be used as a qualitative analysis tool to identify unknown 
materials and determine the quality or consistency of the sample. 
 
An Impact 404 Nicolet spectrometer (UK) with KBr pellet in conjunction with OMNIC 
software was used for γ-PGA produced by bacteria in GS medium. A background scan was 
first performed with no sample. Preparation of sample for FT-IR analysis was performed by 
mixing 0.5 g of γ-PGA thoroughly with 0.5 g KBr using a mortar and pestle. A hydraulic 
press (Graseby Specac) was used to produce a sample disc, which was then placed in the 
sample holder and scanned. The FT-IR spectra of produced γ-PGA were compared with the 
spectra of a commercially available γ-PGA sample (Crescent Innovations Inc.). 
 
For γ-PGA produced by bacteria in medium E, a Genesis II FTIRTM (UK) was used. This 
instrument does not need any sample preparation. 0.5 g of finely ground γ-PGA was placed 
onto the diamond attenuated total reflector. A background scan was performed after which, 
the sample was scanned to produce spectra. 
 
3.1.7.3 Elemental analysis of γ-PGA 
γ-PGA produced by bacteria in different media could be either in the form of a salt or free 
acid or a mixture of the two. To assess the percentages of different salt forms and free acid 
form of γ-PGA, elemental analysis was performed using Inductively Coupled Plasma-Atomic 
Emission Spectroscopy (ICP-AES). ICP-AES is an analytical technique used for the detection 
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of elements in a compound. It involves the use of inductively coupled plasma that produces 
excited atoms and ions which emit electromagnetic radiation at wavelengths characteristic of 
a particular element. The intensity of this emission is representative of the concentration of 
the element within the sample.  SPECTRO CIROS
CCD
 was used for ICP-AES analysis.  
Sample preparation is crucial for ICP-AES. First, the γ-PGA sample needs to be dissociated 
into its component elements. Therefore, prior to the analysis, 6 ml HNO3 (70%) and 1 ml 
H2O2 (30% w/v) was added to 0.25 g of dried γ-PGA. The volume was made up to 25 ml and 
this solution was digested using an ETHOS 900 Microwave Labstation (Milestone 
Microwave Laboratory System) using a previously fed program. For ICP-AES analysis, the 
sample was aspirated using a sipper probe connected to a peristaltic pump. The sample was 
then scanned for a range of elements and the concentration of each element in the sample was 
represented in ppm. The concentration of the elements obtained after ICP-AES analysis 
represents the salt form of γ-PGA of that particular element. The concentration of salt form in 
percentage (from ppm) was calculated as follows: 
 
 % content of salt form of γ-PGA = (Mw of γ-PGA salt)   (Concentration of element in ppm)
(Mw of element)   10
6   D          
Where: 
Mw is the molecular weight 
D.F. is the dilution factor 
 
3.1.7.4 Molecular weight of γ-PGA 
Knowledge of γ-PGA molecular weight is crucial since it can directly determine the 
application for which γ-PGA is used. Conventional aqueous based gel permeation 
chromatography (GPC) was used to determine molecular weight (Mw), molecular number 
(Mn) and polydispersity index (Pd). Pd is the measure of distribution of molecular mass in a 
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given polymer sample and is calculated by the formula: 
n
w
M
M
Pd  . Pd can have a value ≥ 1. 
The closer the value of Pd to unity, the more homogenous the polymer is with respect to its 
molecular weight. GPC separates analytes on the basis of their size. Analytes are made to 
pass through porous beads packed in a column. The smaller analytes can easily enter the 
pores and hence spend more time in the column. This increases their retention time. In 
contrast, larger analytes cannot enter the pores as efficiently, and hence, their retention time 
is much shorter. 
 
Molecular weight analysis was performed at Smithers Rapra in Shrewsbury, U.K. An MZ 
Hema guard plus 2 x Hema Linear column was used for analysis. Since γ-PGA is insoluble in 
organic solvents, they cannot be used as an eluent. Hence, 0.2 M NaNO3, 0.01 M NaH2PO4 at 
pH 7 was used as the eluent with a flow rate of 1.0 ml/min at 30°C and a Refractive Index 
(RI) detector (with differential pressure and light scattering). The data was collected and 
analysed using Polymer Laboratories ―Cirrus‖ software. Sample preparation involved adding 
10 ml of eluent to 20 mg of sample to give a concentration of 2 mg/ml. This was left 
overnight to dissolve. The solutions were well mixed and filtered through a 0.45 µm PVDF 
membrane into autosampler vials. GPC system used for this work was calibrated with sodium 
polyacrylate calibrants obtained from Polymer Laboratories. 
 
3.1.7.5 Crystallinity of γ-PGA 
Crystallinity of a polymer influences polymer properties such as hardness, tensile strength, 
stiffness, solubility and melting point. Hence, it plays an important role when selecting a 
polymer for an application. A polymer usually contains both crystalline and amorphous 
phases arranged randomly. A crystalline phase is where the atoms are arranged in a regular 
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repeating pattern in the structure. In contrast, in an amorphous phase, there is no such order 
and the arrangement is haphazard.  
 
Crystallinity was assessed at Queen Mary University of London using powder X-Ray 
Diffraction (XRD) analysis. XRD is an analytical technique where a beam of X-ray is passed 
through a polymer sample. Regularly arranged atoms (crystalline phase) in the sample reflect 
the beam constructively and are represented by sharp, narrow diffraction peaks on the XRD 
spectrum, whereas randomly occurring atoms (amorphous phase) would be represented by 
very broad peaks. Data from XRD analysis of γ-PGA was collected at room temperature with 
a Phillips PW1700, 40kV/40mA, CuKα instrument. 
 
3.2 PROBIOTICS 
 
3.2.1 Bacterial strains for probiotic tests 
Three probiotic bacteria (Bifidobacterium longum NCIMB 8809, Bifidobacterium breve 
NCIMB 8807 and Lactobacillus paracasei NCIMB 8835) were used for the tests. All bacteria 
were obtained from NCIMB. The stock culture was freeze-dried and stored at -20°C. Before 
use, the cultures were revived aseptically and grown anaerobically on Bifidus Selective 
Medium Agar (BSM Agar) for Bifidobacteria and DeMan Rogosa Sharpe (MRS) agar for 
Lactobacillus at 37°C in jars using an atmosphere generation system (Oxoid AnaerogenTM) 
and indicator strip.  
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3.2.2 Growth media 
Trypticase-Phytone-Yeast extract (TPY) and BSM were used for growth and enumeration of 
Bifidobacteria under study (Nualkaekul et al., 2011). TPY can be used for enumeration of 
Bifidobacteria, but it is important to note that it is not a selective medium. TPY broth and 
agar were prepared in the lab from their constituent ingredients. The composition for TPY 
medium is given in Table 3.5. 
 
Table 3.5: Composition of TPY medium 
Chemical Amount Source 
Lag phase tryptone 10g/l Lab M 
Neutralised soya peptone 5g/l Oxoid 
Glucose 5g/l Thornton & Ross 
Tween 80 1ml/l Acros Organic 
Yeast extract 2.5g/l Lab M 
Cystein hydrochloride 0.5 g/l Sigma Aldrich 
Dipotassium phosphate, K2HPO4 2g/l Sigma Aldrich 
Magnesium chloride hexahydrate, MgCl2·6H2O 0.5g/l May & Baker 
Zinc sulphate heptahydrate, ZnSO4·7H2O 0.25g/l AnalaR 
Calcium chloride, CaCl2 0.15g/l Fisher Chemical 
Ferric chloride, FeCl3 Trace Sigma Aldrich 
Agar No. 2 (For TPY agar) 15g/l Lab M 
The final pH of the medium was adjusted to 6.5 ± 0.1 using 3 M NaOH and 3 M HCl. TPY was sterilized at 
110ºC and 0.35 BAR for 30 mins to avoid caramelization of glucose. 
 
For tests which required enumeration of Bifidobacteria in the probable presence of other 
bacteria, BSM agar was used. BSM is used for the selective isolation, identification and 
enumeration of Bifidobacteria. This medium contains selective salts that inhibit the growth of 
moulds, Lactobacilli, Streptococci, Enterococci and other Gram negative bacteria. It also 
contains a compound that inhibits glycolysis by inactivating glyceraldehyde-3-phosphate 
dehydrogenase present, which is important in different bacteria and fungi. The presence of 
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three antibiotics in the medium makes it selective by inhibiting bacterial flora like Bacilli, 
Enterobacteriaceae and Pseudomonas. In addition, BSM contains an azo compound that 
Bifidobacteria can reduce, which gives the colonies a pink-purple colour.  
 
For Lactobacillus, MRS medium was used. BSM agar and MRS broth/agar were purchased 
and prepared according to the manufacturer‘s protocol (Sigma-Aldrich, U.K.). The 
composition of MRS agar/broth has been given in Tables 3.6 & 3.7 below.  
Table 3.6: Composition of MRS agar 
Chemical Amount 
Diammonium hydrogen citrate 2 g/l 
Dipotassium hydrogen phosphate 2 g/l 
D(+)-glucose 20g/l 
Magnesium sulphate 0.1 g/l 
Manganous sulphate 0.05 g/l 
Meat extract 5 g/l 
Sodium acetate 5 g/l 
Universal peptone 10 g/l 
Yeast extract 5 g/l 
Agar 12 g/l 
The final pH of the medium was 6.5 ± 0.2. 
 
Table 3.7: Composition of MRS broth 
Chemical Amount 
Dipotassium hydrogen phosphate 2 g/l 
D(+)-glucose 20g/l 
Magnesium sulphate heptahydrate 0.2 g/l 
Manganous sulphate tetrahydrate 0.05 g/l 
Meat extract 8 g/l 
Peptone 10 g/l 
Sodium acetate trihydrate 5 g/l 
Triammonium citrate 2 g/l 
Yeast extract 4 g/l 
The final pH of the medium was 6.2 ± 0.2 
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MRS and BSM were prepared using de-ionised water and sterilized at 121ºC and 1.035 BAR 
for 20 min.  
 
3.2.3 Sterilization of γ-PGA 
Sterilization of γ-PGA is an important step before using it for a probiotic application to make 
sure that the residual cell population in the γ-PGA sample does not interfere with the 
subsequent results of probiotic tests. There is no reference to sterilization of γ-PGA in the 
literature. Therefore, several sterilization techniques were assessed before selecting the most 
appropriate for the future tests.  
 
Method 1: 10% γ-PGA solution was filter sterilized using a 0.45µm filter.  
Method 2: The effect of ethanol treatment on γ-PGA was also tested. 95% ethanol was added 
to γ-PGA. Since γ-PGA is insoluble in ethanol, the ethanol treated γ-PGA was centrifuged at 
17000g for 15 minutes. The ethanol (supernatant) was aspirated using a sterile pipette and the 
excess ethanol was evaporated at 50⁰C in an oven to obtain a dry γ-PGA powder. This 
powder was checked for residual contaminants by serially diluting a solution of γ-PGA in 
sterile 1/4
th
 strength Ringer solution and plating on TSA plates which were incubated 
aerobically/anaerobically for 24-48 h at 37˚C. 
Method 3: γ-PGA was also treated with different concentrations of H2O2 (1%, 3%, or 5%) 
for 30 minutes.  γ-PGA is soluble in H2O2. Hence, after treatment, γ-PGA was extracted and 
isolated using ethanol precipitation according to the description in section 2.1.4. After 
precipitation, γ-PGA was centrifuged at 17000g for 30 minutes to obtain wet pellets of γ-
PGA. The pellets were dried in the oven at 50˚C to obtain dry γ-PGA powder and this was 
checked for contamination as described previously. 
 
93 
 
  
Method 4: 10% γ-PGA solution was autoclaved at 121˚C at 1.035 BAR for 20 mins and at 
110˚C at 0.35 BAR for 30 mins. The autoclaved solutions were checked for contamination as 
described previously. 
 
FT-IR analysis was performed on γ-PGA samples sterilized by H2O2 treatment and 
autoclaving to identify any change in the identifiable bonds within γ-PGA due to the 
sterilization process. 
 
3.2.4 Scanning Electron Microscopy (SEM) analysis 
SEM analysis was performed to determine the surface structure of freeze dried cells protected 
with γ-PGA. Samples were prepared by freeze drying and grinding the γ-PGA-protected and 
unprotected cells to obtain a fine dry powder. Samples were then coated with gold using a 
sputter coater. Analysis was done using an SEM (Zeiss EVO50, UK) and photographs were 
analysed using the Smart SEM software. 
 
3.2.5 γ-PGA as cryoprotectant 
Cryoprotectant tests were first performed with γ-PGA that was sterilized by autoclaving at 
110˚C and 0.35 BAR for 30 mins (henceforth mentioned as γ-PGA[S]). For these tests, TPY 
medium was used for growth and enumeration of cells, since the presence of residual bacteria 
in γ-PGA[S] had been eliminated by sterilization. Hence, a selective media for enumeration 
was not necessary. To ascertain whether autoclaving had any effect on the cryoprotective 
ability of γ-PGA, cryoprotectant tests were repeated with untreated γ-PGA (γ-PGA[U]). 
However, for these tests, it was necessary to use a selective and differential media (BSM) for 
enumeration of cells protected with γ-PGA[U], because of the probable presence of some 
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residual bacteria in the γ-PGA sample. To compare results of cryoprotectant tests with γ-
PGA[S] and γ-PGA[U], it was necessary to confirm that the growth of Bifidobacteria on TPY 
and BSM was comparable. Therefore, B. breve and B. longum were grown in TPY broth (22 
h for B. breve and 16 h for B. longum) at 37 °C anaerobically. After incubation, cells were 
enumerated on TPY agar and BSM agar and viable cell counts on both media were compared. 
 
To protect cells with cryoprotectant before freeze drying, Bifidobacteria were inoculated in 
TPY broth (22 h for B. breve and 16 h for B. longum) and Lactobacillus paracasei was 
inoculated in MRS broth (for 48 h) at 37°C anaerobically (as described previously). After 
incubation, viable counts were taken on TPY/BSM agar (Bifidobacteria) and MRS agar 
(Lactobacillus) to determine number of viable cells before freeze drying. The cultures were 
then centrifuged and washed with Phosphate Buffered Saline (PBS) to obtain cell pellets. 
Cells were then mixed thoroughly in 10 ml solutions of 20% γ-PGA, 10% γ-PGA, 5% γ-PGA 
and 10% sucrose. For cells without a cryoprotectant, 10 ml of water was added. The 
suspensions were incubated at room temperature for 1 h and then frozen at -80°C for 24 h. 
The frozen cultures were then freeze dried (Edwards Freeze Dryer, UK) at -40˚C and 5 
MBAR pressure for 48 h. After freeze drying, 10 ml of PBS was added to all the cells and 
viability was measured to determine number of viable cells after freeze drying. After 
appropriate dilution, samples were plated on suitable media and incubated at 37˚C 
anaerobically for 48 h, as described previously. All tests were done in triplicate. These tests 
were repeated with γ-PGA[U] (for B. breve and B. longum). 
 
3.2.6 Protection in fruit juice  
It is important to develop non-dairy foodstuffs for delivering probiotics. Commercially 
available orange juice (Tropicana orange juice, Pure Premium Smooth No Bits) and 
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pomegranate juice (POM Wonderful 100% Pomegranate juice) were purchased from 
Waitrose, Wolverhampton, UK. Fresh samples of these fruit juices were requested. These 
juices were selected because they did not contain any preservatives and they have nutritional 
value. Bacteria were grown anaerobically (as described previously) in TPY broth (22 h for B. 
breve and 16 h for B. longum) at 37 °C. The culture was then centrifuged and washed with 
PBS to obtain cell pellets. Pellets were then mixed thoroughly in a 10% γ-PGA[S] solution. 
This mixture was incubated at room temperature and frozen at -80 °C and freeze dried to 
obtain a dry powder containing cells protected with γ-PGA. 1 ml PBS was added to the dry 
powder and this solution was transferred to 40 ml of orange juice. The final concentration of 
γ-PGA in fruit juice was ~ 2.5 % (w/v). For tests with unprotected cells, cells were inoculated 
in TPY broth using the aforementioned conditions. Cell pellets were obtained after 
centrifugation and washing with PBS. 1 ml of PBS was added to the cells. This solution was 
added to orange juice. Viability was measured at day 0, 2, 4, 6, 8, 11, 13, 20, 28 and 39 for 
unprotected and γ-PGA-protected cells on BSM agar. After appropriate dilution, samples 
were plated on BSM agar and incubated anaerobically (as described previously) at 37˚C for 
48 h. 
 
3.2.7 Organic acid concentration in fruit juice 
It was important to assess the change in organic acid composition of fruit juice when 
unprotected and γ-PGA-protected cells were added to it to determine any alteration in its 
nutritional and organoleptic properties. Organic acid analysis was performed using HPLC 
with an HP series 1100 HPLC instrument at the University of Reading, U.K. A Prevail 
Organic Acid 5µm column with a UV detector was used for citric acid, malic acid, lactic 
acid, acetic acid and ascorbic acid. 25 mM KH2PO4 (pH 2.5 adjusted with phosphoric acid) 
was used as the eluent. Before loading, the samples were filtered using 0.45 µm filters and 
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were diluted 10 fold. Standard curves were prepared using known concentrations of 
chemicals to be analysed (Fig 3.2). 
 
 
 
Fig 3.2: Ascorbic acid, citric acid and malic acid standard curves for determination of change in organic 
content in orange and pomegranate juice on addition of unprotected probiotic cells and γ-PGA-protected 
probiotic cells using HPLC. Standard error bars are too small to be seen. 
 
3.2.8 Protection in simulated gastric juice 
There is a heavy loss in the viability of probiotic bacteria when they pass through the 
stomach, which is a region of high acidity. The time required for food to transit through the 
stomach varies by individual, ranging from 0.5 to 4.5 hours (Hsieh et al., 2009). Hence, the 
protective effect of 2.5% γ-PGA was tested on viability of the 2 Bifidobacteria strains when 
stored in simulated gastric fluid for 4 h. Simulated gastric fluid contained 2 g/l NaCl, 3.2 g/l 
pepsin powder and 20 ml of 1 M HCl (British Pharmacopoeia Commission, 1993). The 
components were diluted in 900 ml deionised water and after pH adjustment (pH 2.0), the 
volume was topped up to 1 L. pH was adjusted using 1 M HCl or 1 M NaOH. This model 
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solution was sterilized by passage through a sterile 0.2 µm syringe filter. Tests were carried 
out in an Electrotek Anaerobic Workstation where a microaerophilic environment was 
maintained (10% CO2 and 5% O2). This would also test the effect of γ-PGA on the viability 
of bacteria when exposed to some oxygen just before ingestion. The aforementioned protocol 
was followed to protect cells with γ-PGA. Viability was measured at 0, 1, 2, 3 and 4 h for γ-
PGA-protected and unprotected cells on BSM agar as described previously.  
 
3.3 STATISTICAL ANALYSES 
All results were analysed using Microsoft Excel 2010 and GraphPad Prism 5. Two-factor 
Anova and student‘s T test were used to compare data. The Bonferroni multiple comparison 
test was used for non-parametric analysis of data to determine the difference between 
individual groups in a data set. P value ≤ 0.05 was considered to be statistically significant. 
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4. RESULTS - BACTERIAL γ-PGA PRODUCTION  
IN SHAKE FLASKS 
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4.1 Introduction 
This section describes the production of γ-PGA using eight different strains of Bacillus in GS 
and E media. Of these bacteria, B. subtilis natto and B. licheniformis 9945a have been 
investigated for γ-PGA production previously (Bajaj and Singhal, 2011; Buescher and 
Margaritis, 2007; Shih and Van, 2001). However, the remaining six bacteria used in this 
study have not previously been used for this purpose. Hence, this study would contribute new 
bacteria for γ-PGA production. Samples were taken at regular intervals during the shake flask 
cultures to assess growth of bacteria producing γ-PGA. In addition, nutrient consumption 
analysis was performed to assess the bacterial utilization of nutrients in different growth 
media to identify which medium is best suited for growth and γ-PGA production for each 
bacterium. After production of γ-PGA in shake flasks, yield of γ-PGA obtained by bacteria in 
different growth media was evaluated and the product was identified using FT-IR. On 
identifying the polymer as γ-PGA, the form, crystallinity and molecular weight was assessed 
using ICP-AES, XRD and aqueous based GPC respectively. Characterization of γ-PGA with 
respect to these properties is important to produce a more consistent and a better quality 
product. Identifying different properties of γ-PGA is also crucial because they determine for 
which application γ-PGA could be used. It was found that the yield of γ-PGA and other 
properties, such as molecular weight, crystallinity and form (acid/salt) can be different for 
each bacterium in each medium. 
 
4.2 Growth and nutrient utilization for Bacillus strains 
Eight different bacteria were grown in GS and E media at 37˚C and 150 rpm for 96 h in shake 
flasks to investigate the production of γ-PGA. Samples were taken aseptically at regular 
intervals (6, 24, 48, 72 and 96 h) to determine growth and assess how nutrients in both media 
were utilized by the cells. It is important to ascertain how nutrient utilization and growth 
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change with different bacteria and media to get more insight into appropriate medium for 
bacterial growth and γ-PGA production. It is also important to identify a relationship between 
growth and utilization of a nutrient, if any, for each bacterial strain. Growth was measured 
using the Miles & Misra plate count technique. Nutrient consumption analysis was performed 
using HPLC. L-glutamic acid and sucrose consumption was evaluated for bacterial culture 
grown in GS medium, whereas L-glutamic acid and glycerol consumption was assessed for 
those grown in medium E. 
 
4.2.1 B. subtilis 23856 
In GS medium, a rapid increase in cell count (from 4.96 log CFU/ml to 7.8 log CFU/ml. See 
Fig 4.1a) was observed in the first 24 h. The bacterial cell count reached maximum by 24 h, 
after which stationary phase commenced. A reduction in cell count was seen after 72 h. B. 
subtilis 23856 also utilized a considerable amount (37.76 g/l of the 50 g/l provided) of 
sucrose in the first 24 h of growth. Eventually, bacteria consumed 12.94 g/l of the 20 g/l of L-
glutamic acid provided and 45.33 g/l of sucrose by 96 h. The concentration of sucrose in the 
medium did not change significantly once cells entered death phase (after 72 h). 
 
In medium E, an increase in the viable cell count for B. subtilis 23856 (from 5.40 log CFU/ml 
to 7.41 log CFU/ml. See Fig 4.1b) in the first 24 h of growth was accompanied by 
consumption of 27.23 g/l of glycerol. The maximum cell count (7.95 log CFU/ml) was 
achieved by 72 h of growth in medium E. Bacteria consumed approximately half (39.91 g/l) 
of the provided glycerol by 96 h. Some glycerol was also consumed after the cell count 
started decreasing after 72 h (i.e. during death phase). Also, only 4.89 g/l of L-glutamic acid 
was utilized by the cells at the end of 96 h. 
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Fig 4.1: Growth and nutrient utilization for B. subtilis 23856 when grown in a) GS medium & b) medium 
E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in triplicate 
(n = 3). 
 
4.2.2 B. subtilis 23857 
When B. subtilis 23857 was grown in GS medium, the cell count increased (from 4.96 log 
CFU/ml to 7.93 log CFU/ml) in the first 24 h, which is when the maximum cell count was 
attained (Fig 4.2a). A rapid decrease in the sucrose and L-glutamic acid concentration in first 
24 h of growth was observed. Eventually, cells utilized 44.09 g/l of the 50 g/l of sucrose 
provided and 11.70 g/l of the 20 g/l of L-glutamic acid provided by 96 h. 
 
In medium E, the maximum cell count was attained by 48 h (7.72 log CFU/ml), although cell 
counts at 24 h and 72 h were not significantly different (P > 0.05. See Fig 4.2b). Rapid cell 
growth in the first 24 h was accompanied by a reduction in glycerol (from 80 g/l to 47.78 g/l) 
and L-glutamic acid concentration (from 20 g/l to 16.64 g/l) in the medium. Eventually cells 
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consumed 43.34 g/l of glycerol by 96 h, whilst only 5.94 g/l of L-glutamic acid was 
consumed by this time. No drastic loss in cell viability was seen after 72 h. 
 
 
 
Fig 4.2: Growth and nutrient utilization for B. subtilis 23857 when grown in a) GS medium and b) 
medium E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in 
triplicate (n = 3). 
 
4.2.3 B. subtilis 23858 
Bacillus subtilis 23858 reached a maximum cell count of 9.58 log CFU/ml after 72 h of 
growth in GS medium (Fig 4.3a). A steady decrease in sucrose concentration was seen over 
96 h, with 45.38 g/l of sucrose being consumed by the cells at the end of the culture. The L-
glutamic acid concentration decreased to 3.55 g/l after 96 h, indicating that cells utilized most 
of the provided nutrients. Although L-glutamic acid concentration increased slightly after 72 
h, it was not significantly differently from the concentration at 72 h (P > 0.05). 
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In medium E, the cell count of B. subtilis 23858 did not reach as high as that in GS medium 
(Fig 4.3b). A rapid increase in cell growth was seen in the first 24 h, when viable cell count 
increased from 5.10 to 7.60 log CFU/ml. The maximum cell count was achieved after 72 h 
(7.91 log CFU/ml) and 40.20 g/l of glycerol was consumed by the cells by 96 h. The glycerol 
concentration was seen to decrease slightly even after cell death had commenced. 5.70 g/l of 
the 20 g/l of L-glutamic acid provided was utilized by cells at the end of 96 h.  
 
 
 
Fig 4.3: Growth and nutrient utilization for B. subtilis 23858 when grown in a) GS medium and b) 
medium E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in 
triplicate (n = 3). 
 
4.2.4 B. subtilis 23859 
In GS medium, B. subtilis 23859 grew to a maximum cell count of 8.76 log CFU/ml (Fig 
4.4a). Rapid cell growth was seen in the first 24 h of growth (5.08 – 7.43 log CFU/ml), when 
bacteria consumed 16.82 g/l of sucrose. At the end of 96 h, a total of 42.16 g/l of sucrose was 
4.5
5.5
6.5
7.5
8.5
9.5
10.5
0 10 20 30 40 50 60 70 80 90 100
L
o
g
 C
F
U
/m
l 
Time (h) 
Growth curve  
 B. subtilis 23858 - GS medium 
B. subtilis 23858
2
4
6
8
10
12
14
16
18
20
0
5
10
15
20
25
30
35
40
45
50
0 10 20 30 40 50 60 70 80 90 100
L
-g
lu
ta
m
ic
 a
ci
d
 (
g
/l
) 
S
u
cr
o
se
 (
g
/l
) 
Time (h) 
Nutrient utilization   
B. subtilis 23858 - GS medium 
Sucrose
L-glutamic acid
5
5.5
6
6.5
7
7.5
8
8.5
0 10 20 30 40 50 60 70 80 90 100
L
o
g
 C
F
U
/m
l 
Time (h) 
Growth curve  
 B. subtilis 23858 - Medium E 
B. subtilis 23858
14
15
16
17
18
19
20
35
40
45
50
55
60
65
70
75
80
0 10 20 30 40 50 60 70 80 90 100
L
-g
lu
ta
m
ic
 a
ci
d
 (
g
/l
) 
G
ly
ce
ro
l 
(g
/l
) 
Time (h) 
Nutrient utilization   
B. subtilis 23858 - Medium E 
Glycerol
L-glutamic acid
a) 
b) 
 
104 
 
  
consumed. With the exception of the growth period between 6 h and 24 h, when only 1.49 g/l 
of sucrose was consumed, a steady decrease in the sucrose concentration was seen over 96 h. 
A rapid decrease in the L-glutamic acid concentration (9.76 g/l) was also seen in the first 6 h 
of growth, after which a steady decrease was observed. At the end of the culture, 13.45 g/l of 
L-glutamic acid was consumed by the cells.  
 
In medium E, B. subtilis 23859 reached a maximum cell count of only 7.55 log CFU/ml after 
24 h (Fig 4.4b). A loss in viability was seen between 72 and 96 h (from 7.14 to 4.93 log 
CFU/ml). A total of 50.37 g/l of glycerol and 5.26 g/l of L-glutamic acid were consumed by 
96 h. Glycerol and L-glutamic concentration was seen to decrease even after the cell count 
started decreasing (after 72 h). 
 
 
 
Fig 4.4: Growth and nutrient utilization for B. subtilis 23859 when grown in a) GS medium & b) medium 
E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in triplicate 
(n = 3). 
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4.2.5 B. subtilis natto 
For B. subtilis natto, a rapid increase in the viable cell count (from 4.99 log CFU/ml to 9.03 
log CFU/ml) was observed in the first 24 h of growth, which was accompanied by a rapid 
utilization of sucrose (Fig 4.5a). A loss in cell viability was seen after 72 h, whilst there was 
no change in the sucrose concentration observed after this time. At the end of 96 h, B. subtilis 
natto utilized almost all (19 g/l) of the 20 g/l of L-glutamic acid provided. The L-glutamic 
acid concentration rapidly decreased in the first 24 h of cell growth and continued to 
decrease, even after cell death commenced in the culture.  
 
 
 
 
Fig 4.5: Growth and nutrient utilization for B. subtilis natto when grown in a) GS medium & b) medium 
E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in triplicate 
(n = 3). 
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In medium E, B. subtilis natto reached a maximum cell count (8.11 log CFU/ml) only after 72 
h (Fig 4.5b). The cells appeared to increase in number gradually and could not grow in 
medium E as quickly as they did in GS medium. Of the 80 g/l of glycerol provided in 
medium E, only 39.65 g/l was utilized by B. subtilis natto. Approximately 30 g/l of glycerol 
was consumed in the first 24 h of growth, after which only 9.5 g/l was consumed. Only 4.66 
g/l of the provided L-glutamic acid (20 g/l) was consumed after 96 h. Interestingly, the L-
glutamic acid concentration at 96 h was significantly higher (P < 0.05) than that observed at 
72 h. In contrast to observations in GS medium, a rapid reduction in cell count was not seen 
in medium E after 72 h. This could possibly be due to the fact that nutrients were still 
available and cells were still in stationary phase at the end of 96 h.  
 
4.2.6 B. licheniformis 1525 
In GS medium, rapid cell growth of B. licheniformis 1525 was observed for the first 24 h, 
reaching a maximum cell count of 9.02 log CFU/ml after 48 h (Fig 4.6a). This was followed 
by stationary phase, with cell death being seen after 72 h in culture. 47.38 g/l of sucrose was 
consumed at the end of 96 h, although very little sucrose was consumed after 72 h, when cell 
viability decreased. A total of 7.84 g/l of L-glutamic acid was consumed by the cells.  
 
In medium E, cells grew to a maximum cell count of 8.57 log CFU/ml by 72 h, after which a 
reduction in cell viability was seen (Fig 4.6b). B. licheniformis 1525 utilized 52.51 g/l of 
glycerol and 6.84 g/l of L-glutamic acid after 96 h. Glycerol and L-glutamic acid 
concentration was seen to decrease even after cell death commenced in the culture.   
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Fig 4.6: Growth and nutrient utilization for B. licheniformis 1525 when grown in a) GS medium and b) 
medium E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in 
triplicate (n = 3). 
 
4.2.7. B. licheniformis 6816 
In GS medium, B. licheniformis 6816 achieved a maximum cell count of 8.95 log CFU/ml 
after 24 h, after which stationary phase commenced (Fig 4.7a). Very little (1.65 g/l) sucrose 
was consumed after 72 h, when cell death commenced in the culture. After 96 h, cells 
consumed 48.98 g/l of sucrose and 6.77 g/l of L-glutamic acid.  
 
When cells were grown in medium E, a maximum cell count of 8.54 log CFU/ml was 
achieved after 48 h (Fig 4.7b). Cells were seen to grow rapidly in the first 24 h (increasing 
from 5.59 to 8.34 log CFU/ml). A drastic loss in viability was seen after 72 h (from 8.42 to 
6.59 log CFU/ml). The glycerol concentration was also seen to reduce during this period. At 
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the end of 96 h, the culture had utilized 54.07 g/l and 8.89 g/l of glycerol and L-glutamic acid 
provided respectively. 
 
 
 
Fig 4.7: Growth and nutrient utilization for B. licheniformis 6816 when grown in a) GS medium and b) 
medium E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in 
triplicate (n = 3).   
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glutamic acid remained constant from 24-72 h. At the end of the culture, 7.21 g/l of L-
glutamic acid was consumed. 
 
 
 
Fig 4.8: Growth and nutrient utilization for B. licheniformis 6816 when grown in a) GS medium and b) 
medium E at 37˚C & 150 rpm for 96 h to evaluate production of γ-PGA. Experiments were conducted in 
triplicate (n = 3). 
 
4.3 γ-PGA yield  
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5.0
6.0
7.0
8.0
9.0
10.0
0 10 20 30 40 50 60 70 80 90 100
L
o
g
 C
F
U
/m
l 
Time (h) 
Growth curve  
 B. licheniformis 9945a - GS medium 
B. licheniformis 9945a
15
16
17
18
19
20
5
15
25
35
45
0 10 20 30 40 50 60 70 80 90 100
L
-g
lu
ta
m
ic
 a
ci
d
 (
g
/l
) 
S
u
cr
o
se
 (
g
/l
) 
Time (h) 
Nutrient utilization   
B. licheniformis 9945a - GS medium 
Sucrose
L-glutamic acid
5
5.5
6
6.5
7
7.5
8
8.5
9
0 10 20 30 40 50 60 70 80 90 100
L
o
g
 C
F
U
/m
l 
Time (h) 
Growth curve  
 B. licheniformis 9945a - Medium E 
B. licheniformis 9945a
12
13
14
15
16
17
18
19
20
20
30
40
50
60
70
80
0 10 20 30 40 50 60 70 80 90 100
L
-g
lu
ta
m
ic
 a
ci
d
 (
g
/l
) 
G
ly
ce
ro
l 
(g
/l
) 
Time (h) 
Nutrient utilization   
B. licheniformis 9945a - Medium E 
Glycerol
L-glutamic acid
a) 
b) 
 
110 
 
  
produced by B. subtilis 23856, B. subtilis 23858, B. licheniformis 9945a and B. licheniformis 
6816 in medium GS and E were comparable and were not significantly different (P ≥ 0.05). 
Only B. subtilis natto produced more γ-PGA in GS medium than in medium E (P < 0.05). In 
fact, B. subtilis natto produced the lowest yield of γ-PGA in medium E (5.7 g/l, P < 0.05). Of 
the other bacteria under study, B. subtilis 23857, B. subtilis 23859 and B. licheniformis 1525 
produced significantly more γ-PGA in medium E than in GS medium (P < 0.05). In GS 
medium, the lowest yield of γ-PGA was produced by B. licheniformis 6816 (13.3 g/l), 
whereas B. subtilis natto produced the highest yield of γ-PGA (17.77 g/l, P < 0.05). In 
medium E, B. licheniformis 1525 produced the highest yield of γ-PGA (22.3 g/l, P < 0.05).    
 
Fig 4.9: Comparison of yields of γ-PGA (g/l) produced by different Bacillus strains grown in GS and E 
medium in flasks and incubated at 37˚C & 150 rpm for 96 h. “*” indicates that the yield of γ-PGA 
produced by bacteria in GS medium was significantly different (P < 0.05) from that in medium E. 
Experiments were conducted in triplicate. 
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4.4 Identification of γ-PGA 
After 96 h, the polymer produced was recovered in the form of a dry powder. It was observed 
that cells grown in GS medium produced a white powder. In medium E, cells produced a 
brownish product. It was important to identify the produced polymer as γ-PGA and hence, 
FT-IR spectroscopy was performed. The spectra of the polymer produced by eight bacterial 
strains in both media were also compared to the spectra of a commercially available γ-PGA 
sample. 
 
The polymer produced by all bacteria was identified as γ-PGA using FT-IR (see Figs 4.10 & 
4.11). Each spectrum shown is a mean of 3 spectra. FT-IR spectra for γ-PGA obtained by the 
strains under investigation were similar and they compared well to that of a commercially 
available γ-PGA sample. The infrared spectra of γ-PGA samples showed characteristic strong 
amide absorption at ~1618 cm
−1
, carbonyl absorption at 1395–1454 cm−1, and strong 
hydroxyl absorption at 3400–3460 cm−1. The absorption peak at 3400–3460 cm−1 is 
characteristic of OH stretching from the bound hydroxyl group and adsorbed water 
molecules. The absorption peaks around 1600–1640 cm−1 and 1390–1410 cm−1 are 
characteristic of amide groups and C=O groups respectively. The strong absorption peaks 
observed in the range from 1132 cm
−1
 to 1138 cm
−1
 and ~ 620 cm
−1 
are characteristic of C–N 
groups and N-H, oop bending respectively. γ-PGA produced from all Bacillus strains in both 
media showed the presence of all of these characteristic peaks. 
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a) 
 
 
b) 
 
Fig 4.10: FT-IR spectra for γ-PGA produced by a) B. subtilis 23856 & 23857 and b) B. subtilis 23858 & 
23859 in GS medium compared to that of a commercial γ-PGA sample. γ-PGA was produced using eight 
different bacteria using two media in flasks at 37˚C & 150 rpm for 96 h. Experiments were conducted in 
triplicate. Each FT-IR spectrum is a mean of 3 spectra.  
        Fig 4.10 continued overleaf 
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c) 
 
d) 
 
Fig 4.10 (contd): FT-IR spectra for γ-PGA produced by c) B. licheniformis 6816 & 1525 and d) B. subtilis 
natto & B. licheniformis 9945a in GS medium compared to that of a commercial γ-PGA sample. γ-PGA 
was produced using eight different bacteria using two media in flasks at 37˚C & 150 rpm for 96 h. 
Experiments were conducted in triplicate. Each FT-IR spectrum is a mean of 3 spectra. 
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a) 
 
b) 
 
Fig 4.11: FT-IR spectra for γ-PGA produced by a) B. subtilis natto, B. subtilis 23856, B. subtilis 23857 & 
B. subtilis 23858 and b) B. licheniformis 1525, B. licheniformis 6816, B. licheniformis 9945a & B. subtilis 
23859 in medium E. γ-PGA was produced using eight different bacteria using two media in flasks at 37˚C 
& 150 rpm for 96 h. Experiments were conducted in triplicate. Each FT-IR spectrum is a mean of 3 
spectra. 
*Note that % transmittance is dimensionless because these are a composite of 4 individual spectra. 
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4.5 Elemental analysis 
Before using γ-PGA for any application, it is important to have knowledge of the form of the 
polymer for a better quality and a more consistent product. Moreover, assessing the form of 
γ-PGA is important since the percentage salt composition of the polymer would affect its 
solubility and would in turn affect the application for which it is used. Elemental analysis of 
γ-PGA produced by different bacteria in two media will also throw light on the factors 
affecting the form of γ-PGA.  
 
On identifying the polymer as γ-PGA using FT-IR, elemental analysis was performed using 
ICP-AES to identify whether the salt or the acid form of γ-PGA was produced in both the 
media (Table 4.1). On conclusion of the analysis, it was seen that the majority of the γ-PGA 
obtained by all bacteria grown in GS medium was the sodium salt of γ-PGA (Na-γ-PGA), 
with the remainder being either the P, Mg and K salt forms. B. licheniformis 1525 produced 
the highest percentage of Na-γ-PGA (97.39%). None of the strains produced the acid form of 
γ-PGA (H+-γ-PGA) in GS medium. In contrast, bacteria grown in medium E produced a 
considerable amount of H
+
-γ-PGA (37-58%) along with Na-γ-PGA. The presence of Na-γ-
PGA was possibly because the pH of medium E was adjusted using 3 M NaOH. B. 
licheniformis 6816 produced the highest percentage of H
+
-γ-PGA (57.97%) amongst all 
strains under study. 
 
 
 
 
 
 
 
116 
 
  
Table 4.1: Proportions of Na-γ-PGA and H+-γ-PGA obtained in a) GS medium and b) Medium E. 
Analysis was performed using ICP-AES (SPECTRO CIROS
CCD
). Results are expressed as γ-PGA in its 
Na-salt form and acid (H
+
) form. Experiments were conducted in triplicate (n = 3). 
a)  
Bacteria % Na-γ-PGA (w/w) 
B. subtilis 23856 86.90 ± 3.16 
B. subtilis 23857 87.55 ± 0.70 
B. subtilis 23858 80.26 ± 4.76 
B. subtilis 23859 82.41 ± 0.74 
B. subtilis natto 85.38 ± 0.12 
B. licheniformis 1525 97.39 ± 2.45 
B. licheniformis 6816 88.37 ± 0.25 
B. licheniformis 9945a 90.31 ± 3.53 
 
b) 
Bacteria % Na-γ-PGA (w/w) % H+-γ-PGA (w/w) 
B. subtilis 23856 59.90 ± 1.23 37.76 ± 0.68 
B. subtilis 23857 52.68 ± 0.47 44.98 ± 2.63 
B. subtilis 23858 56.00 ± 3.61 41.91 ± 1.43 
B. subtilis 23859 56.29 ± 0.22 41.73 ± 1.11 
B. subtilis natto 52.31 ± 1.10 44.56 ± 4.60 
B. licheniformis 1525 50.33 ± 2.96 48.09 ± 0.13 
B. licheniformis 6816 38.84 ± 3.33 57.97 ± 3.18 
B. licheniformis 9945a 64.47 ± 0.58 32.89 ± 0.19 
 
4.6 Crystallinity 
For the same reasons we needed to analyse the form of γ-PGA produced, it is crucial to assess 
whether the γ-PGA is crystalline or amorphous, before testing it for any application. 
Crystallinity of a polymer influences polymer properties such as hardness, tensile strength, 
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stiffness, solubility and melting point. Crystallinity of γ-PGA produced by eight bacteria in 
two media in this study was analysed using XRD spectroscopy.  
 
 
The XRD spectra of γ-PGA produced by the strains grown in GS and E media are presented 
in Fig 4.12 & 4.13. Each XRD spectrum is a mean of 3 spectra. Presence of sharp and narrow 
diffraction peaks was observed in the XRD spectra for γ-PGA obtained from bacteria grown 
in GS medium (Fig 4.12), thus indicating that all strains produced crystalline γ-PGA in GS 
medium. 
             
 
Fig 4.12: Crystallinity of γ-PGA produced by a) B. subtilis 23856, B. subtilis 23857, B. subtilis 23858, B. 
subtilis 23859 and b) B. subtilis natto, B. licheniformis 1525, B. licheniformis 6816 and B. licheniformis 
9945a in GS medium. Crystallinity was assessed by performing XRD spectroscopy (Phillips PW1700). 
Experiments were conducted in triplicate. Each XRD spectrum is a mean of 3 spectra. 
 
 
 
In contrast to the spectra obtained for γ-PGA produced in GS medium, broad peaks were seen 
to be present in the spectra obtained for γ-PGA produced in medium E (Fig 4.13), thus 
indicating that all bacteria produced amorphous γ-PGA when grown in this medium.  
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Fig 4.13: Crystallinity of γ-PGA produced by different Bacillus strains in Medium E. Crystallinity was 
assessed by performing XRD spectroscopy (Phillips PW1700). Experiments were conducted in triplicate. 
Each XRD spectrum is a mean of 3 spectra. 
 
4.7 Molecular weight 
As mentioned previously (see section 1.6), γ-PGA can be produced with different molecular 
weights. The molecular weight is an important characteristic of any polymer produced, since 
it can directly affect the application for which it is used. For instance, lower molecular weight 
γ-PGA can be used for its antifreeze activity (Mitsuiki et al., 1998; Shih et al., 2003), 
whereas a higher molecular weight polymer is required for waste water treatment applications 
(Inbaraj et al., 2006; Sung et al., 2005). Analysing the molecular weight of γ-PGA would also 
demonstrate whether it is dependent on bacteria or medium of production or both. Another 
important characteristic of the polymer is its polydispersity (Pd). The closer the value of Pd to 
unity, the more homogenous the polymer is with respect to its molecular weight. 
 
The molecular weight and Pd for γ-PGA produced by eight bacteria in GS and E media was 
determined using aqueous based GPC. When grown in GS medium, B. licheniformis 1525, B. 
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licheniformis 6816 and B. subtilis natto produced high molecular weight γ-PGA (Table 4.2). 
The other strains under study produced a lower molecular weight product (~3000 Da).  
 
Table 4.2: Molecular weight of γ-PGA produced by bacteria grown in GS medium at 37˚C & 150 rpm for 
96 h. Molecular weight was analysed using GPC (MZ Hema guard plus 2 x Hema Linear column). 
Experiments were conducted in triplicate (n = 3). 
Strain name Molecular weight 
(Da) (Mw) 
Molecular number 
(Mn) 
Polydispersity 
(Mw/Mn) 
B. licheniformis 1525 871000 647000 1.35 
B. licheniformis  6816 850000 596500 1.45 
B. subtilis natto 257000 54550 4.75 
 
In medium E, B. licheniformis 6816 and B. subtilis natto produced γ-PGA with a high 
molecular weight (Table 4.3). B. licheniformis 1525, which produced a high molecular 
weight polymer in GS medium, produced a low molecular weight polymer in medium E. The 
remaining bacterial strains under study also produced a low molecular weight product (< 
3000 Da). 
 
Table 4.3: Molecular weight of γ-PGA produced by bacteria in Medium E. Molecular weight analysis was 
performed using GPC (MZ Hema guard plus 2 x Hema Linear column). Experiments were conducted in 
triplicate (n = 3). 
 
Strain name Molecular weight 
(Da) (Mw) 
Molecular number 
(Mn) 
Polydispersity 
(Mw/Mn) 
B. licheniformis 1525 < 3000 - - 
B. licheniformis 6816 856500 715500 1.2 
B. subtilis natto 760000 605000 1.3 
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4.8 Summary of γ-PGA production in shake flasks 
When γ-PGA production in eight Bacillus strains grown in GS and E media was investigated, 
it was observed that all bacteria produced a white polymer when grown in GS medium and a 
brown polymer when grown in medium E. The produced polymer was identified as γ-PGA 
using FT-IR analysis, where the spectra for γ-PGA produced by the eight Bacillus strains 
showed all the characteristic peaks and compared well to the FT-IR spectrum of a 
commercially available γ-PGA.  
 
Samples were taken at regular intervals during shake flask culture for growth and nutrient 
consumption analysis. Fig 4.14 shows the growth of all bacterial strains in GS and E medium. 
At 0 h, all bacteria had a cell count of ~5 log CFU/ml. Amongst all bacteria under study, in 
GS medium, B. subtilis 23858 reached the highest cell count of 9.58 log CFU/ml at 72 h (Fig 
4.14a). In medium E, B. licheniformis 1525 reached a maximum cell count of 8.57 log 
CFU/ml at 72 h (Fig 4.14b). In medium E, the maximum cell counts for the five B. subtilis 
strains (~7.5-8.1 log CFU/ml) were not as high as those observed with the B. licheniformis 
strains (~8.5 log CFU/ml). B. subtilis 23858 & 23859 and B. licheniformis 1525, 6816 & 
9945a had a higher cell count at 96 h in GS medium than in medium E. In fact, B. subtilis 
23859 did not grow well in medium E, with a maximum cell count of 7.55 log CFU/ml after 
24 h and a cell count of ~ 4.9 log CFU/ml at the end of 96 h. It was also evident that each 
individual bacterial strain reached a higher cell count in GS medium than in medium E using 
shake flasks. 
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Fig 4.14: Growth curves for 8 Bacillus strains when grown in a) GS medium & b) medium E at 37˚C & 
150 rpm for 96 h. Experiments were conducted in triplicate (n = 3). 
 
 
Table 4.4 shows the decrease in sucrose and L-glutamic acid concentration in GS medium at 
the end of the shake flask culture of the eight bacteria, along with the maximum cell count 
observed and yield of γ-PGA produced after 96 h. In GS medium, all strains utilized more 
than 84% of the sucrose provided. The least amount of sucrose was consumed by B. subtilis 
23859 (84.32%, P < 0.05), whereas B. licheniformis 6816 utilized sucrose the most (97.96%, 
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P < 0.05). In GS medium, B. subtilis strains consumed more L-glutamic acid than B. 
licheniformis strains. B. subtilis natto consumed the most L-glutamic acid at the end of 96 h 
(~95%, P < 0.05) whereas B. licheniformis 9945a utilized only 17.46% of the provided L-
glutamic acid. Incidentally, B. subtilis natto also produced the highest yield of γ-PGA in GS 
medium (~17.7g/l, P < 0.05). 
 
Table 4.4: Nutrient utilization, maximum viable cell count and yield of γ-PGA for 8 bacteria when grown 
in GS medium at 37˚C/150 rpm for 96 h. Experiments were conducted in triplicate (n = 3). 
Parameters  
 
Sucrose 
(g/l) 
L-glutamic  
acid 
(g/l) 
Maximum  
cell count 
(Log CFU/ml) 
Yield 
(g/l) 
Yield 
(ng/cell) 
Bacteria  
B. subtilis 23856 45.33 ± 0.88 12.94 ± 0.42 7.80 ± 0.10 13.55 ± 0.45 0.21 
B. subtilis 23857 44.09 ± 0.96 11.70 ± 0.26 7.93 ± 0.07 16.51 ± 0.20 0.19 
B. subtilis 23858 45.38 ± 0.71 16.45 ± 0.00 9.58 ± 0.11 14.88 ± 0.48 0.004 
B. subtilis 23859 42.16 ± 0.55 13.45 ± 0.91 8.76 ± 0.05 16.03 ± 0.03 0.03 
B. subtilis natto 44.97 ± 2.05 19.00 ± 0.09 9.03 ± 0.03 17.77 ± 0.52 0.02 
B. licheniformis 1525 47.38 ± 0.61 7.84 ± 2.43 9.02 ± 0.02 15.93 ± 0.18 0.02 
B. licheniformis 6816 48.98 ± 1.80 6.77 ± 3.40 8.95 ± 0.06 13.3 ± 0.30 0.01 
B. licheniformis 9945a 43.49 ± 1.83 3.49 ± 0.81 8.73 ± 0.11 14.05 ± 0.18 0.03 
 
 
The three B. licheniformis strains utilized more glycerol in medium E, than the B. subtilis 
strains under study (Table 4.5). Glycerol in medium E was consumed better than sucrose was 
in GS medium by the three B. licheniformis strains and B. subtilis 23859 (P < 0.05). The 
remaining strains preferred sucrose as the C source. B. licheniformis 1525 reached the highest 
maximum cells count (8.57 log CFU/ml) and also produced the highest yield of γ-PGA (22.3 
g/l) in medium E (P < 0.05). B. subtilis natto utilized 14.34 g/l more of L-glutamic acid in GS 
medium than that in medium E. It also produced the lowest yield of γ-PGA in medium E (5.7 
g/l, P < 0.05). Interestingly, all bacteria produced more γ-PGA/cell in medium E than in GS 
medium. 
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Table 4.5: Nutrient utilization, maximum viable cell count and yield of γ-PGA for 8 bacteria when grown 
in medium E at 37˚C/150 rpm for 96 h. Experiments were conducted in triplicate (n = 3). 
Parameters  
 
Glycerol 
(g/l) 
L-glutamic  
acid 
(g/l) 
Maximum 
 cell count 
(Log CFU/ml) 
Yield 
(g/l) 
Yield 
(ng/cell) 
Bacteria 
B. subtilis 23856 39.91 ± 1.23 4.89 ± 0.07 7.41 ± 0.14 12.93 ± 1.11  0.5 
B. subtilis 23857 43.34 ± 0.46 5.94 ± 0.26 7.72 ± 0.05 21.75 ± 0.05 0.41 
B. subtilis 23858 40.20 ± 0.92 5.70 ± 0.23 7.91 ± 0.06 19.32 ± 0.37 0.24 
B. subtilis 23859 50.38 ± 0.59 5.26 ± 0.23 7.55 ± 0.08 21.15 ± 0.07 0.60 
B. subtilis natto 39.65 ± 0.85 4.66 ± 0.05 8.11 ± 0.14 5.7 ± 0.35 0.04 
B. licheniformis 1525 52.52 ± 1.27 6.84 ± 0.27 8.57 ± 0.19 22.30 ± 0.12 0.06 
B. licheniformis 6816 54.07 ± 0.77 8.89 ± 0.41 8.54 ± 0.07 12.70 ± 0.45 0.04 
B. licheniformis 9945a 56.53 ± 0.73 7.20 ± 0.16 8.41 ± 0.09 12.58 ± 0.24 0.05 
 
 
A summary of the properties of γ-PGA obtained with the 8 Bacillus strains grown in GS and 
E medium is presented in Tables 4.6 & 4.7. It was seen that all bacteria produced a 
crystalline polymer when grown in GS medium. In contrast, amorphous γ-PGA was obtained 
when bacteria were grown in medium E. Most of the γ-PGA produced by bacteria in GS 
medium was the sodium salt of the polymer (Na-γ-PGA), whereas the acid form of γ-PGA 
(H
+
-γ-PGA) was also produced when bacteria were grown in medium E. Hence, crystallinity 
and form of γ-PGA were dependent on medium of γ-PGA production. On the other hand, the 
molecular weight of γ-PGA produced was seen to be dependent on the medium and the 
bacterial strain producing it. Although B. licheniformis 6816 produced γ-PGA with similar 
molecular weight in GS and E media, the molecular weights of γ-PGA produced by B. 
subtilis natto and B. licheniformis 1525 in GS and E medium were different. 
 
This study has contributed 6 bacteria that have not been previously used for γ-PGA 
production. In addition, the γ-PGA produced by all of the 8 bacteria investigated was 
characterized in terms of its yield, form, crystallinity and molecular weight.  
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Table 4.6: Summary of properties of γ-PGA produced from 8 Bacillus strains in GS medium. 
Organism Yield (g/l) Crystallinity % Na-γ-PGA Molecular weight 
(Da) 
No. of glutamic 
acid monomers 
B. subtilis 23856 13.55 ± 0.78 Crystalline 86.90 ~ 3000  ~20 
B. subtilis 23857 16.52 ± 0.35 Crystalline 87.55 ~ 3000 ~20 
B. subtilis 23858 14.88 ± 0.84 Crystalline 80.26 ~ 3000 ~20 
B. subtilis 23859 16.03 ± 0.06 Crystalline 82.40 ~ 3000 ~20 
B. subtilis natto 17.77 ± 0.9 Crystalline 85.38 257500 (Pd = 4.75) ~1752 
B. licheniformis 1525 15.93 ± 1.16 Crystalline 97.40 871000 (Pd = 1.35) ~5925 
B. licheniformis 6816 13.3 ± 0.52 Crystalline 88.37 850000 (Pd = 1.45) ~5782 
B. licheniformis 9945a 14.05 ± 0.31 Crystalline 90.30 ~ 3000 ~20 
 
Table 4.7: Summary of properties of γ-PGA produced from 8 Bacillus strains in medium E. 
Organism Yield (g/l) Crystallinity % Na-γ-PGA % H+-γ-PGA Molecular 
weight (Da) 
No. of glutamic 
acid monomers 
B. subtilis 23856 12.93 ± 0.07 Amorphous 59.90 37.76 <3000  ~20 
B. subtilis 23857 21.75 ± 0.34 Amorphous 52.68 44.98 <3000  ~20 
B. subtilis 23858 19.32 ± 0.09 Amorphous 56 41.91 <3000 ~20 
B. subtilis 23859 21.15 ± 0.12 Amorphous 56.29 41.73 <3000 ~20 
B. subtilis natto 5.7 ± 0.25 Amorphous 52.31 44.56 760000 
 (Pd = 1.3) 
5170 
B. licheniformis 1525 22.3 ± 0.15 Amorphous 50.32 48.09 <3000 ~20 
B. licheniformis 6816 12.7 ± 0.45 Amorphous 38.84 57.97 856500 
 (Pd = 1.2) 
~5827 
B. licheniformis 9945a 12.58 ± 0.24 Amorphous 64.47 32.89 <3000 ~20 
 
After identification and characterization of the polymer produced by eight bacteria in GS and 
E media (see Tables 4.6 & 4.7), it was evident that B. subtilis natto would be a good choice 
for the probiotic food application. This is because B. subtilis natto is food derived (natto is a 
traditional Japanese food item) and hence, it can be used for a food application. Although, all 
the eight bacteria under study produced a sodium salt of γ-PGA in GS medium, which is 
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desirable for the probiotic research undertaken in this study, because it is known to have good 
antifreeze properties (Mitsuiki et al., 1998; Shih et al., 2003), B. subtilis natto produced the 
highest yield of γ-PGA in GS medium compared to the other bacteria and hence, it would 
provide the highest quantities of Na-γ-PGA for probiotic tests. Also, γ-PGA produced by B. 
subtilis natto in GS medium was white in colour, which is a desirable property for additives 
to food products.  
 
It was essential to scale up the production of γ-PGA by B. subtilis natto from shake flasks to a 
fermenter, because a higher yield of γ-PGA could be produced when bacteria are grown in a 
fermenter, where the parameters that affect cell growth and γ-PGA production can be 
controlled and monitored. In addition, by increasing the volume of production, the total 
quantity of γ-PGA that would be produced in a fermenter would also be higher than that in 
shake flasks. The next section will describe the production of γ-PGA using B. subtilis natto 
grown in GS medium in 4 l fermentations.  
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5. RESULTS – BACTERIAL γ-PGA PRODUCTION - 
FERMENTATION CULTURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
  
5.1 Introduction 
On investigating the properties of γ-PGA produced by eight bacteria in two different media, 
γ-PGA produced by B. subtilis natto grown in GS medium was chosen for testing a novel 
probiotic application (See Section 4.8). For testing the effect of γ-PGA on the viability of 
probiotic bacteria, scaling up γ-PGA production was important to increase the yield of γ-PGA 
produced by B. subtilis natto (when grown in a more controlled environment than shake 
flasks) and for increasing the total quantity of γ-PGA produced so that enough γ-PGA was 
available for testing the probiotic application. For this purpose, cellular growth and γ-PGA 
production by B. subtilis natto was studied during growth in 4 l fermentations (Electrolab 
batch fermenter) where temperature, pH, agitation, aeration and dissolved O2 could be 
controlled.  
 
5.2 Fermentation of B. subtilis natto to produce γ-PGA 
Fermentations were run for 96 h and parameters that can affect the growth of cells and 
production of γ-PGA were monitored and controlled. It was seen that dO2 decreased to 40% 
saturation within the first 10 h of growth, after which it was maintained at that value by 
controlling agitation and aeration rates. The control of dO2 by maintaining agitation rates can 
be seen in Fig 5.1a. The pH of the culture was maintained at 6.8 throughout the fermentation 
by addition of 3 M HCl and 3 M NaOH as required (Fig 5.1b). Temperature was controlled at 
37˚C throughout the 96 h fermentation run. 
 
When grown in 4 l fermentations, B. subtilis natto reached a maximal cell count of 10.11 log 
CFU/ml at 72 h (Fig 5.1c), which subsequently decreased to 9.23 log CFU/ml over 96 h. The 
yield of γ-PGA produced by B. subtilis natto by the end of fermentation was 27.94 g/l ± 0.81 
g/l.  
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Fig 5.1: a) Agitation & dO2, b) temperature & pH and c) growth during fermentation of B. subtilis natto 
to produce γ-PGA in a 5 l fermenter. Cells were grown at 37˚C for 96 h in GS medium, after which γ-
PGA was recovered from the medium. 
 
5.3 Analysis of γ-PGA obtained from B. subtilis natto grown in a fermenter 
γ-PGA obtained from growth of B. subtilis natto in a 4 l fermentation was purified using 
dialysis and both crude and purified γ-PGA were identified using FT-IR spectroscopy. This 
analysis was performed to confirm that the produced polymer was γ-PGA and to identify 
differences (if any) in the spectra of crude and pure γ-PGA. The FT-IR spectra of the γ-PGA 
produced by fermentation were plotted as before. Crude γ-PGA showed peaks at 3292 cm-1 , 
1564 cm
-1
, 1401 cm
-1
, 1133 cm
-1
, 854 cm
-1
 and 616 cm
-1
 which corresponded to carboxyl, 
amide II stretch, C=O symmetric stretch, C-N stretch, C-H stretch and N-H oop bending 
respectively (Fig 5.4). Purified γ-PGA showed peaks at 3263 cm-1, 1535 cm-1, 1393 cm-1, 
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1165 cm
-1
, 891 cm
-1
 and 668 cm
-1
 which represent the presence of hydroxyl, amide II stretch, 
C=O symmetric stretch, C-N stretch, C-H stretch and N-H out-of-plane bending respectively. 
In addition, purified γ-PGA also showed peaks at 1641 cm-1 and 1236 cm-1, which correspond 
to amide I N-H bending and C-O stretch respectively. The additional peaks that are present 
on the spectra of γ-PGA purified using dialysis could be used to identify the polymer better. 
 
Fig 5.4: FT-IR spectra for crude and purified (dialyzed) γ-PGA produced by fermentation of B. subtilis 
natto. Each FT-IR spectrum is a mean of 3 spectra. 
 
In addition, the crude and purified γ-PGA were analysed using ICP-AES, to determine the 
difference in salt content of γ-PGA. It was seen that crude γ-PGA had a high concentration of 
Na ions (910.27 ppm). However, when purified, the same sample of γ-PGA showed the 
presence of a lower concentration of sodium ions (340.10 ppm). Similarly, crude γ-PGA had 
27.33 ppm of K, whereas pure γ-PGA only had 15.06 ppm of K. The lower concentration of 
these ions in purified γ-PGA indicates that purification using dialysis eliminated lower 
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molecular weight impurities and hence purification is an important step before γ-PGA is used 
for subsequent applications.  
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6. RESULTS – PROTECTIVE EFFECT OF γ-PGA ON 
PROBIOTIC BACTERIA 
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6.1 Introduction 
γ-PGA was produced using B. subtilis natto grown in GS medium in 4 l fermentations. The 
produced polymer was isolated from growth media, purified, identified and characterized. 
This polymer was then used for novel probiotic applications to protect cells during different 
conditions. Firstly, the protective effect of this polymer on the viability during freeze drying 
of three probiotic bacteria was tested. Secondly, there is a need to come up with probiotic 
delivery platforms other than dairy products. Fruit juices are a potential alternative, but 
introduction of probiotic bacteria into fruit juices is challenging, since they present more 
stressful conditions to the bacteria, resulting in a loss in viability. Therefore, two 
Bifidobacteria strains were protected with γ-PGA and introduced in orange and pomegranate 
juice to test their survival. Finally, there is heavy loss in cell viability when probiotic bacteria 
pass through the harsh conditions of the stomach. Hence, γ-PGA was used to protect two 
Bifidobacteria strains in simulated gastric juice for 4 h.  
 
6.2 Sterilization of γ-PGA 
Sterilization of γ-PGA is important because there is a need to eradicate any residual bacteria 
from the fermentation that might interfere with subsequent viable cell count results for the 
probiotic bacteria. Therefore, different sterilization techniques were tested to identify the 
most appropriate method to effect sterilization, but without substantially disrupting the 
structure of γ-PGA. The results of the techniques used are shown in Table 6.1. 
 
Autoclaving γ-PGA at 0.35 BAR at 110˚C for 30 mins was obviously the more preferred 
method of sterilization since it exposed the polymer to less stressful conditions than 
autoclaving γ-PGA at 1.035 BAR at 121˚C for 20 mins.  
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Table 6.1: Various methods used to sterilize γ-PGA and their outcomes. 
Sterilization method Outcome Comments 
Filtration through 0.45 µ filter Not effective 10% γ-PGA solution too viscous to pass through 
filter 
 
Ethanol treatment Not effective Does not kill spores of B. subtilis 
U.V. Not effective Only surface sterilization achieved. 
3% Hydrogen peroxide Effective Effectively sterilizes γ-PGA, but could have 
adverse effects on γ-PGA structure. Cannot 
completely get rid of peroxide. 
 
Autoclaving at 1.035 BAR at 121˚C 
for 20 mins 
Effective Could have adverse effects on structure and 
functionality of γ-PGA. Need to check with FT-IR. 
 
Autoclaving at 0.35 BAR at 110˚C 
for 30 mins 
Effective Could have adverse effects on structure and 
functionality of γ-PGA. Need to check with FT-IR. 
 
 
The effect of autoclaving (0.35 BAR at 110˚C for 30 mins) on the characteristic bonds of γ-
PGA was tested using FT-IR. γ-PGA samples sterilized by autoclaving and with hydrogen 
peroxide treatment were compared to a non-sterile γ-PGA sample using FT-IR to determine 
any disruption in functional groups because of the sterilization technique (Fig 6.1).  
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Fig 6.1: FT-IR spectra of a) untreated γ-PGA b) 3% H2O2 treated γ-PGA and c) autoclaved γ-PGA (0.35 
BAR at 110˚C for 30 mins) produced by B. subtilis natto grown in GS medium in a 5 l fermenter.  Each 
FT-IR spectrum is a mean of 3 spectra. 
 
It was seen that the spectrum for autoclaved γ-PGA compared well to that of the untreated γ-
PGA and showed the presence of peaks corresponding to all the previously mentioned 
characteristic functional groups (see Fig 6.1). However, whilst the spectrum for γ-PGA 
treated with 3% H2O2 showed all the peaks present in the non-sterile sample, it was noted that 
peaks at 1564 cm
-1
 and 1401 cm
-1
 (corresponding to amide II stretch and C=O symmetric 
stretch respectively) were less pronounced in γ-PGA samples treated with peroxide (see 
Less pronounced 
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circled region in Fig 6.1). This could mean that peroxide treatment might have caused some 
disruption within these functional groups.  
 
Because of the results obtained above, autoclaving γ-PGA at 0.35 BAR at 110˚C for 30 min 
was the chosen method for sterilizing γ-PGA. γ-PGA sterilized using this method will 
henceforth be referred to as sterilized γ-PGA or γ-PGA[S]. Likewise, γ-PGA that has not 
been sterilized will be referred to as untreated γ-PGA or γ-PGA[U]. 
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6.3 Use of γ-PGA as cryoprotectant for 3 probiotic bacteria 
After assessing different sterilization techniques, autoclaving at 110˚C at 0.35 BAR for 30 
mins was chosen to sterilize γ-PGA for probiotic tests. Sterilized γ-PGA (γ-PGA[S]) and 
untreated γ-PGA (γ-PGA[U]) were used to coat probiotic bacteria and the cryoprotectant 
properties were evaluated by comparison to sucrose as a cryoprotectant during freeze drying. 
This is a novel application, since γ-PGA has never been used to protect probiotic bacteria 
during freeze drying. 
 
6.3.1 Testing γ-PGA[S] as cryoprotectant for 3 probiotic bacteria 
γ-PGA[S] was first tested as a cryoprotectant for probiotic bacteria. Three commonly used 
probiotic bacteria (L. paracasei, B. breve and B. longum) were used for the tests. 10% sucrose 
has been shown to offer better protection during freeze drying of probiotic Lactobacilli when 
compared to trehalose and sorbitol (Siaterlis et al., 2009). Hence, the effect of 10% γ-
PGA[S], 5% γ-PGA[S] and 10% sucrose was tested on viability of the bacteria before and 
after freeze drying (Fig 6.2). On conclusion of these tests, it was observed that when no 
cryoprotectant was used to protect the cells, L. paracasei showed a reduction in viability of 
1.34 log CFU/ml. When 10% sucrose was used to protect L. paracasei during freeze drying, 
0.91 log CFU/ml reduction in viability was observed. However, for 10% γ-PGA[S]-protected 
cells, loss in viability was reduced to 0.51 log CFU/ml. For L. paracasei, 10% γ-PGA[S] was 
able to protect the cells significantly better than 10% sucrose (P ≤ 0.05). The cryoprotectant 
ability of 5% γ-PGA[S] was comparable to, but not significantly different (P > 0.05) from 
10% sucrose.  
 
A more pronounced reduction in viability (2.47-2.52 log CFU/ml) was observed when both 
Bifidobacteria strains were freeze dried without any cryoprotectant. When the cells were 
 
137 
 
  
protected with 10% γ-PGA[S], only 1.24-1.26 log CFU/ml reduction in viability was 
observed. The cryoprotectant ability of 10% sucrose and 10% γ-PGA[S] for Bifidobacteria 
was comparable (P ≥ 0.05). 
 
Fig 6.2: Effect of γ-PGA[S] and sucrose on viability of probiotic bacteria during freeze drying. Cells were 
freeze dried at -40˚C and 5 MBAR pressure and viability was measured before and after freeze drying on 
TPY agar. Experiments were conducted in triplicate (n = 3). 
 
6.3.2 Testing γ-PGA[U] as a cryoprotectant for 3 probiotic bacteria   
On conclusion of tests with γ-PGA[S] as a cryoprotectant, it was important to ascertain 
whether autoclaving affected the cryoprotectant abilities of γ-PGA. Even though it was 
confirmed that autoclaving did not affect the structure of γ-PGA, it could have affected its 
molecular weight. Molecular weight, in turn, can have an effect on γ-PGA as a 
cryoprotectant. Hence, γ-PGA[U] was also tested for its ability to protect cells during freeze 
drying. From the previous tests, it was evident that Bifidobacteria were more sensitive than 
Lactobacillus. Hence, only the former were used for the tests.  
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The viable plate counts for tests with γ-PGA[S] were done on TPY agar, which is a non-
selective media for enumeration of Bifidobacteria. This could be done because pressure 
cooking eliminated any residual bacteria in γ-PGA. For tests with γ-PGA[U], it was 
important to use a selective and differential media for enumeration, which would inhibit the 
growth of other bacteria while differentiating Bifidobacteria. Hence, BSM agar was used. 
Bifidobacteria grown on BSM agar plates were a purplish-brown colour. When a 10% 
solution of γ-PGA[U] was plated onto BSM agar and incubated for 24-48 h under anaerobic 
conditions, no colonies were observed. To compare the results of cryoprotectant tests with γ-
PGA[S] & γ-PGA[U], it was important to compare the counts of the same Bifidobacteria 
culture on TPY and BSM and check if they were comparable (see Table 6.2). It was seen that 
22 h and 16 h cultures of B. breve and B. longum showed similar counts on TPY and BSM, 
hence the viable cell count was not significantly different (P > 0.05). Thus, it was concluded 
that BSM could be used for tests with γ-PGA[U]. 
 
Table 6.2: Comparison of growth of Bifidobacteria on TPY and BSM when incubated anaerobically. B. 
breve were incubated for 22 h and B. longum were incubated for 16 h. 
Organism Count on TPY (Log CFU/ml) Count on BSM (Log CFU/ml) 
Bifidobacterium breve 8.55±0.15 8.48±0 
Bifidobacterium longum 8.52±0.18 8.60±0.12 
 
The effect of 10% γ-PGA[U] was then tested on the viability of Bifidobacteria during freeze 
drying and was compared with the cryoprotective ability of 10% γ-PGA[S] (Fig 6.3). Similar 
to the tests with γ-PGA[S], a log reduction of ~2.82 CFU/ml was observed when cells were 
freeze dried without any cryoprotectant. When cells were protected using 10% γ-PGA[U], a 
log reduction of 1.92-1.99 CFU/ml was observed. However, when 10% γ-PGA[S] was used 
to protect Bifidobacteria during freeze drying, 1.34-1.38 log CFU/ml reduction in viability 
was observed. Hence, although 10% γ-PGA[U] could protect the cells during freeze drying as 
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compared to when no cryoprotectant was used, it was not as effective (P < 0.05) as 10% γ-
PGA[S]. Thus, sterilization using autoclaving had the added advantage of improving the 
cryoprotectant ability of γ-PGA.  
 
 
 
Fig 6.3: Effect of γ-PGA[S] & γ-PGA[U] on viability of probiotic bacteria during freeze drying. Cells were 
freeze dried at -40˚C and 5 MBAR pressure and viability was measured before and after freeze drying on 
BSM agar. Experiments were conducted in triplicate (n = 3). 
 
6.3.3 SEM analysis 
Freeze dried powders containing unprotected Bifidobacteria and Bifidobacteria protected 
with γ-PGA[S] were analysed using SEM to understand how the cells may be protected by 
embedding within the polymer. It should be noted that SEM analysis only shows a surface 
image. As is evident from Figs 6.4a & 6.4b, freeze dried B. longum cells protected with γ-
PGA appear to be encapsulated within a thin layer of γ-PGA. The thickness of γ-PGA coating 
could be calculated with further testing using transmission electron microscopy (TEM). In 
addition, cells are also seen embedded within the γ-PGA matrix.  
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Fig 6.4: SEM image of a) Freeze dried B. longum cells b) Freeze dried B. longum protected with γ-PGA. 
SEM analysis was performed using Zeiss EVO50, U.K. and photographs were analysed using the 
software provided by Zeiss EVO50. 
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6.4 γ-PGA protection of Bifidobacteria in orange and pomegranate juice 
After confirming that γ-PGA can be used as a cryoprotectant for probiotic bacteria to reduce 
their loss in viability during freeze drying, γ-PGA was tested for its effect on the viability of 
two probiotic bacteria during storage in orange and pomegranate juice. This work is 
important, because there is a need to develop non-dairy based foods that can deliver probiotic 
bacteria. Juices are a good platform for this purpose. However, the survival conditions that 
the bacteria are exposed to in fruit juices are less favourable than those in dairy products. 
Therefore, it is important to come up with a technology that can help probiotic bacteria 
survive in these juices during their shelf life. γ-PGA has never been used for protection of 
probiotic bacteria in fruit juices and hence, this is a novel application.  
 
6.4.1 Use of BSM for enumeration of bacteria in orange and pomegranate juice 
Before testing γ-PGA with probiotic bacteria, it was important to identify the best medium 
that could be used for determining the viability of the bacteria. Commercial orange and 
pomegranate juices are pasteurized during manufacture. This means that although the juice is 
free of spoilage/disease causing bacteria, it may not be completely free of other residual 
bacteria. Therefore, for probiotic juice tests, it was essential to use a selective and differential 
media for enumeration of Bifidobacteria, hence BSM agar was used for this purpose. When 
Tropicana orange juice was plated onto TSA and incubated at 37˚C for 24 h, residual bacteria 
in the juice appeared on the plate in the form of colonies. However, when the same juice was 
plated on BSM, no growth was seen, thus confirming that the residual bacteria in orange juice 
would not interfere with Bifidobacteria counts, when they are introduced into the juice. 
Similar results were obtained with pomegranate juice that was used for the study. 
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6.4.2 Protection of probiotic bacteria in orange juice 
Once BSM was identified as the appropriate medium for enumeration of probiotic bacteria 
for these tests, γ-PGA-protected B. longum and B. breve were introduced into orange juice 
and stored at 4˚C. Viability was measured at regular intervals. 
 
6.4.2.1 B. longum 
The effect of 2.5% γ-PGA on the viability of B. longum in orange juice for 39 days was tested 
(Fig 6.5). Bacteria that were not protected with γ-PGA failed to survive in orange juice for 20 
days. In contrast, γ-PGA-protected cells survived well for 39 days with a viability of 6.48 log 
CFU/ml, when compared to their initial count of 9.47 log CFU/ml.  
 
 
 
Fig 6.5: Protective effect of 2.5% (w/v) γ-PGA on viability of B. longum in orange juice. Unprotected and 
γ-PGA protected cells were introduced into fresh orange juice and viability was measured at regular 
intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
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A log reduction of 3.37 CFU/ml was seen in viability of B. longum cells that were not 
protected with γ-PGA after 13 days, whereas a log reduction of only 1.10 CFU/ml was 
observed for γ-PGA-protected cells. On day 20, unprotected B. longum showed complete loss 
in viability. Even on day 11, the number of unprotected cells was much less (4.86 log 
CFU/ml) than the recommended FAO value of 6-7 log CFU/ml (Kurmann and Rasic, 1991).  
 
6.4.2.2 B. breve 
The effect of 2.5% γ-PGA was also tested on viability of B. breve when stored in orange juice 
for 39 days (Fig 6.6). Similar to tests with B. longum, cells that were not protected with γ-
PGA failed to survive in orange juice for 20 days. In contrast, γ-PGA protected cells survived 
well for 39 days with a viability of 6.61 log CFU/ml, when compared to their initial count of 
8.66 log CFU/ml. γ-PGA protected B. breve cells showed only 0.54 log reduction in viability 
after 13 days in comparison to a 3.97 log decrease in viability for unprotected cells. On day 
20, unprotected B. breve cells showed complete loss in viability. Even on day 11, the number 
of unprotected cells was much less (4.5 log CFU/ml) than the recommended value of 6-7 log 
CFU/ml by the FAO (Kurmann and Rasic, 1991).  
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Fig 6.6: Protective effect of 2.5% (w/v) γ-PGA on viability of B. breve in orange juice. Unprotected and γ-
PGA protected cells were introduced into fresh orange juice and viability was measured at regular 
intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
  
6.4.3 Protection of probiotic bacteria in pomegranate juice 
Similar to orange juice, tests were also performed with pomegranate juice to determine the 
effect of γ-PGA on the viability of probiotic bacteria during juice storage. 
 
6.4.3.1 B. longum 
The effect of 2.5% γ-PGA was tested on the viability of B. longum in pomegranate juice. It 
was observed that unprotected cells survived for only 4 days with a viability of 4.07 log 
CFU/ml (Fig 6.7). Complete cell death was observed by day 6. In contrast, when the cells 
were protected with γ-PGA, cell viability of 6.17 log CFU/ml was observed at day 4. Polymer 
protected cells survived for 13 days with a viability of 3.37 log CFU/ml. Cells lost complete 
viability within 20 days.  
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Fig 6.7: Protective effect of 2.5% (w/v) γ-PGA on viability of B. longum in pomegranate juice. 
Unprotected and γ-PGA protected cells were introduced into fresh pomegranate juice and viability was 
measured at regular intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
 
6.4.3.2 B. breve 
The effect of 2.5% γ-PGA was also tested on the viability of B. breve in pomegranate juice. 
Unprotected cells died within 2 days of storage in pomegranate juice (Fig 6.8). On 
inoculation, the viability of unprotected cells was 5 log CFU/ml. When the cells were 
protected with γ-PGA, they survived for 11 days, after which complete loss in viability was 
observed. Even on day 2, viable cell count of γ-PGA-protected cells was 5.13 log CFU/ml, 
which is below the recommended FAO value of 6-7 log CFU/ml (Kurmann and Rasic, 1991).  
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 Fig 6.8: Protective effect of 2.5% (w/v) γ-PGA on viability of B. breve in pomegranate juice. Unprotected 
and γ-PGA protected cells were introduced into fresh pomegranate juice and viability was measured at 
regular intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
 
6.4.4 Change in organic acid concentration/pH in orange and pomegranate juice 
It was important to identify changes in concentration of organic acids, if any, when probiotic 
bacteria and γ-PGA are introduced, to preserve the organoleptic properties of the juice. 
Organic acid analysis was performed using HPLC.  
 
6.4.4.1 B. longum in orange juice 
It was seen that fresh orange juice contained 425.09 mg/l of ascorbic acid (Table 6.3). This 
concentration dropped to 160.97 mg/l for juice that was stored at 4˚ C for 39 days. When B. 
longum was added to orange juice without γ-PGA, it was seen that the concentration of 
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ascorbic acid in the juice after 39 days reduced further to 79.14 mg/l. Likewise, when B. 
longum protected with γ-PGA was added to orange juice, the concentration of ascorbic acid 
after 39 days was 71.52 mg/l.  
 
Table 6.3: Organic acid content of fresh or expired orange juice, with γ-PGA-protected and unprotected 
B. longum. “a” & “b” indicate value is significantly (P < 0.05) and insignificantly (P > 0.05) different from 
that in expired orange juice, respectively. Experiments were conducted in triplicate (n = 3). 
Condition Ascorbic acid (mg/l) Citric acid (g/l) Malic acid (g/l) 
Fresh orange juice –  
No cells 
 
425.09 ±  2.26
a
 9.95 ± 0.02
b
 3.84 ± 0.01
b
 
Expired orange juice – 
No cells after 6 weeks 
 
160.97 ± 35.97
 
9.75 ± 0.02 3.95 ± 0.01 
Unprotected B. longum in 
orange juice after 6 weeks 
 
79.14 ± 14.71
a 
9.19 ± 0.08
b 
4.01 ± 0.15
b
 
γ-PGA-protected B. longum 
in orange juice after 6 weeks 
71.52 ± 0.61
a 
8.78 ± 0.18
b 
3.63 ± 0.06
b
 
 
The concentrations of citric acid and malic acid in fresh orange juice were 9.95 g/l and 3.84 
g/l respectively. After 39 days, the difference in concentration of citric and malic acid in 
orange juice without B. longum was not statistically significant when compared to that of 
fresh juice (P > 0.05). After 39 days, orange juice with unprotected B. longum showed a 
slightly reduced (9.19 g/l) concentration of citric acid, but this reduction was also not 
statistically significant (P > 0.05). The citric acid concentration was further reduced slightly 
(8.78 g/l) for orange juice with γ-PGA-protected cells. The concentration of malic acid in 
orange juice with unprotected cells and with γ-PGA-protected cells did not differ 
significantly from that of orange juice without cells after 39 days (P > 0.05).  
 
The pH of fresh orange juice was 3.91 (Table 6.4). When B. longum protected with γ-PGA 
were added to the juice, the pH was seen to increase to 4.36 after 39 days. 
 
 
148 
 
  
Table 6.4: pH of fresh or expired orange juice, with γ-PGA-protected and unprotected B. longum. “a” 
indicates value is significantly different from that in expired orange juice (P<0.05). Experiments were 
conducted in triplicate (n = 3). 
Condition pH 
Fresh orange juice – No cells 
 
3.91 ± 0.00 
Expired orange juice - after 6 weeks - No cells 
 
3.82 ± 0.00 
B. longum in orange juice – No γ-PGA – after 6 weeks 
 
3.71 ± 0.00
a 
B. longum in orange juice – with γ-PGA – after 6 weeks 4.36 ± 0.01a 
 
 6.4.4.2 B. breve in orange juice 
When unprotected B. breve was added to orange juice, it was seen that the concentration of 
ascorbic acid in the juice reduced to 173.23 mg/l after 39 days (Table 6.5). When B. breve 
protected with γ-PGA was added to orange juice, the concentration of ascorbic acid after 39 
days was 193.76 mg/l. The change in ascorbic acid concentration in both conditions was not 
statistically significant (P > 0.05) when compared to its concentration in orange juice without 
cells after 39 days (160.97 mg/l).  
 
Orange juice with B. breve showed a slightly reduced citric acid concentration (9.29 g/l) after 
39 days, but this reduction was statistically insignificant (P > 0.05). The citric acid 
concentration further reduced slightly (8.31 g/l) for orange juice with γ-PGA protected cells 
(P > 0.05). The concentration of malic acid in orange juice with unprotected B. breve did not 
significantly differ (P > 0.05) from that of orange juice without cells after 39 days. The malic 
acid concentration in orange juice with γ-PGA protected cells showed a small change in 
concentration (0.52 g/l) in comparison to orange juice without any cells and γ-PGA after 39 
days.  
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Table 6.5: Organic acid content of fresh or expired orange juice, with γ-PGA-protected and unprotected 
B. breve. “a” & “b” indicate value is significantly (P<0.05) and insignificantly (P>0.05) different from that 
in expired orange juice, respectively. Experiments were conducted in triplicate (n = 3). 
Condition Ascorbic acid (mg/l) Citric acid (g/l) Malic acid (g/l) 
Fresh orange juice - No cells 
 
425.09 ±  2.26
a
 9.95 ± 0.02
b
 3.84 ± 0.01
b
 
Expired orange juice - No 
cells after 6 weeks 
 
160.97 ± 35.97 9.75 ± 0.02 3.95 ± 0.01 
Unprotected B. breve in 
orange juice after 6 weeks 
 
173.23 ± 18.48
b
 9.29 ± 0.22
b
 3.92 ± 0.08
b
 
γ-PGA-protected B. breve in 
orange juice after 6 weeks 
193.76 ± 12.49
b
 8.31 ± 0.02
b 
3.43 ± 0.03
b 
 
The pH of fresh orange juice was 3.91 (Table 6.6). When B. breve cells protected with γ-
PGA were added to the juice, the pH was seen to increase to 4.22 after 39 days. 
 
Table 6.6: pH of fresh or expired orange juice, with γ-PGA-protected and unprotected B. breve. “a” 
indicates value is significantly different from that in expired orange juice (P<0.05). Experiments were 
conducted in triplicate (n = 3). 
Condition pH 
Fresh orange juice – No cells 
 
3.91 ± 0.00 
Expired orange juice - after 6 weeks - No cells 
 
3.82 ± 0.00 
B. breve in orange juice – No γ-PGA – after 6 weeks 
 
3.65 ± 0.00
a 
B. breve in orange juice – with γ-PGA – after 6 weeks 4.22 ± 0.02a 
 
6.4.4.3 B. longum in pomegranate juice 
When the change in organic acid concentration for pomegranate juice was assessed (see 
Table 6.7), it was seen that there was no significant difference (P > 0.05) in concentrations of 
citric acid and malic acid in juice stored for 39 days with or without γ-PGA-protected B. 
longum. The ascorbic acid concentration in fresh pomegranate juice was negligible (9 mg/l). 
The concentration was seen to increase slightly in juice with γ-PGA protected B. longum. 
However, even in this case, the concentration was low (25.52 mg/l).  
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Table 6.7: Organic acid content of fresh or expired pomegranate juice, with γ-PGA-protected and 
unprotected B. longum. “a” & “b” indicate value is significantly (P<0.05) and insignificantly (P>0.05) 
different from that in expired pomegranate juice, respectively. Experiments were conducted in triplicate 
(n = 3). 
Condition Citric acid (g/l) Malic acid (g/l) Ascorbic acid (mg/l) 
Fresh pomegranate juice 
 - No cells 
 
17.43 ± 0.48
b
 4.75 ± 0.90
b
 9.00 ± 1.51
b
 
Expired pomegranate juice -
No cells - after 6 weeks -  
 
17.22 ± 0.51 2.76 ± 0.10 11.39 ± 0.19 
Unprotected B. longum in 
pomegranate juice after 6 
weeks 
 
19.32 ± 1.10
b 
2.95 ± 0.46
b
 10.96 ± 6.57
a
 
γ-PGA-protected B. longum 
in pomegranate juice after 6 
weeks 
17.84 ± 1.07
b
 3.64 ± 0.19
b
 25.52 ± 0.72
a
 
 
The pH of fresh pomegranate juice was 3.18 (Table 6.8). When B. longum cells protected 
with γ-PGA were added to the juice, the pH was seen to increase to 4.15 after 39 days. 
 
Table 6.8: pH of fresh or expired pomegranate juice, with γ-PGA-protected and unprotected B. longum. 
“a” indicates value is significantly different from that in expired pomegranate juice (P<0.05). 
Experiments were conducted in triplicate (n = 3). 
Condition pH 
Fresh pomegranate juice – No cells 
 
3.18 ± 0.00 
Expired pomegranate juice - after 6 weeks - No cells 
 
3.19 ± 0.00 
B. longum in pomegranate juice – No γ-PGA – after 6 weeks 
 
3.14 ± 0.00 
B. longum in pomegranate juice – with γ-PGA – after 6 weeks 4.15 ± 0.06a 
 
6.4.4.4 B. breve in pomegranate juice 
When the change in organic acid concentration for pomegranate juice was assessed (see 
Table 6.9), it was observed that there was no significant difference (P > 0.05) in 
concentrations of citric acid and malic acid in juice stored for 39 days with or without γ-
PGA-protected B. breve. The concentration of ascorbic acid in pomegranate juice under 
various conditions was negligible (≤ 13.31 mg/l). 
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Table 6.9: Organic acid content of fresh or expired pomegranate juice, with γ-PGA-protected and 
unprotected B. breve. “b” indicates value is insignificantly (P > 0.05) different from that in expired 
pomegranate juice. Experiments were conducted in triplicate (n = 3). 
 
The pH of fresh pomegranate juice was 3.18 (Table 6.10). When B. breve cells protected 
with γ-PGA were added to the juice, the pH was seen to increase to 4.05 after 39 days. 
 
Table 6.10: pH of fresh or expired pomegranate juice, with γ-PGA-protected and unprotected B. breve. 
“a” indicates value is significantly different from that in expired pomegranate juice (P<0.05). 
Experiments were conducted in triplicate (n = 3). 
Condition pH 
Fresh pomegranate juice – No cells 
 
3.18 ± 0.00 
Expired pomegranate juice - after 6 weeks - No cells 
 
3.19 ± 0.00 
B. breve in pomegranate juice – No γ-PGA – after 6 weeks 
 
3.18 ± 0.00
a 
B. breve in pomegranate juice – with γ-PGA – after 6 weeks 4.05 ± 0.02a 
 
 
 
 
 
 
  
Condition Citric acid (g/l) Malic acid (g/l) Ascorbic acid (mg/l) 
Fresh pomegranate juice – 
 No cells 
 
17.43 ± 0.48
b
 4.75 ± 0.90
b
 9.00 ± 1.51
b
 
Expired pomegranate juice - No 
cells - after 6 weeks 
 
17.22 ± 0.51 2.76 ± 0.10 11.39 ± 0.19 
Unprotected B. breve in 
pomegranate juice after 6 weeks 
 
16.10 ± 0.66
b 
4.02 ± 0.07
b 
13.31 ± 2.60
b
 
γ-PGA-protected B. breve in 
pomegranate juice after 6 weeks 
14.06 ± 0.25
b
 5.23 ± 0.60
b
 4.19 ± 3.65
b
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6.4.5 Protection of bacteria in simulated gastric juice 
A heavy loss in the viability of probiotic bacteria has been seen when they pass through the 
stomach, which is a region of high acidity (Figueroa-González et al., 2011; Vasiljevic and 
Shah, 2008). Therefore, it is important to help probiotic bacteria survive better in such an 
environment. γ-PGA has a unique property of staying stable in a highly acidic environment, 
where it forms an α-helical structure (Ho et al., 2006a). It also disintegrates in a weaker 
acidic or neutral pH by conforming to a linear random-coil formation. This property of γ-
PGA has not been previously used for protection of probiotic bacteria. After testing the effect 
of γ-PGA on the viability of Bifidobacteria in orange and pomegranate juice, the protective 
effect of the polymer was tested for Bifidobacteria in a simulated gastric juice environment 
for 4 h.  
 
6.4.5.1 B. longum 
When the effect of 2.5% γ-PGA was tested on the viability of B. longum in simulated gastric 
juice, it was seen that bacteria protected with the polymer showed a marginal reduction in 
viability of 0.47 log CFU/ml after 4 h (P < 0.05. See Fig 6.9). However, unprotected cells 
showed complete loss in viability within 2 h. Even after an hour in simulated gastric juice, the 
number of live cells in the absence of γ-PGA (3.96 log CFU/ml) was not significant enough 
to provide any benefit to the host.  
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Fig 6.9: Protective effect of 2.5% (w/v) γ-PGA on viability of B. longum in simulated gastric juice (pH 
2.0). Unprotected and γ-PGA protected cells were introduced into the juice and viability was measured at 
regular intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
 
6.4.5.2 B. breve 
The effect of 2.5% γ-PGA was also tested on the viability of B. breve in simulated gastric 
juice for 4 h (Fig 6.10). B. breve protected with the polymer showed even less reduction in 
viability (0.20 log CFU/ml after 4 h) than B. longum. In fact, the number of viable γ-PGA-
protected cells after 0 h and 4 h was comparable and was not significantly different (P > 
0.05). However, unprotected cells showed complete loss in viability within 2 h. Even after an 
hour in simulated gastric juice, the number of live cells in the absence of γ-PGA (4.22 log 
CFU/ml) was not significant enough to provide any benefit to the host.  
 
0
1
2
3
4
5
6
7
8
9
0 1 2 3 4
L
o
g
 (
C
F
U
/m
l)
 
Time (h) 
Unprotected
cells
Cells protected 
with γ-PGA 
 
154 
 
  
 
 
Fig 6.10: Protective effect of 2.5% (w/v) γ-PGA on viability of B. breve in simulated gastric juice (pH 2.0). 
Unprotected and γ-PGA protected cells were introduced into the juice and viability was measured at 
regular intervals on BSM agar. Experiments were conducted in triplicate (n = 3). 
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7. DISCUSSION 
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7.1 Investigation of γ-PGA production in eight bacteria  
Eight Bacillus strains (B. subtilis natto, B. licheniformis 9945a, B. subtilis 23856, B. subtilis 
23857, B. subtilis 23858, B. subtilis 23859, B. licheniformis 1525 and B. licheniformis 6816) 
were grown in GS and E media to investigate γ-PGA production. Of these bacteria, B. subtilis 
natto and B. licheniformis 9945a have been used for γ-PGA production previously 
(Cromwick et al., 1996; Cromwick and Gross, 1995a; Ho et al., 2006a; Kedia et al., 2010; 
Shih and Van, 2001; Ko and Gross, 1998), however, the other 6 strains used in this study 
have not been utilized for this purpose. B. subtilis 23856 has been previously used for the 
production of the volatile hydrocarbon 2-methyl-1,3-butadiene or isoprene while B. subtilis 
23857 has been used as a source of genomic DNA of mannose-6-phosphate isomerase 
(Kuzma et al., 1995; Yeom et al., 2009). B. licheniformis NCIMB 6816 was used for the 
production of penicillin (Rao, 1944). After these bacteria were grown in GS and E media, it 
was observed that all of them produced γ-PGA with various properties (high/low molecular 
weight, amorphous/crystalline, salt and acid form). Yields of up to 22.3 g/l of γ-PGA in shake 
flasks were obtained. Therefore, this study contributes six new bacteria for γ-PGA production 
and helps towards production of more consistent and better quality polymers that are suited to 
application needs by characterizing the produced γ-PGA. 
 
7.2 Growth and nutrient utilization of Bacillus in different media 
It is known that bacteria produce γ-PGA in the late logarithmic and stationary phases of 
growth (Bajaj and Singhal, 2011; Buescher and Margaritis, 2007) and hence, it is important 
to monitor cell growth in different media. When the eight bacteria were grown in GS 
medium, it was seen that all bacteria had attained the stationary phase of growth by the first 
24 to 48 h (Fig 4.14). When grown in medium E, all bacteria (with the exception of B. 
licheniformis 1525, B. licheniformis 6816 and B. subtilis 23859) took longer to reach 
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stationary phase of growth as compared to when they were grown in GS medium. This could 
possibly be due to the presence of a high concentration of glycerol (80 g/l) in medium E, 
which is known to inhibit cell growth initially (Wu et al., 2010a).  It was also evident that 
each individual bacterial strain reached a higher cell count in GS medium than in medium E. 
This could be because medium E does not include vitamins in its formulation, whereas GS 
medium does. B. subtilis strains are fastidious in nature (Kedia et al., 2010) and grow to 
higher numbers in the presence of vitamins. Again, a high concentration of glycerol could 
also be a reason for lower cell counts in medium E. 
 
γ-PGA production makes the medium viscous which impedes the oxygen mass transfer, thus 
causing oxygen depletion, hence, controlled agitation and aeration are crucial for optimizing 
γ-PGA production (Bajaj and Singhal, 2011). None of the strains under study that were 
grown in shake flasks in GS and E media reached a cell number  greater than 10 log CFU/ml. 
This could probably be due to the lack of pH control/aeration control in shake flasks. Such 
cell numbers have been achieved when B. subtilis natto was grown in fermenters in this study 
(Fig 5.1) and in a previous study when aeration and agitation could be controlled (Kedia et 
al., 2010).  
 
Analysis of nutrient utilization by HPLC revealed that B. subtilis strains consumed more of 
the L-glutamic acid in GS medium than the B. licheniformis strains (Tables 4.4 & 4.5). In 
contrast, B. licheniformis strains consumed more L-glutamic acid than B. subtilis strains did 
in medium E. In fact, apart from B. licheniformis 6816 and B. licheniformis 9945a, which 
consumed more L-glutamic acid in medium E than when they were grown in GS medium, all 
bacteria consumed more L-glutamic acid when they were grown in GS medium than when 
they were grown in medium E. The function of L-glutamic acid in γ-PGA production using 
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B. subtilis IFO3335 has been described previously (Kunioka and Goto, 1994). It was found 
that this bacterium does not produce γ-PGA in the absence of exogenously supplied L-
glutamic acid. When L-glutamic acid was supplied in the medium, γ-PGA was produced. 
However, the L-glutamic acid provided was not metabolized by the cells for γ-PGA 
synthesis. It was concluded that L-glutamic acid added in the medium merely acted as an 
activator of enzymes responsible for γ-PGA synthesis. In our study, it can be observed that L-
glutamic acid was clearly metabolized by the cells (especially by B. subtilis strains in GS 
medium), which indicates that bacteria may have utilized exogenous L-glutamic acid as a 
substrate for γ-PGA production, as was observed in a previous study (Yao et al., 2010). 
However, additional tests must be done to confirm this. For classification purposes, γ-PGA 
producing bacteria have been divided into two groups depending on whether they require L-
glutamic acid in the medium and the ones that do not require L-glutamic acid (Bajaj and 
Singhal, 2011; Buescher and Margaritis, 2007; Shih and Van, 2001; Sung et al., 2005). For 
L-glutamic acid dependent bacteria, the γ-PGA yield increases with an increase in the L-
glutamic acid concentration in the medium. In a follow up study to our work, it was seen that 
the concentration of γ-PGA produced by the bacteria increased with an increase in the 
concentration of L-glutamic acid in the medium (data not shown), thus indicating that these 
γ-PGA producing bacteria were L-glutamic acid dependent. 
 
Important information can be obtained when L-glutamic acid concentration is monitored 
during cell culture for γ-PGA production. For instance, L-glutamic acid concentration 
increased after 72 h when B. subtilis natto were grown in medium E (Fig 4.5b). This could 
indicate the presence of γ-PGA depolymerase activity. γ-PGA depolymerase is an 
extracellular enzyme which is active in some bacteria in the late stationary phase and can 
break down the polymer. This releases L-glutamic acid units, hence causing an increase in the 
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L-glutamic acid concentration. Degradation of synthesized γ-PGA could be one of the 
reasons why B. subtilis natto produced only 5.7 g/l γ-PGA after 96 h in medium E. It has 
been shown previously that B. subtilis produces γ-PGA degradation enzymes such as GGT, 
YwtD and PgdS (Ashiuchi et al., 2006; Jeong et al., 2010; Mitsui et al., 2011; Yao et al., 
2009). The increase in L-glutamic acid concentration after 72 h in our study could be a 
consequence of the components of such an enzyme degradation system. Interestingly, L-
glutamic acid concentration did not increase after 72 h when B. subtilis natto was grown in 
GS medium. This provides important information on when γ-PGA should be recovered from 
culture in different media. Presence of γ-PGA depolymerase activity can alter yield and 
molecular weight of isolated γ-PGA and hence, it is important to recover γ-PGA from culture 
media before γ-PGA depolymerase becomes active. It would be interesting to recover γ-PGA 
for B. subtilis natto grown in medium E at 72 h, to test whether an increased yield is obtained. 
 
At the end of 96 h in medium E, about 40-55 g/l of glycerol of the 80 g/l provided was 
consumed by all bacteria in shake flasks with low aeration conditions (Table 4.5). Similar 
results were obtained by Cromwick and co-workers (1996) when the consumption of glycerol 
was assessed in low aeration conditions for B. licheniformis 9945a (Cromwick et al., 1996). 
In high aeration conditions and at pH 6.5, most of the glycerol was consumed in their study. 
In another study (Birrer et al., 1994), when B. licheniformis 9945a was grown in shake flasks 
in medium E, it was seen that glycerol and L-glutamic acid were not completely consumed 
and substantial quantities of these nutrients were still left in the medium after 96 h and only 
35 g/l of glycerol and 8 g/l of L-glutamic acid were consumed by bacteria by the end of the 
culture. A similar observation was made in our study for L-glutamic acid consumption, where 
B. licheniformis 9945a consumed ~ 7 g/l of L-glutamic acid. However, more glycerol was 
consumed in our study (57 g/l) and this is probably why B. licheniformis 9945a produced 
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more γ-PGA (12.58 g/l) after 96 h in this study than that produced using the same strain (11 
g/l) in the study by Birrer and co-workers (1994).  
 
Yao and co-workers (2010) assessed the consumption of glucose in B. subtilis NX-2 and 
found that only a small fraction of γ-PGA repeat units were formed from exogenously 
supplied glucose and most of the glucose was used as the growth-limiting substrate for cell 
growth (Yao et al., 2010). It was noted that for all strains in our study (except B. subtilis 
23858 and B. subtilis 23859), the sucrose concentration remained stable after 72 h (Figs 4.1 
to 4.7). This could indicate that sucrose could not be transported inside the cells once they 
were in death phase. In contrast, glycerol concentration was seen to decrease after 72 h for all 
bacteria (except B. subtilis 23857 and B. subtilis natto) and hence it can be stated that 
glycerol transport inside the cells continued even after they were in death phase. It has been 
shown previously that glycerol is responsible for increasing the permeability of the cell 
membrane, thus improving the transport of γ-PGA outside the cell (Bajaj and Singhal, 2011; 
Wu et al., 2010a). This could be one of the reasons for utilization of glycerol even after cell 
death commenced in culture.  
 
 Overall, it can be seen (Tables 4.4 & 4.5) that all of the B. subtilis strains (except B. subtilis 
23859) consumed more sucrose (in GS medium) than glycerol (in medium E). Sucrose has 
been preferred to other C sources for γ-PGA production in B. subtilis previously (Ashiuchi 
and Misono, 2002; Kedia et al., 2010). On the other hand, B. licheniformis consumed more 
glycerol (in medium E) than sucrose (in GS medium) in our study. Improved yield of γ-PGA 
using B. licheniformis has been obtained when glycerol was used as the C source in a 
previous study (Du et al., 2005).  In terms of L-glutamic acid consumption, all of the B. 
subtilis strains consumed more L-glutamic acid when grown in GS medium than in medium 
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E, whereas it was utilized more by all of the B. licheniformis strains (except B. licheniformis 
1525) grown in medium E. Utilization of nutrients has been compared for bacteria grown 
under different pH, aeration and agitation conditions (Cromwick et al., 1996; Wu et al., 
2010b). In our study, the utilization of sucrose, glycerol and L-glutamic acid in two media by 
B. subtilis and B. licheniformis has been compared and adds to the existing knowledge on γ-
PGA production. 
 
Since the initial experiments were performed in shake flasks, where pH and aeration of the 
culture were not controlled, it could have some impact on nutrient consumption. The initial 
pH for both media (7.2) decreased to ~ 6.5 after 30 h, but increased to ~ 6.8 at the end of 96 
h. The decrease in pH is believed to be due to acid formation (Thorne et al., 1954). The 
agitation during production of γ-PGA using bacteria in shake flask cultures (where the 
volume ratio of culture to flask was 1:2) was controlled at 150 rpm. Cromwick et al. (1996) 
have previously highlighted the importance of pH and aeration for nutrient utilization in B. 
licheniformis 9945a (Cromwick et al., 1996). Their study showed that bacteria utilized 
glutamate, glycerol and citric acid maximally when the pH was maintained at 6.5 under high 
aeration conditions (agitation speed 800 rpm, aeration rate 2.0 L/min). The yield obtained 
under such conditions was much better (23 g/l) than when bacteria were grown in low 
aeration and agitation conditions in their study (6.3 g/l). In another study, it was found that a 
pH of 7.0 was optimum for γ-PGA production from B. subtilis IFO3335 (Richard and 
Margaritis, 2003a). In some cases, a two stage pH shift strategy needs to be employed when 
the optimal pH for growth and γ-PGA production are different. For instance, when γ-PGA 
production in B. subtilis CGMCC 0833 was analysed (Wu et al., 2010b), it was found that the 
optimum pH for glutamate utilization was 6.5, whereas the optimum pH for cell growth was 
found to be 7.0. Consequently, a two stage pH shift strategy was proposed, in which the pH 
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was kept at 7.0 for 24 h for maximum cell growth, followed by a pH shift to 6.5 for 
maximum utilization of glutamate. Hence, it is evident that control of pH is important for γ-
PGA production and the optimum pH depends on the strain of bacteria used. 
  
After extracting the polymer in the form of a dry powder, it was weighed to calculate the 
yield of γ-PGA produced. The yield obtained by different bacteria in GS and E media was 
compared (Fig 4.9). Even though the C source and L-glutamic acid were not as fully utilized 
in medium E (Tables 4.4 & 4.5), three of the eight bacterial strains (B. subtilis 23857, B. 
subtilis 23859 and B. licheniformis 1525) produced significantly more γ-PGA in E medium 
(P < 0.05). Interestingly, while all bacteria reached a higher cell count in GS medium, they 
produced more γ-PGA/cell in medium E. This could indicate that presence of sucrose (GS 
medium) improved cell growth, but glycerol (medium E) was better for γ-PGA production. 
Glycerol has been shown to increase the yield of γ-PGA production previously, by improving 
the permeability of the cell membrane and hence facilitating the secretion of γ-PGA into the 
medium of production (Bajaj and Singhal, 2011; Du et al., 2005; Wu et al., 2010a; Jeong et 
al., 2010). In addition, presence of glycerol is known to increase the amount of glutamic acid 
formed by increasing the flux from 2-oxoglutarate to glutamic acid (Wu et al., 2008). 
Although increase in glycerol concentration in the medium has been shown to improve γ-
PGA concentration in cell broth, it does not necessarily increase cell growth. This could be 
the reason why bacteria in our study could produce more γ-PGA in medium E, even though 
they reached a higher cell number in GS medium. Also, glycerol is known to reduce medium 
viscosity and hence improve utilization of other nutrients by the cells. However, a recent 
study showed that a very high concentration of glycerol (80 g/l), such as that used in our 
study, inhibits cell growth of B. subtilis NX-2 and hence it has been suggested that glycerol 
could be added at ~16 h to reduce the initial inhibition of cell growth (Wu et al., 2010a). Our 
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investigations were performed before this study was published. However, the effects of 
glycerol and its consumption would differ with the bacterial strain used for γ-PGA production 
and would need to be investigated. The presence of citric acid in medium E could also 
explain the increased production of γ-PGA/cell in this medium. Citric acid is the best 
precursor for production of γ-PGA (Du et al., 2005; Xu et al., 2005a) and can be used by the 
cells for the production of endogenous L-glutamic acid which is then incorporated into the 
growing γ-PGA chain (see Section 1.4.2). Ammonium ions, which are necessary for the 
endogenous production of glutamic acid from citric acid, are also present in medium E 
(Kunioka and Goto, 1994).  
 
The only strain that produced significantly more γ-PGA (P < 0.05) in GS medium than in 
medium E was B. subtilis natto (Fig 4.9). It also consumed ~95% of the L-glutamic acid 
present. GS medium was obviously more suited for growth and γ-PGA production by B. 
subtilis natto. This is in accordance with the findings of Kedia and co-workers (Kedia et al., 
2010). Our investigation with eight strains indicates that nutrient consumption alone cannot 
provide an indication of the yield of γ-PGA produced. Yield is dependent on bacterial strain, 
media components and how efficiently the available nutrients are converted into γ-PGA by 
the bacteria.  
 
B. licheniformis 9945a has been previously investigated for γ-PGA production using medium 
E (Cromwick et al., 1996). When the bacteria were grown in fermenters, where pH could be 
controlled at 6.5, the yield of γ-PGA obtained after 96 h was 15 g/l. When these bacteria were 
grown in medium E for our study, yield of γ-PGA obtained after 96 h was 12.58 g/l. The 
lower yield was expected because bacteria were grown in shake flasks, where pH, aeration 
and agitation could not be controlled. Whilst we could have investigated production of γ-
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PGA using all strains in fermenters, the aim of our study was to characterize and compare γ-
PGA produced by a range of bacteria in two media. Therefore, investigation experiments 
were performed in shake flasks. However, it must be noted that γ-PGA yield obtained using 
B. licheniformis 9945a in our study was comparable to that achieved by Kedia and co-
workers (Kedia et al., 2010). 
 
When production of γ-PGA by B. licheniformis WBL-3 was optimized using different 
concentrations of glycerol (0 to 110 g/l) in modified medium E in shake flasks, a maximum 
yield of 16.7 g/l was obtained (Du et al., 2005). Four of the eight strains in our study (B. 
subtilis 23857, B. subtilis 23858, B. subtilis 23859 and B. licheniformis 1525) produced γ-
PGA with yields higher than 19 g/l in medium E without any optimization (Fig 4.9). It would 
be worth optimizing the production of γ-PGA with respect to carbon source and nitrogen 
source for these bacteria within fermenters.  
 
7.3 Biopolymer characterization 
The polymer produced by all bacteria in GS medium was white in colour. When medium E 
was used to grow cells, a brownish product was obtained, possibly due to the presence of 
residual ferric ions (0.2 g/l FeCl3
.
6H2O). It must be noted that the colour for γ-PGA obtained 
using medium E is white when precipitated. However, it changes to brown on exposure to 
oxygen when it is dried. The colour of the polymer produced is important for some 
applications. A white product, such as that produced by cells in GS medium, would be ideal 
for applications in the cosmetic and food industries. On the other hand, a brownish polymer, 
such as that produced in medium E, could be used in its natural form in the waste water 
treatment industry.  
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It is evident that all bacteria produced γ-PGA in both media, as confirmed by FT-IR 
spectroscopy (Figs 4.10 & 4.11) and spectra for γ-PGA obtained from all strains in both 
media compared well to that of a commercially available γ-PGA sample. Ho and co-workers 
(2006a) have highlighted the characteristic peaks present in the IR spectra of γ-PGA (Ho et 
al., 2006a).Whilst the spectra obtained in our studies are similar to those of Ho et al. (2006a), 
some differences were noted. The FT-IR spectra for γ-PGA samples produced by all bacteria 
and that of the commercial sample we used for comparison showed a distinct peak between 
820 - 850 cm
-1
, which was not seen in the spectra produced by Ho and co-workers. This peak 
represents C-H bending and could further help in the identification of γ-PGA. Overall, the 
FT-IR spectra for γ-PGA produced in our study in both media showed distinct peaks at the 
characteristic wavelengths described in the work of Ho et al (2006a).  
 
Solubility of γ-PGA is an important parameter with respect to its application. For example, 
the hydrophilic insoluble form of γ-PGA can be used for water absorption in diapers (Qu and 
Varennes, 2009; Ho et al., 2008).  The free acid form of γ-PGA is insoluble in water and is 
only soluble in the organic solvent DMSO (Ho et al., 2006a). On the other hand, the salt 
forms of γ-PGA are completely soluble in water. In addition, crystallinity of the polymer can 
also affect its solubility in water. γ-PGA produced using eight bacteria in both media was 
analysed for crystallinity and form (acid/salt) using XRD and ICP-AES respectively (Figs 
4.12 & 4.13). The results shown in Sections 4.5 & 4.6 indicate that the production medium 
has an impact on the form (acid or salt form of γ-PGA) and crystallinity of γ-PGA produced, 
independent of the bacterial strain used for production. When GS medium was used, all B. 
subtilis and B. licheniformis strains produced the salt form of γ-PGA (majorly being sodium 
salt; see Table 4.1), possibly due to the presence of a high concentration (50 g/l) of NaCl in 
the medium. However, in medium E, the acid form was also obtained along with the sodium 
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salt form. The production of sodium salt form of γ-PGA in medium E (which does not 
originally contain sodium) could be explained due to addition of 3M NaOH for adjustment of 
pH. It would be interesting to exclude sodium completely from medium E by using NH4OH 
instead of NaOH for adjustment of pH to determine whether the bacteria then produce a pure 
acid form of the polymer.  
 
Likewise, bacteria grown in GS medium produced a crystalline polymer, whereas they 
produced an amorphous product in medium E. As mentioned above, bacteria produced the 
sodium salt of γ-PGA in GS medium. The presence of sodium ions in the polymer could 
possibly reduce electrostatic repulsion and hence encourage the formation of crystal lattices. 
When the orientation of the component L- and/or D-glutamic acid residues in γ-PGA follows 
a uniform pattern, a crystalline polymer is produced. Conversely, an amorphous polymer 
would be produced when the orientation of the enantiomers is random. The racemase enzyme 
(responsible for conversion of L-glutamic acid to D-glutamic acid) might be regulated 
differently by the components of GS and E media, thus having an effect on crystallinity of γ-
PGA. This would warrant further investigation since the factors affecting the crystallinity of 
γ-PGA have not been previously reported.  
 
The eight bacterial strains produced γ-PGA with different forms and crystallinity, which 
could have multiple applications depending on requirement of solubility and form of the 
polymer. Although a lot of research has been done to assess the production and properties of 
γ-PGA, not much attention has been given to crystallinity. Similar to characterizing the form 
of γ-PGA, knowledge of the crystallinity of the product could also determine its application.  
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It is known that γ-PGA can be composed of only L, or only D, or both L and D forms of 
glutamic acid in varying proportions (Buescher and Margaritis, 2007). A mechanism for 
racemization of L-glutamic acid to D-glutamic acid (Fig 1.3) has been proposed and has been 
explained by multiple researchers (Ho et al., 2006a; Shih and Van, 2001). Upon 
racemization, the L-glutamic acid and D-glutamic acid are incorporated into the growing γ-
PGA chain. It has also been found that when γ-PGA is composed of only L or only D 
glutamic acid residues, it is soluble in ethanol (Candela and Fouet, 2006). When it has an 
equimolar proportion of both D and L subunits, it precipitates in ethanol. Since in this study, 
the γ-PGA obtained from all bacterial strains precipitated in ethanol, it can be concluded that 
it contained both L and D isomers of glutamic acid, probably mixed in equimolar amounts 
This would be in accordance with the information provided by Ho and co-workers (2006), 
which stated that γ-PGA produced by B. subtilis natto contained both L (48%) and D (52%) 
enantiomers of glutamic acid (Ho et al., 2006a). However, the exact D/L composition of γ-
PGA produced by bacteria in our study needs to be analysed.   
 
Molecular weight could be affected by how many glutamic acid residues bacteria are able to 
polymerize before transporting it outside the cell, presence of extracellular depolymerase 
activity and nutrients available in the growth medium. The molecular weight of γ-PGA 
produced in our study ranged from 3000 Da to 871,000 Da and was dependent on both 
bacterial strain and media used (Tables 4.2, 4.3, 4.6 & 4.7). Although B. licheniformis 6816 
and B. subtilis natto produced a high molecular weight polymer in both media, B. 
licheniformis 1525 produced a high molecular weight polymer in GS medium alone. All other 
bacteria produced γ-PGA with a low molecular weight (~3000 Da). 
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Molecular weight plays an important role during optimization of γ-PGA for an application. γ-
PGA with different molecular weights could be used for different applications. For instance, 
molecular weight has been found to be a decisive factor for drug delivery applications of γ-
PGA (Buescher and Margaritis, 2007). Polymers of different molecular weights are required 
to control the drug‘s release into the tissue. Low molecular weight γ-PGA has been shown to 
exhibit a high antifreeze activity (Mitsuiki et al., 1998; Shih et al., 2003). In contrast, Kim 
and co-workers have shown that administering γ-PGA with a molecular weight as high as 2 x 
10
6
 Da orally, induces significant Natural Killer (NK) cell-mediated antitumour immunity in 
mice bearing MHC class I-deficient tumours (Kim et al., 2007). The antimutagenic properties 
of γ-PGA itself have been shown to be dependent on molecular weight, where γ-PGA with 
molecular weights of greater than 5 x 10
4
 Da and lower than 6 x 10
6
 Da showed distinct 
antimutagenic property. γ-PGA with a molecular weight of 9.9 x 105 Da has been shown to 
be effective for waste water treatment applications (Inbaraj et al., 2006). In addition, a study 
(Sung et al., 2005) has indicated that molecular weight of γ-PGA has an effect on calcium 
solubility, where the soluble calcium uptake in mice was significantly higher when they were 
administered γ-PGA with a higher molecular weight (5 x 106 Da) than γ-PGA with a lower 
molecular weight (1 x 10
6 
Da).  
 
7.4 Importance of characterizing γ-PGA from different bacterial strains 
There has been a lot of attention paid to the application of γ-PGA for use in the field of 
medicine, food, cosmetics, waste water treatment etc. (Hsieh et al., 2005; Izumi et al., 2007; 
Mitsuiki et al., 1998; Octavio et al., 2012; Sonaje et al., 2010; Sung et al., 2007; Tanimoto et 
al., 2007; Tsao et al., 2011; Uotani et al., 2011; Ye et al., 2006). However, characterisation of 
γ-PGA and identification of the factors affecting γ-PGA characteristics have not been covered 
in as much detail. An understanding of these characteristics is important to produce a better 
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quality polymer with more consistency. The γ-PGA produced using the eight strains in this 
study, six of which (B. subtilis 23856, B. subtilis 23857, B. subtilis 23858, B. subtilis 23859, 
B. licheniformis 1525 & B. licheniformis 6816) having not previously been used for γ-PGA 
production, was characterized with respect to crystallinity, form and molecular weight. It was 
found that crystallinity and form of the polymer are dependent on medium of production and 
not on the bacterial strain. On the other hand, yield and molecular weight of γ-PGA produced 
in our study were dependent on both bacteria and medium used for production. γ-PGA with 
yields (up to 22.3 g/l) and different properties produced in this study could not only be used 
for current applications, but also for some potential novel applications such as maintaining 
probiotic viability under different conditions. Molecular weight, crystallinity and form of γ-
PGA affect its solubility, which in turn would affect its application.  
 
As mentioned in section 7.3, low molecular weight γ-PGA produced in this study is 
especially important for drug delivery applications. Researchers often have to resort to 
molecular weight reduction techniques for γ-PGA applications that require a low molecular 
weight polymer (Shih and Van, 2001). In our research, bacteria have produced low molecular 
weight polymer (~3000 Da), which could be used directly for such applications. This would 
make the extra step of molecular weight reduction unnecessary, thus making the process 
more time and cost efficient. On the other hand, high molecular weight γ-PGA can be used 
for other applications such as waste water treatment. γ-PGA possesses the unique property of 
remaining stable in low pH environments and disintegrating in a near neutral environment, 
which can be exploited for novel functional food applications.  
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7.5 Large scale production of γ-PGA by B. subtilis natto 
After identification and characterization of the polymer produced by eight bacteria in both 
media, γ-PGA produced by B. subtilis natto in GS medium was chosen for probiotic tests for 
the following reasons. Firstly, γ-PGA produced by this bacterium is ideal for food 
applications. B. subtilis natto is food derived since it was isolated from a traditional Japanese 
food item called natto. In GS medium, all strains tested produced Na-γ-PGA (Table 4.6), 
which is known to have good antifreeze activity (Mitsuiki et al., 1998; Shih et al., 2003) and 
could serve as a cryoprotectant for maintaining viability of probiotic bacteria when they are 
freeze dried. In addition, Na-γ-PGA is tasteless and hence can be added to food products 
without considerably changing their taste (Ho et al., 2006a). Also, due to the existence of 
strong intra-molecular hydrogen bonding, Na-γ-PGA is known to conform to a stable and 
compact α-helical structure in an environment with a low pH (Ho et al., 2006a). In contrast, 
at a higher pH, the intra-molecular hydrogen bonding is disrupted, thus disintegrating the 
polymer into a random coil conformation. This property of Na-γ-PGA would be useful to 
protect probiotic bacteria in the stomach, which is a region of high acidity (pH 2.0). Also, 
once Na-γ-PGA reaches the intestine, which is a region of weak acidic-neutral pH, the 
polymer should disintegrate because of the disruption of hydrogen bonds and release the 
bacteria into the target site. Moreover, γ-PGA produced in GS medium is white in colour 
which is preferred for a food application. Compared to other bacteria under study, B. subtilis 
natto produced the highest yield of γ-PGA (17.77 g/l) in GS medium (Table 4.6), and hence, 
it would produce the highest quantity of γ-PGA for probiotic tests.  
 
B. subtilis natto, produced a very high molecular weight polymer in medium E (Table 4.7). A 
high molecular weight polymer would have a high water absorption capability and would 
hence form hydrogels when introduced in food. This would change the consistency of the 
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food product, which is undesirable. It has been shown previously that γ-PGA with a 
molecular weight of less than 20,000 Da has excellent antifreeze activity (Mitsuiki et al., 
1998; Shih et al., 2003). In GS medium, γ-PGA with a molecular weight of 257,000 Da was 
produced (Table 4.6). The molecular weight of this γ-PGA could be reduced using a simple 
aqueous hydrolysis technique (Goto and Kunioka, 1992). Therefore, γ-PGA with a moderate 
molecular weight, such as the one produced by B. subtilis natto in GS medium, was deemed 
to be more appropriate for the probiotic application.  
 
It was important to scale up the production of γ-PGA using B. subtilis natto from 250 ml 
shake flasks to 4 l fermentations for increasing the yield of γ-PGA obtained through growth 
in a controlled fermenter environment, and to increase the total quantity of γ-PGA to test the 
novel probiotic applications.   
 
When B. subtilis natto were grown in GS medium in shake flasks, a maximum cell count of 
9.03 log CFU/ml was achieved (Table 4.4). However, when grown in a fermenter, a cell 
count of 10.11 log CFU/ml was attained (Fig 5.1). This was probably because parameters 
known to affect the cell growth and production of γ-PGA, such as pH, temperature, aeration 
and agitation could be controlled and maintained to their optimum levels in the fermenter. γ-
PGA production makes the medium viscous which hampers the mass transfer rate of dO2, 
thus making it extremely important to ensure that reduction in the saturation percentage of 
dO2 does not hamper cell growth. The saturation percentage of dO2 was maintained above 
40% throughout the fermentation of B. subtilis natto by automatically controlling the 
agitation and aeration. Increased biomass and optimized growth conditions could be the 
reason why a significantly higher (P < 0.05) yield of γ-PGA was obtained in fermenters 
(27.94 g/l) than in shake flasks (17.7 g/l). The yield of γ-PGA from B. subtilis natto grown in 
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fermenters in this study is comparable to that achieved by previous researchers (Ho et al., 
2006a; Kedia et al., 2010). 
 
γ-PGA produced by B. subtilis natto in a 4 l fermentation was analysed by FT-IR 
spectroscopy and spectra for both crude and pure (dialyzed) γ-PGA were compared (Fig 5.4). 
γ-PGA that was purified using dialysis showed additional peaks at 1641 cm-1 and 1236 cm-1, 
which correspond to amide I N-H bending and C-O stretch respectively. Also, ICP-AES 
analysis showed that pure γ-PGA had a lower concentration of sodium and potassium ions 
than the crude polymer. This indicates that the presence of lower molecular weight γ-PGA 
and salt impurities in crude γ-PGA can be eliminated by dialysis. This is the first report that 
demonstrates the difference between characteristics of crude and pure γ-PGA. 
 
7.6 γ-PGA sterilization  
According to our knowledge, this is the first report on sterilization of γ-PGA available in the 
literature. Whilst γ-irradiation of γ-PGA could work on a large scale, it is too costly when 
smaller amounts of γ-PGA need to be sterilized. In addition, irradiation would result in cross-
linking of γ-PGA, thus increasing its water absorption capability (Sung et al., 2005). A 
polymer with a high water absorption capability would form hydrogels in solution. This is not 
ideal since it would change the palatability of the foodstuff in which it is to be used.  
 
Different techniques were tested for the sterilization of γ-PGA (Table 6.1) and of these, 
autoclaving at 0.35 BAR & 110˚C for 30 min, autoclaving at 1.035 BAR & 121˚C for 20 
mins and treatment with 3% hydrogen peroxide were effective for γ-PGA sterilization. These 
techniques could completely eradicate the residual bacteria and their spores. Obviously, 
autoclaving γ-PGA at 0.35 BAR & 110˚C for 30 mins would expose it to less stressful 
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conditions than autoclaving it at 1.035 BAR & 121˚C for 20 mins. Between autoclaving at 
0.35 BAR & 110˚C for 30 mins and treatment with 3% hydrogen peroxide, autoclaving was 
preferred for sterilization of γ-PGA produced in our study. This is because from FT-IR 
analysis, it was evident that autoclaving did not affect the structural integrity of γ-PGA, 
whereas the spectrum of γ-PGA treated with 3% hydrogen peroxide indicated changes in the 
amide II stretch and C=O symmetric stretch regions when compared to the spectrum for 
untreated γ-PGA (Fig 6.1). This could mean that 3% hydrogen peroxide treatment affects the 
structure of the polymer. In addition, it is possible that any traces of hydrogen peroxide that 
may be left after recovery of sterilized γ-PGA could affect the subsequent viability of 
probiotic bacteria to be tested.  Moreover, although hydrogen peroxide is routinely used for 
sterilization of foodstuffs such as salads, there could be palatability and odour issues. 
 
Results presented here thus indicate that steam sterilization by autoclaving did not seem to 
affect the structure of γ-PGA. A previous study (Ho et al., 2006a) has reported that the 
decomposition temperature of Na-γ-PGA is 340˚C. Therefore, heating γ-PGA at 110˚C would 
not disrupt its structure. An added advantage of heating up the polymer in an aqueous 
solution is manipulation of molecular weight. When Goto and Kunioka (1992) performed 
aqueous hydrolysis of γ-PGA at 100˚C, the molecular weight of γ-PGA reduced from 226 
KDa to 117 KDa in 30 mins, whilst heating an aqueous solution of the polymer at 120˚C for 
30 mins reduced the molecular weight from 226 KDa to 18 KDa (Goto and Kunioka, 1992). 
The authors also mention that the activation energy of the polymer chain scission due to the 
hydrolysis of γ-PGA by heating is approximately 120 kJ/M. The relative bond strengths of 
the C-C, C-N and C-O bonds are greater than 300 kJ/M. Hence, the breaking of the bonds by 
heating at 120˚C is unexpected. In our study, an aqueous solution of γ-PGA with a molecular 
weight of 257 KDa was heated at 110˚C for 30 mins at 0.35 BAR Therefore, it can be said 
 
174 
 
  
that although using this technique for sterilization of γ-PGA did not affect the structural 
bonds within the polymer, it reduced its molecular weight below 257 KDa (possibly between 
20 and 133 KDa). It has been shown previously that γ-PGA with a lower molecular weight 
(~20 KDa) has a better antifreeze activity than a higher molecular weight γ-PGA (Mitsuiki et 
al., 1998; Shih et al., 2003). Therefore, autoclaving γ-PGA could not only sterilize the 
polymer, but might also improve its efficiency in protecting the cells when they are freeze 
dried (see Section 7.7). The reduction in molecular weight of γ-PGA when it is autoclaved 
needs to be assessed using GPC. 
 
7.7 Cryoprotection of probiotic bacteria with γ-PGA 
Although the antifreeze activity of γ-PGA has been assessed previously (Mitsuiki et al., 
1998; Mizuno et al., 1997; Shih et al., 2003), it has never been used to maintain and protect 
the viability of bacteria. This study is the first to assess the effect of γ-PGA on the viability of 
probiotic bacteria when they are freeze dried.  
 
Since autoclaving would reduce the molecular weight of the polymer, it was essential to 
determine whether sterilizing γ-PGA changed its ability to protect the cells during freeze 
drying. Therefore, γ-PGA sterilized by autoclaving (γ-PGA[S]) and untreated γ-PGA (γ-
PGA[U]) were tested as cryoprotectants for L. paracasei, B. breve and B. longum. A non-
selective medium, TPY agar, was used for enumeration of cells for tests with γ-PGA[S]. A 
selective and differential medium for Bifidobacteria (BSM agar) was used for tests with γ-
PGA[U] so that the residual bacteria in γ-PGA[U] would not interfere with subsequent 
viability counts of probiotic bacteria. When 22 h and 16 h cultures of B. breve and B. longum 
were plated on TPY and BSM agar, it was seen that the counts on both media were not 
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significantly different (P > 0.05. See Table 6.2). Hence, the results obtained for the freeze 
drying experiments using TPY and BSM could be compared.  
 
When unprotected bacteria, or bacteria protected with γ-PGA[S], or sucrose were freeze dried 
(Fig 6.2), it was seen that L. paracasei was more resistant to the freeze drying process than 
both the Bifidobacteria strains under study. There was 1.34 log CFU/ml reduction in viability 
of L. paracasei when they were freeze dried without a cryoprotectant (i.e. unprotected cells). 
For the Bifidobacteria strains, 2.47-2.52 log CFU/ml reduction in viability was observed for 
unprotected cells.  
 
The results for freeze drying with γ-PGA as a cryoprotectant showed that for L. paracasei, 
10% γ-PGA[S] could protect the cells during freeze drying significantly better than 10% 
sucrose (P < 0.05). Although 5% γ-PGA[S] was also able to protect the cells during freeze 
drying, it was not as efficient as 10% γ-PGA[S]. However, its cryoprotectant ability was 
comparable to 10% sucrose (P > 0.05). For B. longum and B. breve, 10% γ-PGA[S] and 10% 
sucrose were equally efficient in maintaining viability during freeze drying (P > 0.05). 5% γ-
PGA[S] was able to protect the cells during freeze drying, but was not as effective as 10% γ-
PGA[S] or 10% sucrose. The effect of 20% γ-PGA[S] was also tested. However, the solution 
was too viscous and was difficult to manipulate. Because of this, the results obtained were 
inconsistent and are not discussed here. 
 
When γ-PGA[U] was tested for its effect on the viability of probiotic bacteria during freeze 
drying, it was seen that it could protect the cells when compared to cells that were freeze 
dried without any cryoprotectant (Fig 6.3). However, compared to γ-PGA[S], it was not as 
effective. This could be due to the fact that heating γ-PGA in an aqueous solution at 110˚C 
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for 30 min reduces its molecular weight. Therefore, it is evident that a lower molecular 
weight γ-PGA is a better cryoprotectant than a high molecular weight γ-PGA. This is in 
accordance with work done previously to determine the antifreeze activity of γ-PGA 
(Mitsuiki et al., 1998; Shih et al., 2003).  
 
It has been found that sucrose offers better protection during freeze drying of Lactobacilli 
when compared to trehalose and sorbitol (Siaterlis et al., 2009). Since γ-PGA[S] could 
protect Lactobacilli better than sucrose in our study, it could indicate that γ-PGA[S] is a 
better cryoprotectant than trehalose and sorbitol as well. Nata (bacterial cellulose produced 
by Acetobacter xylinum) has also been used to protect different Lactobacilli during freeze 
drying in a study (Jagannath et al., 2010). When the cells were immobilized using nata and 
freeze dried, it was observed that viable cell number decreased (from 10
9
 – 1010 CFU/g to 107 
CFU/g). In our study, there was only a 0.51 log CFU/ml reduction in viability of γ-PGA[S]-
protected Lactobacilli (see Fig 6.2), hence indicating that γ-PGA may be a better 
cryoprotectant compared to nata. The protection offered by γ-PGA, trehalose, sorbitol and 
nata during freeze drying of Lactobacilli needs to be compared by performing additional tests 
under identical conditions.  
 
On assessing the results obtained in this study, it was evident that 10% γ-PGA[S] can be used 
as an effective cryoprotectant for probiotic bacteria when they are freeze dried. SEM analysis 
suggested that probiotic bacteria may be protected by a dual mechanism (Fig 6.4). The 
bacteria appeared to be embedded into the γ-PGA matrix as well as covered with a thin 
coating of γ-PGA. This afforded them protection against factors that were detrimental to their 
viability during freeze drying. Additional tests with TEM need to be performed to confirm 
this observation.  
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7.8 γ-PGA protection of probiotic bacteria in juice 
Fruit juices are good candidates for incorporation of probiotic bacteria, since they are rich in 
nutrients (Ding and Shah, 2008). Also, fruit juices often have oxygen scavenging agents, such 
as ascorbic acid, which promote anaerobic growth conditions. In addition, fruit juices contain 
high amounts of sugars which could encourage growth of the added probiotic bacteria. 
However, it is often seen that probiotic viability in fruit juice is hampered due to factors such 
as pH, storage temperature, oxygen levels and presence of competing microorganisms 
(Granato et al., 2010). Once it was confirmed that γ-PGA[S] could be used as a 
cryoprotectant for probiotic bacteria, its effect was tested on the viability of probiotic bacteria 
when stored in 2 fruit juices (orange and pomegranate) for 6 weeks. As mentioned previously 
(see Section 1.7.2), γ-PGA can be used as a food additive since it is Generally Recognized 
As Safe (GRAS) by the FDA (Shyu and Sung, 2010). 
 
Because it is known that Bifidobacteria are very sensitive to pH conditions (Cui et al., 2000) 
and our cryoprotectant studies showed that L. paracasei was more resistant in enduring the 
freeze drying process than the Bifidobacteria strains under study, the juice experiments were 
performed with B. breve and B. longum.  
 
It was best to use a selective and differential medium, such as BSM agar, for enumeration of 
bacteria for these tests. This is because even though some bacteria are killed during the 
pasteurization process, the juice is not completely sterile. This was tested by plating some 
orange juice on TSA. As expected, bacterial growth was observed on the plates after 24 h 
(Section 6.4.1). However, when orange and pomegranate juice were plated on BSM agar, no 
bacterial growth was observed, which meant that the residual bacteria in the juice would not 
interfere with the viability counts for subsequent probiotic tests. 
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The final concentration of γ-PGA used for the juice experiments was 2.5% (w/v). The effect 
of γ-PGA was tested on the viability of both Bifidobacteria strains stored in orange juice for 
39 days at 4˚C (Figs 6.5 & 6.6). For both bacteria, cells that were not protected with the 
polymer (unprotected cells), showed complete loss in viability within 20 days. Even on day 
11, the number of unprotected cells (< 5 log CFU/ml) was much less than the recommended 
FAO value of 6-7 log CFU/ml (Kailasapathy and Chin, 2000; Kurmann and Rasic, 1991). 
Cells that were protected with γ-PGA survived well for 39 days in orange juice. B. longum 
showed a viability of 6.48 log CFU/ml on day 39, whereas B. breve showed a viability of 
6.61 log CFU/ml. This proves that, if orange juice were to be used as a delivery agent for 
Bifidobacteria, protecting the cells with γ-PGA could increase the shelf life of the probiotic 
product three times or more, when compared to orange juice with unprotected bacteria. B. 
breve (reduction in viability of 2.05 log CFU/ml) showed better survival in orange juice when 
protected by γ-PGA than B. longum (reduction in viability of 2.99 log CFU/ml) after 39 days. 
 
When  the viability of B. longum encapsulated in Ca-alginate beads in orange juice was 
monitored in a study (Ding and Shah, 2008) for a period of 6 weeks, a reduction of ~3.0 log 
CFU/ml in viability was observed at the end of storage at 4˚C. γ-PGA-protected cells in our 
study also showed similar loss in viability (2.99 log CFU/ml) over 39 days. However, the 
study by Ding and Shah (2008) does not highlight the viability of Ca-alginate encapsulated 
cells in simulated gastric juice environments. It is known from other studies (Anal and Singh, 
2007; Chandramouli et al., 2004; Hansen et al., 2002; Krasaekoopt et al., 2004; Mortazavian 
et al., 2008; Lee and Heo, 2000) that Ca-alginate is not effective in protecting cells in low pH 
conditions and survival depends on various parameters such as alginate concentration and 
bead size. Therefore, although Ca-alginate could help protect cells in orange juice, its 
protective effect after ingestion is questionable. Interestingly, in the study by Ding and Shah 
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(2008), unprotected cells survived for 4 weeks in orange juice and complete loss in viability 
was observed by the 5
th
 week. Our study is not in agreement with this, since complete loss in 
viability of unprotected B. longum cells was seen by week 3.  
 
A recent study (Su et al., 2011) used 1.5% (w/v) alginate – 2% (w/v) human-like collagen 
microspheres to protect B. longum cells during storage in 10% (w/v) skimmed milk at 4˚C for 
3 weeks. After 3 weeks, the survival of the cells decreased from 9.35 to 7.38 log CFU/ml (a 
log reduction in viability of 1.97 CFU/ml). When B. longum cells were protected with γ-PGA 
during storage in orange juice for 3 weeks in our study, a lower log reduction in viability 
(1.30 CFU/ml) was seen. It must also be noted that orange juice has a lower pH than 
skimmed milk and provides a more unsuitable environment for bacteria, especially for 
Bifidobacteria which are sensitive to pH. It is evident that γ-PGA is more efficient in 
protecting B. longum during storage at 4˚C. In addition, production of microspheres requires 
the usage of electrostatic droplet generation technology which could have added initial 
investment implications. Protection of cells with γ-PGA is less complicated. 
 
In another study (Akalin et al., 2004), the prebiotic chicory fructooligosaccharide (FOS) was 
used to protect B. longum and B. animalis in yoghurt for 28 days at 4˚C. B. longum was seen 
to be more sensitive to storage conditions than B. animalis. After 28 days, the viability of B. 
longum protected with FOS decreased from 4.06 x 10
7
 CFU/g to 2 x 10
5
 CFU/g (a log 
reduction in viability of 2.31 CFU/ml). When γ-PGA was used to protect B. longum cells 
during storage in orange juice for 28 days in our study, a log reduction in viability of 1.56 
CFU/ml was observed. It must again be noted that the pH of orange juice (3.91) is lower than 
that of yoghurt (~ 4.5). Thus orange juice is a less suitable environment for B. longum 
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compared to yoghurt. γ-PGA seems to be better at protecting B. longum during storage than 
FOS.  
 
On assessing results obtained from tests conducted with orange juice, it can be said that 
protecting cells with γ-PGA could make orange juice a potential delivery platform for 
probiotic bacteria. The effect of various protective measures on the viability of probiotic 
bacteria in different foodstuffs has been summarized in Table 7.1. 
 
Table 7.1: The use of various protective measures to maintain viability of probiotic bacteria during 
storage in foodstuff 
Organism Foodstuff Method of 
protection 
Duration Log CFU/ml 
reduction in 
viability 
Reference 
B. longum Orange juice γ-PGA 
 
39 days 2.99 See section 6.4.2.1 
B. breve Orange juice γ-PGA 
 
39 days 2.05 See section 6.4.2.2 
B. longum Orange juice Ca-alginate 
 
6 weeks 3.00 (Ding and Shah, 2008) 
B. longum Skimmed milk Alginate – human-
like collagen 
 
3 weeks 1.97 (Su et al., 2011) 
B. longum Yoghurt 
 
FOS 28 days 2.31 (Akalin et al., 2004) 
B. bifidum Stirred yoghurt Whey protein 
concentrate 
35 days 3.00 (Christopher et al., 
2009) 
 
Similarly, the effect of 2.5% (w/v) γ-PGA was tested on the viability of Bifidobacteria when 
stored in pomegranate juice (Fig 6.7 & 6.8). B. longum cells that were not protected with γ-
PGA died within 6 days. γ-PGA-protected B. longum cells died within 20 days. However, 
even on day 6, the viability of the cells was less than 6 log CFU/ml. Unprotected B. breve 
showed complete loss in viability within 2 days, whilst γ-PGA protected-B. breve died within 
13 days. However, even on day 2, the cells showed less viability than the recommended FAO 
value (6-7 log CFU/ml). Clearly, B. breve cells are more sensitive to pomegranate juice than 
B. longum. The viability of unprotected cells in pomegranate juice was very poor, whilst γ-
PGA protected the cells a little better, although this was not good enough to make 
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pomegranate juice a suitable food for delivery of probiotics. Poor survival of unprotected B. 
longum and L. plantarum in pomegranate juice has also been demonstrated in other studies 
(Nualkaekul and Charalampopoulos, 2011; Nualkaekul et al., 2011), where the viability of 
the cells decreased by ~8 log CFU/ml within 1 week (B. longum) and 4 weeks (L. plantarum) 
of storage at 4˚C. γ-PGA-protected B. longum in pomegranate juice survived slightly better in 
our study.  
  
Pomegranate juice contains a much lower content of ascorbic acid than orange juice. 
Ascorbic acid is an oxygen scavenger and helps promote anaerobic conditions which are 
ideal for Bifidobacteria. In addition, pomegranate juice contains a high amount of 
antioxidants and has anti-microbial properties, which has been attributed to its high 
polyphenol content (Johanningsmeier and Harris, 2011). It has been found that the 
antioxidant capacity of pomegranate juice is higher than that of orange juice, where the total 
phenolic content of pomegranate juice is 112.3 mg% in comparison to 22 mg% in orange 
juice (Parashar and Badal, 2011). Pomegranate and its extracts have been used as natural 
antimicrobial agents previously (Hayrapetyan et al., 2012; Devi et al., 2011). Hence, these 
could be the reasons for poor survival of unprotected and γ-PGA-protected probiotic bacteria 
when they were tested in it. The therapeutically beneficial pomegranate constituents include 
ellagic acid, punicic acid, flavonoids, anthocyanidins, anthocyanins, estrogenic flavonols and 
flavones (Devi et al., 2011). Addition of probiotic bacteria to pure pomegranate juice would 
be an added benefit to the health promoting factors already present. However, this study has 
shown this to be challenging and there is a need to come up with a better protective agent for 
incorporating probiotic bacteria into pomegranate juice. 
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To preserve the organoleptic properties and nutritional value of the juice, it was important to 
identify any changes in the organic acid concentration in the juice on addition of probiotic 
bacteria and γ-PGA. Ascorbic, citric and malic acid concentrations were monitored for fresh 
juice and expired orange and pomegranate juice under different conditions (Tables 6.3, 6.5, 
6.7 & 6.9). The initial concentration of malic acid in fresh orange juice was 3.84 g/l. This 
concentration did not change considerably for orange juice without probiotic bacteria, orange 
juice with probiotic bacteria and orange juice with γ-PGA-protected probiotic bacteria. This 
could be because both probiotic bacteria under study do not preferentially metabolize malic 
acid. The concentration of malic acid in fresh pomegranate juice did not change significantly 
on addition of unprotected probiotic and γ-PGA-protected bacteria after 39 days either.  
Similar results were obtained when B. longum were encapsulated with Ca-alginate and stored 
in orange juice for 6 weeks, where change in malic acid concentration was negligible (Ding 
and Shah, 2008). Surprisingly, the study by Ding and Shah (2008) did not assess the change 
in concentrations of ascorbic and citric acid which are important organic acids present in 
orange juice that contribute to its organoleptic and nutritional properties. 
 
The concentration of ascorbic acid in fresh orange juice in our study was 425.09 mg/l. When 
fresh orange juice was stored at 4˚C for 39 days, the concentration of ascorbic acid dropped 
to 160.97 mg/l. This was expected, since ascorbic acid breaks down quickly in the presence 
of oxygen. The exposure of orange juice to oxygen during routine sampling at regular 
intervals would have caused the ascorbic acid to break down and reduce in concentration. 
When B. longum was added to orange juice, the concentration of ascorbic acid was seen to 
reduce further to 79.14 mg/l. Protecting B. longum with γ-PGA did not change the 
concentration of ascorbic acid in orange juice significantly in comparison to orange juice 
with unprotected B. longum after 39 days (P > 0.05). The reduction in ascorbic acid content 
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on addition of B. longum could be an independent or combined effect of metabolism or 
sequestration of ascorbic acid by cells and a physical masking of ascorbic acid by the high 
molecular weight γ-PGA. In contrast, the addition of unprotected B. breve and γ-PGA-
protected B. breve to orange juice did not significantly alter the ascorbic acid concentration 
when compared to that in expired orange juice after 39 days (P > 0.05). This could probably 
mean that B. breve cells did not metabolize or sequester ascorbic acid. Therefore, the addition 
of B. longum reduced the concentration of ascorbic acid slightly, when compared to expired 
orange juice without probiotic cells, whereas addition of B. breve did not affect the 
concentration of ascorbic acid. On the other hand, only 9 mg/l of ascorbic acid was seen to be 
present in fresh pomegranate juice. This is because the pomegranate juice used for the tests is 
flash-pasteurized and hence, most of the ascorbic acid is destroyed. The juice was not 
supplemented with ascorbic acid after pasteurization, hence its concentration in fresh juice is 
very low. 
 
The citric acid concentration in fresh orange juice was found to be 9.95 g/l. The concentration 
of citric acid in orange juice stored for 39 days at 4˚C was not significantly different from 
that in fresh orange juice (P > 0.05). When B. longum and B. breve were added to orange 
juice, the concentration of citric acid was seen to drop slightly (by 0.76 and 0.66 g/l 
respectively). This could be due to either metabolism or sequestration of citric acid by the 
cells. The addition of γ-PGA-protected B. longum and B. breve to orange juice caused an 
additional slight drop in the citric acid concentration, but was not statistically significant (P > 
0.05). The reason for the increased drop in citric acid concentration in the presence of γ-PGA 
could be because probiotic bacteria survive better when protected with γ-PGA, hence, a 
greater number of viable cells would be available to metabolize and sequester citric acid. In 
addition, physical masking of a small amount of citric acid by the high molecular weight γ-
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PGA could be a possibility. The concentration of citric acid in fresh pomegranate juice (17.43 
g/l) did not change significantly after 39 days, even after addition of probiotic bacteria with γ-
PGA. This could be attributed to the poor survival of bacteria in pomegranate juice and hence 
minimal loss in citric acid due to metabolism or sequestration by cells. 
The pH of fresh orange juice and orange juice stored at 4˚C for 39 days was 3.91 and 3.81 
respectively (Tables 6.4 & 6.6). This did not change considerably on addition of unprotected 
probiotic bacteria. When γ-PGA protected cells were added to orange juice, the pH was seen 
to increase slightly (by 0.45 and 0.31 for B. longum and B. breve, respectively). This is due to 
the addition of the sodium salt of polyglutamate. However, the change in pH was very small. 
The change in pH was smaller (0.07) when B. longum were encapsulated with Ca alginate 
and added to orange juice which was stored at 4˚C for 6 weeks (Ding and Shah, 2008). A 
similar trend was observed in pomegranate juice after 39 days (Tables 6.8 & 6.10), where an 
increase in pH of 0.97 and 0.87 was seen when γ-PGA protected B. longum and B. breve, 
respectively, were added to the juice.  
 
After performing tests with probiotic bacteria in orange juice and pomegranate juice, it was 
evident that γ-PGA protects the cells well in orange juice and that orange juice can be a good 
medium through which probiotic bacteria could be administered. Presently, dairy probiotic 
products dominate the probiotic food market. This study provides another food range in 
which probiotic bacteria could be delivered. This would be beneficial, especially for 
individuals who are lactose intolerant or allergic to milk proteins, and are unable to consume 
dairy probiotic products. An added advantage of adding low concentration of γ-PGA to fruit 
juices is that it enhances taste and drinkability of the juice (Yamanaka and Kikuchi, 1991). 
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7.9 γ-PGA protection of probiotic bacteria in simulated gastric juice 
A probiotic food product would be useful only if an adequate number of live probiotic 
bacteria reach the target site. A heavy loss in viability of probiotic bacteria has been 
demonstrated in the stomach, which is a region of high acidity (Cui et al., 2000; Su et al., 
2011; Vasiljevic and Shah, 2008). Since, γ-PGA has a unique property of staying stable in an 
acidic environment and disintegrating in a weaker acidic or neutral environment, the 
protective effect of γ-PGA was tested on the viability of B. longum and B. breve in a 
simulated gastric environment (Fig 6.9 & 6.10). Unprotected Bifidobacteria cells (B. longum 
and B. breve) died within 2 h of incubation in simulated gastric fluid. In fact, even after an 
hour of incubation, the cell count dropped to ~4 log CFU/ml. However, γ-PGA-protected B. 
longum cells showed marginal loss in viability over 4 h in simulated gastric juice. For B. 
breve, the number of cells at 0 h and 4 h was not significantly different (P > 0.05). Hence, it 
can be said that protection by γ-PGA caused little or no loss in viability for probiotic 
Bifidobacteria over a period of 4 h in a simulated gastric environment. This is possibly due to 
the fact that γ-PGA remains structurally stable in a low pH environment. In a pH stability 
study (Ho et al., 2006a), strong intra-molecular hydrogen bonding existed in γ-PGA at pH 
2.0, where it formed a stable compact α-helix conformation. When pH was increased to 4.09, 
about 50% of the insoluble α-helix conformations transformed into linear random-coil 
conformations. When the pH was increased to 6.0, all the intra-molecular hydrogen bonding 
was disrupted and a complete change in conformation was seen from α-helix to random-coils. 
This property of Na-γ-PGA was possibly useful in protecting probiotic bacteria in the 
simulated gastric juice environment with a high acidic pH (pH 2.0). Also, once Na-γ-PGA 
reaches the intestine, which is a region of weak acidic-neutral pH, the polymer would 
disintegrate because of the disruption of hydrogen bonds and release the bacteria into the 
target site. 
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When 1.5% (w/v) alginate – 2% (w/v) human-like collagen microspheres was used to protect 
B. longum in a simulated gastric juice (pH 2.0) for 2 h, a log reduction in cell viability of 4.66 
CFU/ml was observed (Su et al., 2011). This was 4.19 log CFU/ml higher than the reduction 
in viability observed with γ-PGA in this study, despite the fact that the incubation time was 
twice as long. It is evident that γ-PGA is much better at protecting cells in simulated gastric 
juice than alginate – human-like collagen microspheres. In addition, γ-PGA protection of 
cells does not require the use of any complicated technology to achieve a protective coating 
of the cells. 
 
In another study (Cui et al., 2000), the survival and stability of B. bifidum in simulated gastric 
juice was assessed after they were loaded in alginate poly-L-lysine microparticles. After 2 h, 
a 2 log CFU/ml reduction in viability was observed when protected cells were incubated in 
simulated gastric juice. This reduction in viability was thought to be due to the surface 
pinholes in microparticles, through which the simulated gastric juice could enter. γ-PGA was 
much better at protecting Bifidobacteria in simulated gastric juice for 4 h, where a maximum 
log reduction in viability of 0.47 CFU/ml was observed.  
 
Recently, chocolate matrices have also been used as delivery agents for probiotic bacteria 
(Possemiers et al., 2010). Dark and milk chocolates were evaluated for their effect on the 
viability of probiotic bacteria during their passage through the stomach and small intestine. 
Milk chocolate offered better protection (91% and 80% survival for L. helveticus and B. 
longum, respectively) than dark chocolate after the cells were passed through simulated 
gastric and intestinal juices for 3.5 h, and this was thought to be due to the presence of 5-fold 
lower polyphenol content in milk chocolate. Although milk chocolate protected probiotic 
bacteria well, γ-PGA-protected B. longum survived much better in simulated gastric juice, 
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where 94.83% survival was seen after 4 h. In addition using milk chocolate as a health 
promoting food is questionable and it would be particularly unsuitable for diabetic patients. 
The survival of cells protected with γ-PGA in simulated intestinal juice needs to be tested. 
 
The effect of different protective measures on the viability of probiotic bacteria in simulated 
gastric juice has been summarized in Table 7.2. 
 
Table 7.2: The effect of various protective measures on viability of probiotic bacteria  in simulated gastric 
juice 
Organism in 
simulated gastric 
juice 
Method of 
protection 
Duration Reduction in 
viability 
Reference 
B. longum γ-PGA 4 h 0.47 log CFU/ml 
(94.83% survival) 
 
See section 6.4.5.1 
B. breve γ-PGA 
 
4 h No loss in viability See section 6.4.5.2 
B. longum Alginate – human-like 
collagen 
 
2 h 4.66 log CFU/ml (Su et al., 2011) 
B. bifidum 
 
Alginate-poly-l-lysine 2 h 2 log CFU/ml (Cui et al., 2000) 
B. longum  
(sim gastric and 
intestinal juice) 
 
Milk chocolate 3.5 h 80% survival (Possemiers et al., 
2010) 
B. lactis Maple sap concentrate 1.3 h 0.4 - 1.2 log CFU/ml (Khalf et al., 2010) 
 
 
Thus, it is clear that γ-PGA could potentially help in improved survival and viability of 
probiotic bacteria in the stomach. Once the cells are transported to the intestine, it has been 
demonstrated that γ-PGA breaks down steadily into its component glutamic acid residues 
(Singer, 2005). This would release probiotic bacteria into the target site. Glutamic acid can 
enter normal cellular metabolism and is not excreted by the kidney. 
 
Saarela et al. (2006) highlight the importance of choosing a cryoprotectant to protect 
probiotic bacteria during freeze drying that would also protect them during storage in the 
appropriate food delivery system (Saarela et al., 2006). Not only does γ-PGA protect bacteria 
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during freeze drying and storage in orange juice, but it also protects bacteria in simulated 
gastric juice, hence making it an ideal choice for a delivery tool for protection of probiotic 
bacteria.  
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8. CONCLUSION 
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γ-PGA is a unique biopolymer made up of repeating units of glutamic acid. It is 
biodegradable, non-toxic and non-immunogenic, and as such, has the potential to be used for 
multiple applications. It is important to investigate new bacteria for γ-PGA production and to 
characterize the biopolymer they produce, because this would help deliver a more consistent 
and better quality polymer for use in different industries.  
 
In this study, γ-PGA production in eight different bacteria was investigated in two media (GS 
and E). Two of these bacteria (B. subtilis natto and B. licheniformis 9945a) have been used 
for γ-PGA production before. The other six bacteria (B. subtilis 23856, B. subtilis 23857, B. 
subtilis 23858, B. subtilis 23859, B. licheniformis 1525 and B. licheniformis 6816) have not 
been used previously for this purpose.  
 
Overall, it was seen that bacteria grown in GS medium reached a higher cell count (up to 9.58 
log CFU/ml) than when they were grown in medium E (up to 8.57 log CFU/ml). This was 
possibly due to the presence of a vitamin solution in GS medium. In addition, more sucrose 
was consumed by most of the B. subtilis strains when grown in GS medium than glycerol 
when they were grown in medium E. Conversely, all B. licheniformis strains consumed more 
glycerol in medium E than sucrose in GS medium. It was also found that most of the B. 
subtilis strains consumed more L-glutamic acid when sucrose was used as the carbon source, 
whereas most B. licheniformis strains consumed more L-glutamic when glycerol was used as 
the carbon source.  
 
The highest yield of γ-PGA in medium E (22.3 g/l) was produced by B. licheniformis 1525 
and the highest γ-PGA yield in GS medium (17.77 g/l) was produced by B. subtilis natto. 
Three bacteria, B. subtilis 23857, B. subtilis 23859 and B. licheniformis 1525 produced more 
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γ-PGA (g/l) in medium E than in GS medium. In fact, all bacteria produced more γ-PGA/cell 
in medium E. This was possibly due to the presence of citric acid and glycerol. It can be 
concluded that sucrose (GS medium) improved cell growth whereas presence of glycerol and 
citric acid (medium E) increased γ-PGA production.  For B. subtilis natto, GS medium was 
more suited for L-glutamic acid consumption and total γ-PGA production than medium E, 
since it utilized the maximum amount of L-glutamic acid (19 g/l) and produced the highest γ-
PGA yield (17.77 g/l). When compared to other bacteria, B. subtilis natto utilized the least L-
glutamic acid (4.66 g/l) and produced the lowest yield of γ-PGA (5.7 g/l) in medium E.  
 
The properties of the γ-PGA produced are crucial, since they can determine the application 
for which it is used. γ-PGA that was produced by bacteria grown in GS medium was white in 
colour, whereas cells produced a brown polymer when grown in medium E. The colour of the 
polymer is important since a white polymer is ideal for medical and food applications 
whereas a brown polymer could be used for applications in the waste water treatment 
industry. 
 
All bacteria produced γ-PGA, which was confirmed by FT-IR analysis. It was found that 
crystallinity and form of γ-PGA were dependent on the medium of γ-PGA production and not 
on the bacteria producing it, since all bacteria produced a crystalline, Na-salt form of γ-PGA 
when grown in GS medium and an amorphous acid form of γ-PGA when grown in medium 
E. This is the first report that establishes a dependence of crystallinity and form of γ-PGA on 
the medium of production.  
 
Knowledge of molecular weight of γ-PGA is extremely crucial before it is used for an 
application. Eight bacteria grown in two different media produced γ-PGA with molecular 
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weights ranging from ~3000 Da to 871,000 Da. A low molecular weight γ-PGA is especially 
important for medical applications whereas a high molecular weight polymer can be used for 
applications in the cosmetic and waste water treatment industry. Unlike crystallinity and form 
of γ-PGA (which were only dependent on the medium), molecular weight of the produced 
polymer was seen to be dependent on both bacteria and medium used for its production  
 
After characterization studies of γ-PGA produced by the eight bacteria in both media, the best 
γ-PGA producer was selected for subsequent investigations. B. subtilis natto grown in GS 
medium was chosen to produce γ-PGA for testing novel probiotic applications. Production of 
γ-PGA from the bacterium was scaled up by growing it in a 5 l fermenter to increase the yield 
of γ-PGA produced as well as the total quantity of γ-PGA obtained. On growing bacteria in a 
fermenter, where parameters such as temperature, pH, dO2, aeration and agitation could be 
monitored and controlled, cell counts of up to 10.11 log CFU/ml and γ-PGA yield of up to 
27.94 g/l were achieved. Before the γ-PGA obtained from fermentations was used for 
probiotic tests, different methods of sterilization of γ-PGA were tested. There is no report on 
sterilization of γ-PGA in the literature. On assessing different techniques, autoclaving γ-PGA 
at 110˚C and 0.35 BAR for 30 mins was found to be the best method, because it completely 
eliminated residual bacteria in γ-PGA without disrupting the structural integrity of the 
polymer.  
 
Bacteria are usually freeze dried to lengthen storage time. However, the freeze drying process 
itself is detrimental to the viability of bacteria. Although the antifreeze activity of γ-PGA has 
been assessed previously, it has never been used to maintain viability of probiotic bacteria 
during freeze drying. Three probiotic bacteria (L. paracasei, B. longum & B. breve) were 
protected with sterilized and untreated γ-PGA along with sucrose (which is commonly used 
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as a cryoprotectant commercially) and the viability before and after freeze drying was 
determined. It was found that L. paracasei was more resistant to the freeze drying process 
than the Bifidobacteria strains, because a 1.34 log CFU/ml reduction in viability was seen for 
L. paracasei that were not protected with a cryoprotectant in contrast to 2.47-2.52 log 
CFU/ml reduction in viability for unprotected Bifidobacteria. Also, for L. paracasei, 10% γ-
PGA[S] offered significantly better protection (P < 0.05) than 10% sucrose. The 
cryoprotectant activities of 5% γ-PGA[S] and 10% sucrose were comparable (P > 0.05). For 
Bifidobacteria, 10% γ-PGA[S] and 10% sucrose were equally efficient in maintaining 
viability during freeze drying. 5% γ-PGA (S) and 10% γ-PGA[U] were not as effective as 
10% γ-PGA[S]. 
 
Most probiotic bacteria in foods are delivered via dairy products such as milk, yoghurts and 
yoghurt drinks. There is a need to develop non-dairy vehicles for administration of probiotics 
for individuals who are lactose intolerant or who are allergic to milk proteins. Fruit juices are 
good candidates for this purpose, since they are rich in nutrients and are palatable. However, 
probiotic viability in fruit juice is hampered due to factors such as pH, storage temperature, 
oxygen levels, naturally present antimicrobials and/or presence of competing 
microorganisms. Hence, it is important to protect the viability of probiotic bacteria in such 
environments. γ-PGA was utilized for this novel application where it was shown to protect B. 
breve and B. longum in orange juice for 39 days at 4˚C. Cells that were not protected with the 
polymer showed complete loss in viability within 20 days. Even on day 11, the number of 
unprotected cells in orange juice was much less than the recommended FAO value of 6-7 log 
CFU/ml. Cells protected with γ-PGA survived well for 39 days with a log reduction in 
viability of less than 2.99 CFU/ml. γ-PGA was not effective in protecting probiotic bacteria 
in pomegranate juice, since the viability of unprotected and γ-PGA-protected Bifidobacteria 
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was poor in the juice, possibly due to the presence of a high amount of antioxidants and anti-
microbial agents.  
 
The change in concentration of organic acids and pH was also determined to assess any 
variation in the organoleptic and nutritional value of fruit juices. No considerable change was 
observed in the concentrations of citric acid, malic acid and ascorbic acid when probiotic 
bacteria and γ-PGA were introduced into orange juice. The pH of orange juice also did not 
change greatly on addition of γ-PGA-protected Bifidobacteria. Overall, it can be said that 
addition of γ-PGA-protected Bifidobacteria did not seem to change the organoleptic and 
nutritional properties of orange juice substantially. γ-PGA protection was shown to improve 
the viability of probiotic bacteria in orange juice and hence, it could be used as a non-dairy 
delivery platform for these bacteria.  
 
Because of the harsh conditions of the stomach, a heavy loss in viability is seen when 
probiotic bacteria are ingested. Due to its unique ability to remain stable in low pH 
environments and to disintegrate in a weaker acidic or neutral environment, γ-PGA can be 
used to improve the survival of these bacteria in the stomach. This was demonstrated by 
protecting B. longum and B. breve with γ-PGA and checking their viability at regular 
intervals when stored in a simulated gastric juice (pH 2.0) for 4 h. It was seen that 
unprotected cells showed poor viability (~4 log CFU/ml) after 1 h of incubation in simulated 
gastric juice and showed complete loss in viability within 2 h. On the other hand, only a 
marginal loss in viability was seen for γ-PGA-protected B. longum after 4 h in simulated 
gastric juice. For B. breve, cell viability at 0 h and 4 h was not significantly different (P > 
0.05). γ-PGA was successful in protecting Bifidobacteria in simulated gastric juice with little 
or no loss in viability. 
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While choosing an agent to protect probiotic bacteria, it is essential to choose the one that 
protects them during different stages where loss in viability can be anticipated. The results 
obtained from our study demonstrates that not only does γ-PGA protect bacteria during freeze 
drying and storage in orange juice, but it also protects bacteria in simulated gastric juice, 
hence making it an ideal choice to protect probiotic bacteria during storage and after 
ingestion.  
 
It can be concluded that this study has increased the information about γ-PGA production in 
bacteria by characterizing six bacterial strains that had not previously been investigated for 
this purpose. Each strain produced γ-PGA with different properties in the two media used in 
this study. γ-PGA was also successfully used for novel probiotic applications, where it 
improved survival of three probiotic bacteria during freeze drying. This study also showed 
that a non-dairy food product, orange juice, could be successfully used to deliver 
Bifidobacteria when they were protected with γ-PGA. Bifidobacteria survived in orange juice 
well at 4˚C after 39 days and the viability of Bifidobacteria in orange juice was higher than 
the minimum viability (6-7 log CFU/ml) recommended by FAO. This would be particularly 
beneficial for individuals who are lactose intolerant or are allergic to milk proteins. Finally, 
this study showed that γ-PGA could be used to protect Bifidobacteria in simulated gastric 
juice (pH 2.0) at 37˚C for 4 h with very little or no loss in viability. Therefore, γ-PGA can 
potentially be used to protect probiotic bacteria in the stomach and eventually deliver them to 
the intestine. γ-PGA would be broken down into component glutamic acid residues and 
absorbed, presenting no residual effect on the host.  
 
 
 
 
196 
 
  
 
 
 
 
 
 
 
 
 
9. FUTURE WORK 
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The results obtained in this study open up interesting opportunities for future work. For 
instance, nutrient consumption analysis revealed that when B. subtilis natto was grown in 
medium E for production of γ-PGA, the L-glutamic acid concentration in the medium 
increased after 72 h. This could indicate the presence of a γ-PGA degradation system, which 
is active in some bacteria in the late stationary phase and can break down the polymer, thus 
releasing L-glutamic acid units into the medium. The presence of the components of this 
system could be investigated further for B. subtilis natto grown in medium E. It was also 
found that B. subtilis natto produced only 5.7 g/l of γ-PGA in medium E, which was the 
lowest among all bacteria grown in this medium. This could be attributed to the presence of 
the γ-PGA degradation system, which seemed to be active after 72 h. Therefore, it would be 
interesting to extract γ-PGA from the medium at an earlier time point and check whether this 
improves the yield of γ-PGA produced.  
 
It was noted that L-glutamic acid was not consumed completely by the cells. This was 
especially true for B. licheniformis strains in GS medium and most bacteria in medium E. It 
would also be interesting to assess the roles of L-glutamic acid, citric acid and carbon source 
used in γ-PGA production for bacteria under study. L-glutamic acid could be completely 
eliminated from the medium and replaced with metabolic precursors such as L-glutamine to 
check whether the bacteria under study still produce γ-PGA. Optimization of the amount of 
L-glutamic acid needed to produce γ-PGA for each bacterium would help reduce the cost of 
γ-PGA production.  
 
It was observed that for most strains in our study, the sucrose concentration remained stable 
once cells started dying in culture. This could also indicate that sucrose is utilized by the cells 
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as the growth-limiting substrate. This could be confirmed by determining the fraction of γ-
PGA repeat units that were formed from exogenously supplied sucrose.  
 
It was seen that bacteria used to produce γ-PGA reached lower cell numbers in medium E 
than they did in GS medium. This could be due to the presence of MS vitamin solution in GS 
medium and/or a very high concentration of glycerol in medium E. A recent study shows that 
a very high concentration of glycerol (80 g/l), such as that used in our study, inhibits cell 
growth in B. subtilis NX-2 and hence it has been suggested that glycerol could be added later 
(for example, at ~16 h) to reduce the initial inhibitory effect on cell growth (Wu et al., 
2010a). This technique could be used for increased cell growth in medium E and it might be 
able to further increase the yield of γ-PGA produced in this medium.  
 
This study has investigated the production of γ-PGA in eight bacteria using medium E. In 
another study (Du et al., 2005), when B. licheniformis WBL-3 was used for the production of 
γ-PGA in modified medium E (using different concentration of glycerol) in shake flasks, a 
maximum yield of 16.7 g/l was obtained. Four of the eight strains in our study produced γ-
PGA with yields higher than 19 g/l in medium E without any modifications or optimization. 
It would be worth optimizing the production of γ-PGA with respect to carbon source and 
nitrogen source for these bacteria in fermenters, where better monitoring and control of 
nutrients is possible. Optimization using a statistical approach has proved beneficial to 
improve the yield of γ-PGA previously (Bajaj and Singhal, 2009b; Bajaj et al., 2009; Jeong et 
al., 2010) and could be used for optimizing yield of γ-PGA produced by bacteria in future. 
Other factors in the medium that can affect the yield of γ-PGA production by each bacterium 
(such as pH, salt concentration, addition of precursors etc.) would also need to be 
investigated.  
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When bacteria were grown in medium E, it was found that the γ-PGA produced was a 
combination of acid form and sodium salt form of the polymer. Because 3 M NaOH was used 
to adjust the pH of medium E, production of a pure acid form of γ-PGA from this medium 
will be attempted by completely eliminating sodium from the medium by adjusting the pH 
with NH4OH instead of NaOH. 
 
γ-PGA is an extracellular product. On the other hand, polyhydroxyalkanoates (PHA‘s) are 
known to be produced by Bacillus strains as intracellular granules (Verlinden et al., 2007). 
After production of γ-PGA, the cells are discarded since the polymer is released into the 
medium. It will be interesting to investigate whether the bacterial strains used to produce γ-
PGA in our study also produce intracellular PHA‘s in GS or E media. If this is possible, it 
could make the process of production of all these useful polymers more economical. 
 
Aqueous hydrolysis of γ-PGA has been performed previously by heating an aqueous solution 
of γ-PGA at different temperatures to reduce its molecular weight (Goto and Kunioka, 1992). 
In this work, γ-PGA produced by B. subtilis natto in GS medium was sterilized by 
autoclaving at 110˚C and 0.35 BAR for 30 mins. γ-PGA with low molecular weight has been 
shown to have higher antifreeze activity than a high molecular weight polymer (Mitsuiki et 
al., 1998; Shih et al., 2003) and this could be the reason why 10% γ-PGA[S] was found to be 
a better cryoprotectant for probiotic bacteria than 10% γ-PGA[U] in our study. FT-IR 
analysis revealed that the structural integrity of the polymer remained intact after 
sterilization. However, GPC analysis could be used to determine the reduction in molecular 
weight of the polymer after autoclaving.  
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γ-PGA was successful in protecting cells during freeze drying, storage in orange juice and 
incubation in simulated gastric juice. It is crucial to reduce the added cost of γ-PGA 
protection as much as possible so that this application of γ-PGA is feasible for use in 
industry. Different concentrations of γ-PGA were tested for their efficiency of protection and 
it was found that 10% γ-PGA could protect cells much better than 5% γ-PGA during freeze 
drying. SEM images of γ-PGA-protected Bifidobacteria revealed that some γ-PGA was still 
available to coat bacteria. Therefore, it would be interesting to increase the number of cells to 
be protected with 10% γ-PGA and check their survival during freeze drying. This might help 
in protecting more bacteria with the same amount of γ-PGA. Lowering the ratio of γ-PGA to 
cells could make this novel application commercially viable.  
 
Comparing the cryoprotectant test results of our study to other studies (Jagannath et al., 2010; 
Siaterlis et al., 2009) indicates that γ-PGA could offer better protection to Lactobacilli during 
freeze drying than trehalose, sorbitol and nata. This needs to be confirmed by performing 
additional tests.  
 
It would be useful to check the viability of freeze-dried bacteria protected with γ-PGA, when 
stored at different temperatures (for example, 4˚C, 25˚C and 37˚C) for a longer duration (2 to 
6 months) to test the long-term stability of γ-PGA-protected bacteria. This would be useful, 
since refrigeration for storage of bacteria is not readily available in some parts of the world 
and long term protection of bacteria at the ambient temperatures found in markets such as 
Asia and Africa could be beneficial. 
 
This study demonstrated that γ-PGA was successful in protecting the cells when they were 
introduced in orange juice and stored for 39 days at 4˚C, but it was not effective in protecting 
 
201 
 
  
the cells in pomegranate juice. Other fruit juices, such as grapefruit, pineapple, blackcurrant, 
strawberry, cranberry, apple, mango, lychee and guava also have nutritional value and the 
protective effect of γ-PGA on probiotic bacteria could be tested in these juices as well. 
 
γ-PGA was very successful in protecting the viability of probiotic bacteria in simulated 
gastric juice, where little or no loss in viability was observed for 4 h. Next, the protective 
effect of γ-PGA on probiotic bacteria will be tested when they are stored in a simulated 
intestinal juice and when they pass through an artificial human gut model. Using Ca-γ-PGA 
(instead of Na-γ-PGA) for protection of probiotic bacteria through the gastrointestinal tract 
could be beneficial, because it has been shown that γ-PGA can increase the calcium 
absorption in the intestine (Tanimoto et al., 2007). This would also be beneficial for 
delivering probiotic bacteria via a non-dairy product such as fruit juice, since the calcium 
usually derived from dairy sources could be obtained from Ca-γ-PGA in the juice. Therefore, 
it would be interesting to assess the protective effect of Ca-γ-PGA on probiotic bacteria under 
different conditions.  
 
Vitamin B12 (Cobalamin) is a water-soluble vitamin and plays a key role in the normal 
functioning of the brain and nervous system. Deficiency of vitamin B12 can potentially cause 
several disorders such as megaloblastic anaemia and vitamin B12 deficiency-associated 
neuropathy. The classic treatment for vitamin B12 deficiency is parenteral administration, 
however, new routes of vitamin B12 administration (oral and nasal) are being investigated. 
Oral administration of vitamin B12 is challenging, because of its instability in the 
gastrointestinal tract. In an earlier study (Sonaje et al., 2010), nanoparticles comprising 
chitosan and γ-PGA have been used for effective oral delivery of insulin. The protective 
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effect of these nanoparticles on vitamin B12 after ingestion could also be tested, which could 
help reduce cost of administration and injection related complications. 
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Table 11.1: Two-factor ANOVA for 3 probiotic bacteria freeze dried using 10% γ-PGA[S], 5% γ-PGA[S] 
and 10% sucrose. Control represents cells that were freeze dried without any cryoprotectant. 
Before freeze drying vs Control t P Value Summary 
B. breve 36.61 P<0.001 *** 
B. longum 37.29 P<0.001 *** 
L. paracasei 18.88 P<0.001 *** 
  
   Before freeze drying vs 10% Sucrose 
   B. breve 18.84 P<0.001 *** 
B. longum 17.46 P<0.001 *** 
L. paracasei 13.52 P<0.001 *** 
  
   Before freeze drying vs 10% γ-PGA[S] 
   B. breve 19.83 P<0.001 *** 
B. longum 19.30 P<0.001 *** 
L. paracasei 8.693 P<0.001 *** 
  
   Before freeze drying vs 5% γ-PGA[S] 
   B. breve 31.05 P<0.001 *** 
B. longum 32.12 P<0.001 *** 
L. paracasei 15.17 P<0.001 *** 
  
   Control vs 10% Sucrose 
   B. breve 17.77 P<0.001 *** 
B. longum 19.83 P<0.001 *** 
L. paracasei 5.368 P<0.001 *** 
  
   Control vs 10% γ-PGA[S] 
   B. breve 16.77 P<0.001 *** 
B. longum 17.99 P<0.001 *** 
L. paracasei 10.19 P<0.001 *** 
  
   Control vs 5% γ-PGA[S] 
   B. breve 5.557 P<0.001 *** 
B. longum 5.172 P<0.001 *** 
L. paracasei 3.715 P<0.01 ** 
  
   10% Sucrose vs 10% γ- PGA(S) 
   B. breve 0.9945 P > 0.05 ns 
B. longum 1.841 P > 0.05 ns 
L. paracasei 4.824 P<0.001 *** 
  
   10% Sucrose vs 5% γ-PGA[S] 
   B. breve 12.21 P<0.001 *** 
B. longum 14.66 P<0.001 *** 
L. paracasei 1.652 P > 0.05 ns 
  
   10% PGA(S) vs 5% γ-PGA[S] 
   B. breve 11.22 P<0.001 *** 
B. longum 12.82 P<0.001 *** 
L. paracasei 6.476 P<0.001 *** 
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Table 11.2: Two-factor ANOVA for change in organic acid concentration in orange juice (OJ) when free 
and γ-PGA-protected probiotic bacteria were added to it and stored at 4˚C for 39 days. (Exp = Expired; 
Con = Control [Unprotected cells]; Test = γ-PGA-protected cells). 
Organic acid t P value Summary 
Fresh OJ vs Exp OJ    
Ascorbic acid concentration mg/l 18.73 P<0.001 *** 
Citric acid concentration g/l 0.01362 P > 0.05 ns 
Malic acid concentration g/l 0.007748 P > 0.05 ns 
  
   Fresh OJ vs Breve OJ Con 
   Ascorbic acid concentration mg/l 17.86 P<0.001 *** 
Citric acid concentration g/l 0.04659 P > 0.05 ns 
Malic acid concentration g/l 0.005830 P > 0.05 ns 
  
   Fresh OJ vs Breve OJ Test 
   Organic acid t P value Summary 
Ascorbic acid concentration mg/l 16.41 P<0.001 *** 
Citric acid concentration g/l 0.1157 P > 0.05 ns 
Malic acid concentration g/l 0.02886 P > 0.05 ns 
  
   Fresh OJ vs Longum OJ Con 
   Ascorbic acid concentration mg/l 24.53 P<0.001 *** 
Citric acid concentration g/l 0.05308 P > 0.05 ns 
Malic acid concentration g/l 0.01210 P > 0.05 ns 
  
   Fresh OJ vs Longum OJ Test 
   Ascorbic acid concentration mg/l 25.08 P<0.001 *** 
Citric acid concentration g/l 0.08222 P > 0.05 ns 
Malic acid concentration g/l 0.01472 P > 0.05 ns 
  
   Exp OJ vs Breve OJ Con 
   Ascorbic acid concentration mg/l 0.8699 P > 0.05 ns 
Citric acid concentration g/l 0.03297 P > 0.05 ns 
Malic acid concentration g/l 0.001918 P > 0.05 ns 
  
   Exp OJ vs Breve OJ Test 
   Ascorbic acid concentration mg/l 2.326 P > 0.05 ns 
Citric acid concentration g/l 0.1021 P > 0.05 ns 
Malic acid concentration g/l 0.03661 P > 0.05 ns 
  
   Exp OJ vs Longum OJ Con 
   Ascorbic acid concentration mg/l 5.803 P<0.001 *** 
Citric acid concentration g/l 0.03946 P > 0.05 ns 
Malic acid concentration g/l 0.004351 P > 0.05 ns 
  
   Exp OJ vs Longum OJ Test 
   Ascorbic acid concentration mg/l 6.344 P<0.001 *** 
Citric acid concentration g/l 0.06861 P > 0.05 ns 
Malic acid concentration g/l 0.02247 P > 0.05 ns 
  
   Breve OJ Con vs Breve OJ Test 
   Ascorbic acid concentration mg/l 1.456 P > 0.05 ns 
Citric acid concentration g/l 0.06912 P > 0.05 ns 
Malic acid concentration g/l 0.03469 P > 0.05 ns 
    
Longum OJ Con vs Longum OJ Test    
Ascorbic acid concentration mg/l 
 
0.5408 P > 0.05 ns 
Citric acid concentration g/l 
 
0.02914 P > 0.05 ns 
Malic acid concentration g/l 0.02682 P > 0.05 ns 
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Table 11.3: Two-factor ANOVA for change in organic acid concentration in pomegranate juice (PJ) when 
unprotected and γ-PGA-protected probiotic bacteria were added to it and stored at 4˚C for 39 days. (Exp 
= Expired; Con = Control [Unprotected cells]; Test = γ-PGA-protected cells). 
Organic acid t P value Summary 
Fresh PJ vs Exp PJ 
   Ascorbic acid concentration mg/l 1.328 P > 0.05 ns 
Citric acid concentration g/l 0.1183 P > 0.05 ns 
Malic acid concentration g/l 1.107 P > 0.05 ns 
  
   Fresh PJ vs Breve PJ Con 
   Ascorbic acid concentration mg/l 2.391 P > 0.05 ns 
Citric acid concentration g/l 0.7395 P > 0.05 ns 
Malic acid concentration g/l 0.4063 P > 0.05 ns 
  
   Fresh PJ vs Breve PJ Test 
   Ascorbic acid concentration mg/l 1.028 P > 0.05 ns 
Citric acid concentration g/l 1.873 P > 0.05 ns 
Malic acid concentration g/l 0.2630 P > 0.05 ns 
  
   Fresh PJ vs Longum PJ Con 
   Ascorbic acid concentration mg/l 4.277 P<0.001 *** 
Citric acid concentration g/l 1.046 P > 0.05 ns 
Malic acid concentration g/l 1.003 P > 0.05 ns 
  
   Fresh PJ vs Longum PJ Test 
   Ascorbic acid concentration mg/l 9.172 P<0.001 *** 
Citric acid concentration g/l 0.2265 P > 0.05 ns 
Malic acid concentration g/l 0.6206 P > 0.05 ns 
  
   Exp PJ vs Breve PJ Con 
   Ascorbic acid concentration mg/l 1.064 P > 0.05 ns 
Citric acid concentration g/l 0.6212 P > 0.05 ns 
Malic acid concentration g/l 0.7002 P > 0.05 ns 
  
   Exp PJ vs Breve PJ Test 
   Ascorbic acid concentration mg/l 2.355 P > 0.05 ns 
Citric acid concentration g/l 1.754 P > 0.05 ns 
Malic acid concentration g/l 1.370 P > 0.05 ns 
  
   Exp PJ vs Longum PJ Con 
   Ascorbic acid concentration mg/l 2.949 P < 0.05 * 
Citric acid concentration g/l 1.164 P > 0.05 ns 
Malic acid concentration g/l 0.1036 P > 0.05 ns 
  
   Exp PJ vs Longum PJ Test 
   Ascorbic acid concentration mg/l 7.844 P<0.001 *** 
Citric acid concentration g/l 0.3447 P > 0.05 ns 
Malic acid concentration g/l 0.4859 P > 0.05 ns 
  
   Breve PJ Con vs Breve PJ Test 
   Ascorbic acid concentration mg/l 3.419 P<0.01 ** 
Citric acid concentration g/l 1.133 P > 0.05 ns 
Malic acid concentration g/l 0.6693 P > 0.05 ns 
    
Longum PJ Con vs Longum PJ Test    
  Ascorbic acid concentration mg/l 4.895 P<0.001 *** 
  Citric acid concentration g/l 0.8195 P > 0.05 ns 
  Malic acid concentration g/l 0.3823 P > 0.05 ns 
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Fig 11.1: Patent filed on 02-09-2011 for “Improved viability of probiotic microorganisms”. 
 
 
 
 
 
 
 
234 
 
  
 
 
 
Fig 11.2: Press release in Science Daily (05/09/2011) 
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Fig 11.3: Press release in Nutraingredients.com (06/09/2011) 
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Fig 11.4: Press release in The Hindu, India (06/09/2011) 
 
